BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7-33. [PMID: 33433946 DOI: 10.3322/caac.21654] [Cited by in Crossref: 6065] [Cited by in F6Publishing: 6715] [Article Influence: 3032.5] [Reference Citation Analysis]
Number Citing Articles
1 Kubala JM, Laursen KB, Schreiner R, Williams RM, van der Mijn JC, Crowley MJ, Mongan NP, Nanus DM, Heller DA, Gudas LJ. NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma. Cancer Biol Ther 2023;24:2170669. [PMID: 36722045 DOI: 10.1080/15384047.2023.2170669] [Reference Citation Analysis]
2 Yang B, Quan Y, Zhao W, Ji Y, Yang X, Li J, Li Y, Liu X, Wang Y, Li Y. Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors. J Enzyme Inhib Med Chem 2023;38:2169282. [PMID: 36656085 DOI: 10.1080/14756366.2023.2169282] [Reference Citation Analysis]
3 Negri A, Marozzi M, Trisciuoglio D, Rotili D, Mai A, Rizzi F. Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells. J Enzyme Inhib Med Chem 2023;38:2163242. [PMID: 36629431 DOI: 10.1080/14756366.2022.2163242] [Reference Citation Analysis]
4 Hao Y, Liu Q, Li R, Mao Z, Jiang N, Wang B, Zhang W, Cui B. Analysis of prognostic factors for cervical mucinous adenocarcinoma and establishment and validation a nomogram: a SEER-based study. J Obstet Gynaecol 2023;43:2153027. [PMID: 36480157 DOI: 10.1080/01443615.2022.2153027] [Reference Citation Analysis]
5 Wang Q, Cheng Y, Wang W, Tang X, Yang Y. Polyetherimide- and folic acid-modified Fe(3) O(4) nanospheres for enhanced magnetic hyperthermia performance. J Biomed Mater Res B Appl Biomater 2023;111:795-804. [PMID: 36382676 DOI: 10.1002/jbm.b.35190] [Reference Citation Analysis]
6 Scholer AJ, Marcus R, Garland-Kledzik M, Chang SC, Khader A, Santamaria-Barria J, Jutric Z, Wolf R, Goldfarb M. Validating biologic age in selecting elderly patients with pancreatic cancer for surgical resection. J Surg Oncol 2023;127:394-404. [PMID: 36321409 DOI: 10.1002/jso.27121] [Reference Citation Analysis]
7 de Queiroz LN, Da Fonseca ACC, Wermelinger GF, da Silva DPD, Pascoal ACRF, Sawaya ACHF, de Almeida ECP, do Amaral BS, de Lima Moreira D, Robbs BK. New substances of Equisetum hyemale L. extracts and their in vivo antitumoral effect against oral squamous cell carcinoma. J Ethnopharmacol 2023;303:116043. [PMID: 36535330 DOI: 10.1016/j.jep.2022.116043] [Reference Citation Analysis]
8 Zhong GC, Zhu Q, Cai D, Hu JJ, Dai X, Gong JP, Sun WP. Ultra-processed food consumption and the risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer 2023;152:835-44. [PMID: 36094042 DOI: 10.1002/ijc.34290] [Reference Citation Analysis]
9 Fernandez-Perez MP, Perez-Navarro E, Alonso-Gordoa T, Conteduca V, Font A, Vázquez-Estévez S, González-Del-Alba A, Wetterskog D, Antonarakis ES, Mellado B, Fernandez-Calvo O, Méndez-Vidal MJ, Climent MA, Duran I, Gallardo E, Rodriguez Sanchez A, Santander C, Sáez MI, Puente J, Tudela J, Martínez A, López-Andreo MJ, Padilla J, Lozano R, Hervas D, Luo J, de Giorgi U, Castellano D, Attard G, Grande E, Gonzalez-Billalabeitia E. A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide. Prostate 2023;83:376-84. [PMID: 36564933 DOI: 10.1002/pros.24469] [Reference Citation Analysis]
10 Padwal J, Baratto L, Chakraborty A, Hawk K, Spunt S, Avedian R, Daldrup-Link HE. PET/MR of pediatric bone tumors: what the radiologist needs to know. Skeletal Radiol 2023;52:315-28. [PMID: 35804163 DOI: 10.1007/s00256-022-04113-6] [Reference Citation Analysis]
11 Ng JY, Bhatt HA, Raja M. Complementary and alternative medicine mention and recommendations in pancreatic cancer clinical practice guidelines: A systematic review and quality assessment. Integr Med Res 2023;12:100921. [PMID: 36684828 DOI: 10.1016/j.imr.2023.100921] [Reference Citation Analysis]
12 Yang Y, Guo FF, Chen CF, Li YL, Liang H, Chen ZF. Antitumor activity of synthetic three copper(II) complexes with terpyridine ligands. J Inorg Biochem 2023;240:112093. [PMID: 36525715 DOI: 10.1016/j.jinorgbio.2022.112093] [Reference Citation Analysis]
13 Dang RR, Kim J, Qureshi MM, Fazeli SR, Zhao Q, Noonan VL, Sundararajan D, Salama A, Truong MT. Impact of depth of invasion on local recurrence in R0 resected node-negative oral tongue squamous cell carcinoma. Head Neck 2023;45:561-6. [PMID: 36513522 DOI: 10.1002/hed.27264] [Reference Citation Analysis]
14 Jiang A, Xu Z, Fang X, Gu D, Dong K, Wu Z, Gan X, Liu B, Ge S, Qu L, Luo P, Wang A, Wang L. RNA modification pattern‐based subtypes reveal heterogenous clinical outcomes and tumor immunity of clear cell renal cell carcinoma. MedComm – Future Medicine 2023;2. [DOI: 10.1002/mef2.30] [Reference Citation Analysis]
15 Mertens LS, Sharma V, Matin SF, Boorjian SA, Houston Thompson R, van Rhijn BW, Masson-lecomte A. Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies. European Urology Open Science 2023;49:60-66. [DOI: 10.1016/j.euros.2023.01.004] [Reference Citation Analysis]
16 Uribe Y, Brown D, Dean JR, O'Brian CA, Simon MA. Intersectionality Between Epigenetics and Cancer Health Disparities Stemming from Social Determinants of Health (SDoH) Through a Gynecologic Oncology Lens: A Narrative Review. Clin Obstet Gynecol 2023;66:53-62. [PMID: 36044628 DOI: 10.1097/GRF.0000000000000744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Felix FA, de Sena ACVP, de Arruda JAA, Tavares TS, Rocha AL, Rodrigues-Fernandes CI, de Cáceres CVBL, Vargas PA, Abreu LG, Amaral TMP, Travassos DV, de Sousa SF, Fonseca FP, Silva TA, Mesquita RA. Fine-needle aspiration cytology for the diagnosis of plasma cell neoplasms in the head and neck region: A systematic analysis of the literature. Diagn Cytopathol 2023;51:198-210. [PMID: 36576947 DOI: 10.1002/dc.25095] [Reference Citation Analysis]
18 Parise CA, Caggiano V. The association of race/ethnicity in male breast cancer survival within similar comorbidity cohorts. Cancer 2023;129:750-63. [PMID: 36597579 DOI: 10.1002/cncr.34592] [Reference Citation Analysis]
19 Zhuang L, Huang C, Ning Z, Yang L, Zou W, Wang P, Cheng CS, Meng Z. Circulating tumor-associated autoantibodies as novel diagnostic biomarkers in pancreatic adenocarcinoma. Int J Cancer 2023;152:1013-24. [PMID: 36274627 DOI: 10.1002/ijc.34334] [Reference Citation Analysis]
20 Chen T, Chen J, Zeng T, Huang Q, Chen D, Chen H, Chen J, Zheng B, Wang M, Chen S, Dai J, Sun H, Chen T, Huang Y, Zhao L, Ma S, Liu X. WZ35 inhibits gastric cancer cell metastasis by depleting glutathione to promote cellular metabolic remodeling. Cancer Lett 2023;555:216044. [PMID: 36574880 DOI: 10.1016/j.canlet.2022.216044] [Reference Citation Analysis]
21 Lao QF, Zhang QQ, Qiao ZP, Li SL, Liu L, Martin FL, Pang WY. Whole transcriptome sequencing and competitive endogenous RNA regulation network construction analysis in benzo[a]pyrene-treated breast cancer cells. Sci Total Environ 2023;861:160564. [PMID: 36455743 DOI: 10.1016/j.scitotenv.2022.160564] [Reference Citation Analysis]
22 Xia C, Yu XQ, Chen W. Measuring population-level cure patterns for cancer patients in the United States. Int J Cancer 2023;152:738-48. [PMID: 36104936 DOI: 10.1002/ijc.34291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Murugesan P, Begum H, Tangutur AD. Inhibitor of DNA binding/differentiation proteins as IDs for pancreatic cancer: Role in pancreatic cancer initiation, development and prognosis. Gene 2023;853:147092. [PMID: 36464175 DOI: 10.1016/j.gene.2022.147092] [Reference Citation Analysis]
24 Bozgeyik I, Ege M, Temiz E, Erdal B, Koyuncu I, Temiz C, Bozgeyik E, Elmastas M. Novel zinc oxide nanoparticles of Teucrium polium suppress the malignant progression of gastric cancer cells through modulating apoptotic signaling pathways and epithelial to mesenchymal transition. Gene 2023;853:147091. [PMID: 36464168 DOI: 10.1016/j.gene.2022.147091] [Reference Citation Analysis]
25 Park C, Heo JH, Mehta S, Han S, Spencer JC. Adherence to Adjuvant Endocrine Therapy and Survival Among Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer. Clin Drug Investig 2023. [PMID: 36740664 DOI: 10.1007/s40261-023-01247-w] [Reference Citation Analysis]
26 Shreves AH, Buller ID, Chase E, Creutzfeldt H, Fisher JA, Graubard BI, Hoover RN, Silverman DT, Devesa SS, Jones RR. Geographic Patterns in U.S. Lung Cancer Mortality and Cigarette Smoking. Cancer Epidemiol Biomarkers Prev 2023;32:193-201. [PMID: 36413442 DOI: 10.1158/1055-9965.EPI-22-0253] [Reference Citation Analysis]
27 Wang X, Zhang S, Jin D, Luo J, Shi Y, Zhang Y, Wu L, Song Y, Su D, Pan Z, Chen H, Cao M, Yang C, Yu W, Tian J. μ-opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial. Cancer Commun (Lond) 2023. [PMID: 36739595 DOI: 10.1002/cac2.12408] [Reference Citation Analysis]
28 Orecchini E, Belladonna ML, Pallotta MT, Volpi C, Zizi L, Panfili E, Gargaro M, Fallarino F, Rossini S, Suvieri C, Macchiarulo A, Bicciato S, Mondanelli G, Orabona C. The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma. Oncoimmunology 2023;12:2170095. [PMID: 36733497 DOI: 10.1080/2162402X.2023.2170095] [Reference Citation Analysis]
29 Johns AC, Yang M, Wei L, Grogan M, Patel SH, Li M, Husain M, Kendra KL, Otterson GA, Burkart JT, Spakowicz D, Hoyd R, Owen DH, Presley CJ. Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy. Cancer Immunol Immunother 2023. [PMID: 36738310 DOI: 10.1007/s00262-023-03371-0] [Reference Citation Analysis]
30 Zhou J, Qiu C, Tang X, Wan R, Wu Z, Zou D, Wang W, Luo Y, Liu T. Investigation of the clinicopathological and prognostic role of circMTO1 in multiple cancers. Expert Rev Mol Diagn 2023. [PMID: 36734331 DOI: 10.1080/14737159.2023.2177102] [Reference Citation Analysis]
31 Liu Y, Ouyang Y, Feng Z, Jiang Z, Ma J, Zhou X, Cai C, Han Y, Zeng S, Liu S, Shen H. RASGRP2 is a potential immune-related biomarker and regulates mitochondrial-dependent apoptosis in lung adenocarcinoma. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1100231] [Reference Citation Analysis]
32 Yamai T, Ikezawa K, Sugimoto N, Urabe M, Kai Y, Takada R, Nakabori T, Uehara H, Kawamura T, Kunimasa K, Yamamoto S, Wakamatsu T, Hayashi T, Kukita Y, Fujisawa F, Inoue T, Yamaguchi Y, Yamasaki T, Honma K, Ohkawa K. Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice. Cancers 2023;15:970. [DOI: 10.3390/cancers15030970] [Reference Citation Analysis]
33 Zhuo F, Luo S, He W, Feng Z, Hu Y, Xu J, Wang Z, Xu J. The Role of Signaling Pathways in Pancreatic Cancer Targeted Therapy. Am J Clin Oncol 2023. [PMID: 36735511 DOI: 10.1097/COC.0000000000000979] [Reference Citation Analysis]
34 Kuşoğlu A, Yangın K, Özkan SN, Sarıca S, Örnek D, Solcan N, Karaoğlu İC, Kızılel S, Bulutay P, Fırat P, Erus S, Tanju S, Dilege Ş, Öztürk E. Different Decellularization Methods in Bovine Lung Tissue Reveals Distinct Biochemical Composition, Stiffness, and Viscoelasticity in Reconstituted Hydrogels. ACS Appl Bio Mater 2023. [PMID: 36728815 DOI: 10.1021/acsabm.2c00968] [Reference Citation Analysis]
35 Sun X, Liu P. Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1073941] [Reference Citation Analysis]
36 Zhang X, Guo L, Sun Z, Han D, Zhao L. Research on the Targeted Treatment of Squamous Cell Carcinoma by Nanographene Drug Delivery System. Advances in Materials Science and Engineering 2023;2023:1-17. [DOI: 10.1155/2023/6336569] [Reference Citation Analysis]
37 Yu J, Feng H, Sang Q, Li F, Chen M, Yu B, Xu Z, Pan T, Wu X, Hou J, Zhu Z, Yan C, Su L, Li J, Liu B. VPS35 promotes cell proliferation via EGFR recycling and enhances EGFR inhibitors response in gastric cancer. EBioMedicine 2023;89:104451. [PMID: 36738481 DOI: 10.1016/j.ebiom.2023.104451] [Reference Citation Analysis]
38 Puła A, Robak P, Jarych D, Mikulski D, Misiewicz M, Drozdz I, Fendler W, Szemraj J, Robak T. The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens. IJMS 2023;24:2938. [DOI: 10.3390/ijms24032938] [Reference Citation Analysis]
39 Barbouchi K, El Hamdi D, Elouedi I, Aïcha TB, Echi AK, Slim I. A transformer‐based deep neural network for detection and classification of lung cancer via PET / CT images. Int J Imaging Syst Tech 2023. [DOI: 10.1002/ima.22858] [Reference Citation Analysis]
40 Han A, Park EG, Yoon JH, Choi JY, Park HK, Hahn S. A time-dependent subdistribution hazard model for major dental treatment events in cancer patients: a nationwide cohort study. BMC Oral Health 2023;23:64. [PMID: 36732739 DOI: 10.1186/s12903-023-02723-7] [Reference Citation Analysis]
41 Jia H, Shao Y, Zhou X, Yang G, Huang L, Aikemu B, Li S, Ding C, Fan X, Hong H, Zhang S, Pan R, Sun J. PKCδ promotes the invasion and migration of colorectal cancer through c-myc/NDRG1 pathway. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1026561] [Reference Citation Analysis]
42 Geng X, Li L, Luo Y, Yang W, Hu J, Zhao Z, Cheng C, Zhang T, Zhang Y, Liu L, Xie Y, Li G, Liu D, Bai R, Bai X, Wang G, Chen H, Wang Y, Chen H, Sun B. Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarcinoma Progression through Extracellular Vesicles Cargo MiR-4736. Adv Sci (Weinh) 2023;:e2203324. [PMID: 36727832 DOI: 10.1002/advs.202203324] [Reference Citation Analysis]
43 Ma L, Zhu K, Shi C, Chen X, Gao Y, Cai C, Wang Y. Association between the patients' symptom burden and their family caregivers' benefit finding in non-small cell lung cancer receiving combined chemotherapy. Support Care Cancer 2023;31:148. [PMID: 36729306 DOI: 10.1007/s00520-023-07590-0] [Reference Citation Analysis]
44 Han S, Yang Y, Wang T, Song R, Hu D, Peng M, Lin Z, Deng Q, Ren H, Ming J. Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer. Front Public Health 2023;11. [DOI: 10.3389/fpubh.2023.1086872] [Reference Citation Analysis]
45 Zhao K, Yang D, Zhou Y, Ding Y. Clinical Features and Prognostic Models in Patients with Intrahepatic Cholangiocarcinoma: a Population-Based Analysis. J Gastrointest Surg 2023. [PMID: 36729234 DOI: 10.1007/s11605-023-05602-2] [Reference Citation Analysis]
46 Ding S, Cheng Y, Huang Y, Gao X, Yan J, Wang L, Zhao H, Wang R, Chen S, Teng T, Liu N, Zhang M, Jin A, Hu Y. Title: Risk factors for non-infectious diarrhea of patients with multiple myeloma after chimeric antigen receptor T-cell immunotherapy: A retrospective observational study.. [DOI: 10.21203/rs.3.rs-2528277/v1] [Reference Citation Analysis]
47 Xu C, Jiang S, Ma X, Jiang Z, Pan Y, Li X, Zhang L, Zhou H, Chen S, Xing X, Chen L, Fu W, Wang Q, Chen W, Li D. CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy. Arch Toxicol 2023;97:441-56. [PMID: 36336710 DOI: 10.1007/s00204-022-03404-0] [Reference Citation Analysis]
48 Chen J, Hu J, Gu L, Ji F, Zhang F, Zhang M, Li J, Chen Z, Jiang L, Zhang Y, Shi R, Ma L, Jia S, Zhang Y, Zhang Q, Liang J, Yao S, Hu Z, Guo Z. Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer. Cancer Immunol Immunother 2023;72:409-25. [PMID: 35925286 DOI: 10.1007/s00262-022-03238-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Wang J, Li C, He K, Kuang Z, Lu J, Yao Y, He F, Li N, Li L, Fu F, Wu Z, Zhou S, Kang D, Qiu X, Wu M, Liu Y, Cao X, Xu M, Chen B, Wu W, Guo F. Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies. Cancer Immunol Immunother 2023;72:493-507. [PMID: 35963895 DOI: 10.1007/s00262-022-03267-5] [Reference Citation Analysis]
50 Song YQ, Hong J, Wang JY, Peng J, Han JH, Luo HL. Dosimetric comparison of different intensity-modulated radiotherapy techniques for whole-breast irradiation of right-breast cancer. Cancer Radiother 2023;27:11-6. [PMID: 35879144 DOI: 10.1016/j.canrad.2022.04.009] [Reference Citation Analysis]
51 Fang X, Zhang T, Chen Z. Solute Carrier Family 7 Member 11 (SLC7A11) is a Potential Prognostic Biomarker in Uterine Corpus Endometrial Carcinoma. IJGM 2023;Volume 16:481-497. [DOI: 10.2147/ijgm.s398351] [Reference Citation Analysis]
52 Gunder LC, Moyer TH, Johnson HR, Auyeung AS, Leverson GE, Zhang W, Matkowskyj KA, Carchman EH. Anal Cancer Prevention Through the Topical Use of Single or Dual PI3K/mTOR Inhibitors. J Surg Res 2023;282:137-46. [PMID: 36274448 DOI: 10.1016/j.jss.2022.09.025] [Reference Citation Analysis]
53 Gon Y, Zha L, Sasaki T, Morishima T, Ohno Y, Mochizuki H, Sobue T, Miyashiro I. Stroke mortality in cancer survivors: A population-based study in Japan. Thromb Res 2023;222:140-8. [PMID: 36682150 DOI: 10.1016/j.thromres.2023.01.005] [Reference Citation Analysis]
54 Gristina V, La Mantia M, Peri M, Iacono F, Barraco N, Perez A, Viscardi G, Cutaia S, Russo TDB, Anwar Z, Incorvaia L, Fulfaro F, Vieni S, Pantuso G, Graceffa G, Russo A, Galvano A, Bazan V. Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible. Crit Rev Oncol Hematol 2023;182:103899. [PMID: 36596401 DOI: 10.1016/j.critrevonc.2022.103899] [Reference Citation Analysis]
55 Huang J, Tong Y, Hong J, Huang O, Wu J, He J, Chen W, Li Y, Chen X, Shen K. Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial. Breast Cancer Res Treat 2023;197:525-33. [PMID: 36525180 DOI: 10.1007/s10549-022-06821-y] [Reference Citation Analysis]
56 Palmieri R, Montgomery RB, Doney K. Allogeneic stem cell transplantation in patients with a prior history of prostate cancer. Ann Hematol 2023;102:407-12. [PMID: 36394580 DOI: 10.1007/s00277-022-05041-0] [Reference Citation Analysis]
57 Wu J, Wang X, Chen L, Wang J, Zhang J, Tang J, Ji Y, Song J, Wang L, Zhao Y, Zhang H, Li T, Sheng J, Chen D, Zhang Q, Liang T. Oxygen microcapsules improve immune checkpoint blockade by ameliorating hypoxia condition in pancreatic ductal adenocarcinoma. Bioactive Materials 2023;20:259-70. [DOI: 10.1016/j.bioactmat.2022.05.022] [Reference Citation Analysis]
58 Lee EE, Singh T, Hu C, Han M, Deville CJ, Halthore A, Greco S, Tran P, Deweese T, Song DY. The impact of salvage radiotherapy initiation at PSA ≤ 0.5 ng/ml on metastasis‐free survival in patients with relapsed prostate cancer following prostatectomy. The Prostate 2023;83:190-197. [DOI: 10.1002/pros.24452] [Reference Citation Analysis]
59 Mima K, Hayashi H, Yumoto S, Matsumoto T, Tsukamoto M, Miyata T, Nakagawa S, Nitta H, Baba H. Disability in perioperative activities of daily living is associated with worse survival outcomes following hepatic resection in patients with intrahepatic cholangiocarcinoma. Hepatol Res 2023;53:135-44. [PMID: 36305859 DOI: 10.1111/hepr.13849] [Reference Citation Analysis]
60 Geng A, Xiao J, Dong B, Yuan S. Analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1071076] [Reference Citation Analysis]
61 Chan Y, Tan H, Lu Y, Zhang C, Cheng C, Wu J, Wang N, Feng Y. Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis. Acta Pharmaceutica Sinica B 2023. [DOI: 10.1016/j.apsb.2023.01.020] [Reference Citation Analysis]
62 Solow M, Perry TE. Multimodal prehabilitation program valuation for thoracic surgical patients. Curr Opin Anaesthesiol 2023;36:61-7. [PMID: 36550606 DOI: 10.1097/ACO.0000000000001212] [Reference Citation Analysis]
63 Liu B, Wang H, Wang X, Long J, Zhuang X, Ji X, Zhu N, Li J, Gao T, Zhang X, Yu J, Zhao S. Four‐gene signature based on machine learning filtration could predict prognosis of patients with breast cancer. Expert Systems 2023;40. [DOI: 10.1111/exsy.13157] [Reference Citation Analysis]
64 Li Y, Wei C, Huang C, Ling Q, Zhang L, Huang S, Liao N, Liang W, Cheng J, Wang F, Mo L, Mo Z, Li L. Long noncoding RNA as a potential diagnostic tool for prostate cancer: a systematic review and meta-analysis. Biomarkers 2023;28:1-10. [PMID: 36323640 DOI: 10.1080/1354750X.2022.2142293] [Reference Citation Analysis]
65 Avulova S, Benidir T, Cheville JC, Packiam VT, Shah P, Frank I, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Kulkarni G, Boorjian SA. Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy. Arch Pathol Lab Med 2023;147:202-7. [PMID: 35700531 DOI: 10.5858/arpa.2021-0409-OA] [Reference Citation Analysis]
66 Knape N, Park JH, Agala CB, Spanheimer P, Morrow M, Downs-Canner S, Baldwin XL. Can We Forgo Sentinel Lymph Node Biopsy in Women Aged ≥ 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer? Ann Surg Oncol 2023;30:1042-50. [PMID: 36217063 DOI: 10.1245/s10434-022-12626-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Wen B, Li S, Ruan L, Yang Y, Chen Z, Zhang B, Yang X, Jie H, Li S, Zeng Z, Liu S. Engulfment and cell motility protein 1 fosters reprogramming of tumor-associated macrophages in colorectal cancer. Cancer Sci 2023;114:410-22. [PMID: 36310143 DOI: 10.1111/cas.15628] [Reference Citation Analysis]
68 Yang Y, Qin H, Ding M, Ji C, Chen W, Diao W, Yin H, Chen M, Gan W, Guo H. Small ankyrin 1 (sANK1) promotes docetaxel resistance in castration-resistant prostate cancer cells by enhancing oxidative phosphorylation. FEBS Open Bio 2023;13:257-69. [PMID: 36508323 DOI: 10.1002/2211-5463.13535] [Reference Citation Analysis]
69 Kouchi Y, Takano S, Harada-kagitani S, Shinomiya Y, Yogi N, Sakamoto T, Mishima T, Fugo K, Kambe M, Nagai Y, Nakatani Y, Ikeda J, Ohtsuka M, Kishimoto T. Complex glandular pattern is an aggressive morphology that predicts poor prognosis of pancreatic ductal adenocarcinoma. Annals of Diagnostic Pathology 2023. [DOI: 10.1016/j.anndiagpath.2023.152110] [Reference Citation Analysis]
70 Sorin M, Rezanejad M, Karimi E, Fiset B, Desharnais L, Perus LJM, Milette S, Yu MW, Maritan SM, Doré S, Pichette É, Enlow W, Gagné A, Wei Y, Orain M, Manem VSK, Rayes R, Siegel PM, Camilleri-Broët S, Fiset PO, Desmeules P, Spicer JD, Quail DF, Joubert P, Walsh LA. Single-cell spatial landscapes of the lung tumour immune microenvironment. Nature 2023. [PMID: 36725934 DOI: 10.1038/s41586-022-05672-3] [Reference Citation Analysis]
71 Xie Z, Xu J, Xiao D, Lei J, Yu J. Dual regulation of Akt and glutathione caused by isoalantolactone effectively triggers human ovarian cancer cell apoptosis. Acta Biochim Biophys Sin (Shanghai) 2023. [PMID: 36727416 DOI: 10.3724/abbs.2023003] [Reference Citation Analysis]
72 Wang Y, Tahiri H, Yang C, Gu M, Ruan X, Hardy P. Overexpression of miR-181a regulates the Warburg effect in triple-negative breast cancer. Climacteric 2023;26:64-71. [PMID: 36459490 DOI: 10.1080/13697137.2022.2147821] [Reference Citation Analysis]
73 Tanutit P, Pakdee W, Laohawiriyakamol T, Iamthanaporn K. Magnetic resonance imaging in differentiating between aggressive and non-aggressive bone tumors. Acta Radiol 2023;64:625-37. [PMID: 35306878 DOI: 10.1177/02841851221082098] [Reference Citation Analysis]
74 Ma T, Miao H, Xiong Y, Ma Y, Dong Z. CircRNA circ-PDCD11 is highly expressed in lung large-cell carcinoma and predicts poor survival. Immunopharmacol Immunotoxicol 2023;45:89-93. [PMID: 36017647 DOI: 10.1080/08923973.2022.2117628] [Reference Citation Analysis]
75 Russell MC, Garelli AM, Reeves DJ. Targeting EGFR Exon 20 Insertion Mutation in Non-small cell Lung Cancer: Amivantamab and Mobocertinib. Ann Pharmacother 2023;57:198-206. [PMID: 35652704 DOI: 10.1177/10600280221098398] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
76 Lyu Y, Chen Y, Meng L, Guo J, Zhan X, Chen Z, Yan W, Zhang Y, Zhao X, Zhang Y. Combination of ultrafast dynamic contrast-enhanced MRI-based radiomics and artificial neural network in assessing BI-RADS 4 breast lesions: Potential to avoid unnecessary biopsies. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1074060] [Reference Citation Analysis]
77 Samora NL, Al Hussein Al Awamlh B, Tosoian JJ. Combined Use of Magnetic Resonance Imaging and Biomarker Testing to Detect Clinically Significant Prostate Cancer. Urologic Clinics of North America 2023;50:91-107. [DOI: 10.1016/j.ucl.2022.09.008] [Reference Citation Analysis]
78 Molony RD, Kerns SL, Marples B, Oshodi E, Chen Y, Lee Y. Postradiotherapy Urinary Extracellular Vesicle Concentrations Predict Late Bladder Toxicity in Patients with Prostate Cancer. JU Open Plus 2023;1. [DOI: 10.1097/ju9.0000000000000009] [Reference Citation Analysis]
79 Guo X, Lin Y, Shen C, Li Y, Zeng X, Lv J, Xiang F, Ruan T, Wu C, Tao K. Comparative Study of Short-Term Efficacy and Safety of Radical Surgery with or without Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer with T4 Stage: A Propensity Score Matching Analysis. JCM 2023;12:1145. [DOI: 10.3390/jcm12031145] [Reference Citation Analysis]
80 Qin K, Xin S, Li G, Zhou K, Pan R, Chen S, Tao T, Li C, Tao J, Han RPS, Tu Y. In vivo near-infrared fluorescence and SPECT-CT imaging of colorectal Cancer using the bradykinin B2R-specific ligand icatibant. J Photochem Photobiol B 2023;239:112648. [PMID: 36641883 DOI: 10.1016/j.jphotobiol.2023.112648] [Reference Citation Analysis]
81 Zhang Q, Fei S, Zhao Y, Liu S, Wu X, Lu L, Chen W. PUS7 promotes the proliferation of colorectal cancer cells by directly stabilizing SIRT1 to activate the Wnt/β-catenin pathway. Mol Carcinog 2023;62:160-73. [PMID: 36222184 DOI: 10.1002/mc.23473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Teke K, Erkut Avci I, Burak Cinar N, Abdullah Baynal E, Bosnali E, Polat S, Yilmaz H, Kara O, Dillioglugil O. El estado inmunológico-inflamatorio-nutricional predice los resultados oncológicos tras la cistectomía radical por carcinoma urotelial de vejiga. Actas Urológicas Españolas 2023. [DOI: 10.1016/j.acuro.2022.12.006] [Reference Citation Analysis]
83 Hou Y, Zi J, Liu S, Ge Q, Ge Z. Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing. Mol Carcinog 2023;62:200-9. [PMID: 36300887 DOI: 10.1002/mc.23476] [Reference Citation Analysis]
84 Matos LL, Guimarães YLM, Leite AK, Cernea CR. Management of Stage III Oral Cavity Squamous Cell Carcinoma in Light of the New Staging System: a Critical Review. Curr Oncol Rep 2023;25:107-13. [PMID: 36585962 DOI: 10.1007/s11912-022-01353-6] [Reference Citation Analysis]
85 Xie L, Cheng L, Wei Y. Mitomycin C enhanced the antitumor efficacy of Rocaglamide in colorectal cancer. Pathology - Research and Practice 2023. [DOI: 10.1016/j.prp.2023.154350] [Reference Citation Analysis]
86 Smeltzer MP, Liao W, Faris NR, Fehnel C, Goss J, Shepherd CJ, Ramos R, Qureshi T, Mukhopadhyay A, Ray MA, Osarogiagbon RU. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening. J Thorac Oncol 2023;18:158-68. [PMID: 36208717 DOI: 10.1016/j.jtho.2022.09.220] [Reference Citation Analysis]
87 Kang Y, Sundaramoorthy P, Gasparetto C, Feinberg D, Fan S, Long G, Sellars E, Garrett A, Tuchman SA, Reeves BN, Li Z, Liu B, Ogretmen B, Maines L, Ben-Yair VK, Smith C, Plasse T. Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma. Ann Hematol 2023;102:369-83. [PMID: 36460794 DOI: 10.1007/s00277-022-05056-7] [Reference Citation Analysis]
88 Auriemma F, Dabizzi E, Facciorusso A, Carrara S, de Nucci G, Manes G, Lamonaca L, Paduano D, Ofosu A, Crinò SF, Repici A, Mangiavillano B. The role of rectal endoscopic ultrasonography plus fine needle aspirartion and fine needle biopsy in pelvic masses. Eur J Gastroenterol Hepatol 2023;35:153-8. [PMID: 36574305 DOI: 10.1097/MEG.0000000000002468] [Reference Citation Analysis]
89 Xu P, Wang L, Mo B, Xie X, Hu R, Jiang L, Hu F, Ding F, Xiao H. Identification of NLE1/CDK1 axis as key regulator in the development and progression of non-small cell lung cancer. Front Oncol 2023;12. [DOI: 10.3389/fonc.2022.985827] [Reference Citation Analysis]
90 Cheung YM, Hoermann R, Van K, Wu D, Healy J, Chao M, White S, Yeo B, Zajac J, Grossmann M. Effects of aromatase inhibitor therapy on visceral adipose tissue area and cardiometabolic health in postmenopausal women with early and locally advanced breast cancer. Clin Endocrinol (Oxf) 2023;98:190-201. [PMID: 36271726 DOI: 10.1111/cen.14839] [Reference Citation Analysis]
91 Okano N, Matsuki R, Toki M, Gondo K, Ochiai K, Watanabe S, Tateishi H, Kogure M, Suzuki Y, Sugiyama M, Nagashima F, Shibahara J, Sakamoto Y, Furuse J. A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Cancer. Intern Med 2023;62:327-34. [PMID: 35793961 DOI: 10.2169/internalmedicine.9504-22] [Reference Citation Analysis]
92 Hernandez L, Young M. The budget impact of introducing mobocertinib for the postplatinum treatment of advanced non-small cell lung cancer harboring epidermal growth factor receptor exon 20 insertion mutations. J Manag Care Spec Pharm 2023;29:172-86. [PMID: 36373869 DOI: 10.18553/jmcp.2022.22251] [Reference Citation Analysis]
93 Zhan Z, Guo W, Wan X, Bai O. Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors. Ann Hematol 2023;102:249-59. [PMID: 36622391 DOI: 10.1007/s00277-023-05095-8] [Reference Citation Analysis]
94 Ziogas DC, Theocharopoulos C, Koutouratsas T, Haanen J, Gogas H. Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome? Cancer Treat Rev 2023;113:102499. [PMID: 36542945 DOI: 10.1016/j.ctrv.2022.102499] [Reference Citation Analysis]
95 Cheng Y, Ouyang W, Jie C, Zhang J, Yu J, Xie C. A case of late and lethal Trousseau's syndrome induced by pembrolizumab in lung adenocarcinoma. Immunotherapy 2023;15:71-5. [PMID: 36628567 DOI: 10.2217/imt-2022-0018] [Reference Citation Analysis]
96 Wu Q, Wu C, Xie X. Efficacy and Safety of Immune Checkpoint Inhibitors in Triple-negative Breast Cancer: A Study Based on 41 Cohorts Incorporating 6558 Participants. J Immunother 2023;46:29-42. [PMID: 36378154 DOI: 10.1097/CJI.0000000000000447] [Reference Citation Analysis]
97 Ding L, Qi H, Wang Y, Zhang Z, Liu Q, Guo C, Liu J, Chen Z, Li J, Chen J, Huang Q, Zhao D, Wang Z, Li X. Recent advances in ginsenosides against respiratory diseases: Therapeutic targets and potential mechanisms. Biomed Pharmacother 2023;158:114096. [PMID: 36502752 DOI: 10.1016/j.biopha.2022.114096] [Reference Citation Analysis]
98 Zhao S, Yue W, Wang H, Yao J, Peng C, Liu X, Xu D. Combined Conventional Ultrasound and Contrast-Enhanced Computed Tomography for Cervical Lymph Node Metastasis Prediction in Papillary Thyroid Carcinoma. J Ultrasound Med 2023;42:385-98. [PMID: 35634760 DOI: 10.1002/jum.16024] [Reference Citation Analysis]
99 Chupradit S, Widjaja G, Radhi Majeed B, Kuznetsova M, Ansari MJ, Suksatan W, Turki Jalil A, Ghazi Esfahani B. Recent advances in cold atmospheric plasma (CAP) for breast cancer therapy. Cell Biol Int 2023;47:327-40. [PMID: 36342241 DOI: 10.1002/cbin.11939] [Reference Citation Analysis]
100 Duan L, Chen YA, Liang Y, Chen Z, Lu J, Fang Y, Cao J, Lu J, Zhao H, Pong RC, Hernandez E, Kapur P, Tran TAT, Smith T, Martinez ED, Ahn JM, Hsieh JT, Luo JH, Liu ZP. Therapeutic targeting of histone lysine demethylase KDM4B blocks the growth of castration-resistant prostate cancer. Biomed Pharmacother 2023;158:114077. [PMID: 36495660 DOI: 10.1016/j.biopha.2022.114077] [Reference Citation Analysis]
101 O'Hern K, Barney R, Chambers M, Baker C, Stevanovic M, Tsongalis GJ, Hughes E, Sriharan A. A novel method to assess copy number variation in melanoma: Droplet digital PCR for precise quantitation of the RREB1 gene in formalin-fixed, paraffin-embedded melanocytic neoplasms, a proof-of-concept study. J Cutan Pathol 2023;50:169-77. [PMID: 36325821 DOI: 10.1111/cup.14352] [Reference Citation Analysis]
102 Tang S, Kapoor E, Ding L, Yu A, Tang W, Hang Y, Smith LM, Sil D, Oupický D. Effect of tocopherol conjugation on polycation-mediated siRNA delivery to orthotopic pancreatic tumors. Biomater Adv 2023;145:213236. [PMID: 36512927 DOI: 10.1016/j.bioadv.2022.213236] [Reference Citation Analysis]
103 Chang YS, Tu SJ, Chen HD, Hsu MH, Chen YC, Chao DS, Chung CC, Chou YP, Chang CM, Lee YT, Yen JC, Jeng LB, Chang JG. Integrated genomic analyses of hepatocellular carcinoma. Hepatol Int 2023;17:97-111. [PMID: 36472800 DOI: 10.1007/s12072-022-10455-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Zhang J, Li Y, Jiang M, Qiu H, Li Y, Gu M, Yin S. Self-Assembled Aza-BODIPY and Iron(III) Nanoparticles for Photothermal-Enhanced Chemodynamic Therapy in the NIR-II Window. ACS Biomater Sci Eng 2023. [PMID: 36725684 DOI: 10.1021/acsbiomaterials.2c01539] [Reference Citation Analysis]
105 Tang B, Wang Y, Xu W, Zhu J, Weng Q, Chen W, Fang S, Yang Y, Qiu R, Chen M, Mao W, Xu M, Zhao Z, Cai S, Zhang H, Ji J. Macrophage xCT deficiency drives immune activation and boosts responses to immune checkpoint blockade in lung cancer. Cancer Lett 2023;554:216021. [PMID: 36455758 DOI: 10.1016/j.canlet.2022.216021] [Reference Citation Analysis]
106 Brawley OW, Lansey DG. Disparities in Breast Cancer Outcomes and How to Resolve Them. Hematology/Oncology Clinics of North America 2023;37:1-15. [DOI: 10.1016/j.hoc.2022.08.002] [Reference Citation Analysis]
107 Sheth VR. Editorial for "Amide Proton Transfer-Weighted Imaging Combined With Intravoxel Incoherent Motion for Evaluating Microsatellite Instability in Endometrial Cancer". J Magn Reson Imaging 2023;57:506-7. [PMID: 35713324 DOI: 10.1002/jmri.28302] [Reference Citation Analysis]
108 Price JB. Digital Imaging. Clinical Applications of Digital Dental Technology 2023. [DOI: 10.1002/9781119800613.ch1] [Reference Citation Analysis]
109 Liu J, Wang X, Sahin IH, Imanirad I, Felder SI, Kim RD, Xie H. Tumor Response-speed Heterogeneity as a Novel Prognostic Factor in Patients With Metastatic Colorectal Cancer. Am J Clin Oncol 2023;46:50-7. [PMID: 36606664 DOI: 10.1097/COC.0000000000000972] [Reference Citation Analysis]
110 Deng T, Luo D, Zhang R, Zhao R, Hu Y, Zhao Q, Wang S, Iqbal MZ, Kong X. DOX-loaded hydroxyapatite nanoclusters for colorectal cancer (CRC) chemotherapy: Evaluation based on the cancer cells and organoids. SLAS Technol 2023;28:22-31. [PMID: 36328181 DOI: 10.1016/j.slast.2022.10.002] [Reference Citation Analysis]
111 Stefura T, Rusinek J, Wątor J, Zagórski A, Zając M, Libondi G, Wysocki WM, Koziej M. Implant vs. autologous tissue-based breast reconstruction: A systematic review and meta-analysis of the studies comparing surgical approaches in 55,455 patients. J Plast Reconstr Aesthet Surg 2023;77:346-58. [PMID: 36621238 DOI: 10.1016/j.bjps.2022.11.044] [Reference Citation Analysis]
112 Bowling GC, Rands MG, Dobi A, Eldhose B. Emerging Developments in ETS-Positive Prostate Cancer Therapy. Mol Cancer Ther 2023;22:168-78. [PMID: 36511830 DOI: 10.1158/1535-7163.MCT-22-0527] [Reference Citation Analysis]
113 Wei M, Su J, Zhang J, Liu S, Ma J, Meng XP. Construction of a DDR-related signature for predicting of prognosis in metastatic colorectal carcinoma. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1043160] [Reference Citation Analysis]
114 Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH. Prolonged endocrine therapy in the management of hormone receptor-positive early-stage breast cancer: What is the appropriate duration? J Obstet Gynaecol Res 2023. [PMID: 36725670 DOI: 10.1111/jog.15553] [Reference Citation Analysis]
115 Pu Y, Wu W, Xiang H, Chen Y, Xu H. CRISPR/Cas9-based genome editing for multimodal synergistic cancer nanotherapy. Nano Today 2023;48:101734. [DOI: 10.1016/j.nantod.2022.101734] [Reference Citation Analysis]
116 Imazu Y, Matsuo Y, Hokuto D, Yasuda S, Yoshikawa T, Kamitani N, Yoshida C, Sasaki T, Sho M. Distinct role of tumor-infiltrating lymphocytes between synchronous and metachronous colorectal cancer. Langenbecks Arch Surg 2023;408:72. [PMID: 36720759 DOI: 10.1007/s00423-023-02815-6] [Reference Citation Analysis]
117 Yu ZL, Liu J, Ning ZK, Tian HK, Wu X, Huang YF, Wu ZC, Zong Z, Zhou TC. The TGF-β/Smad(2/3) signaling pathway is involved in Musashi2-induced invasion and metastasis of colorectal cancer. Mol Carcinog 2023;62:261-76. [PMID: 36345938 DOI: 10.1002/mc.23484] [Reference Citation Analysis]
118 Hou W, Huang H, Wu X, Lan J. Bioactivities and mechanism of action of securinega alkaloids derivatives reported prior to 2022. Biomedicine & Pharmacotherapy 2023;158:114190. [DOI: 10.1016/j.biopha.2022.114190] [Reference Citation Analysis]
119 Rossin G, Zorzi F, Ongaro L, Piasentin A, Vedovo F, Liguori G, Zucchi A, Simonato A, Bartoletti R, Trombetta C, Pavan N, Claps F. Artificial Intelligence in Bladder Cancer Diagnosis: Current Applications and Future Perspectives. BioMedInformatics 2023;3:104-114. [DOI: 10.3390/biomedinformatics3010008] [Reference Citation Analysis]
120 Ranjitha Guttapadu, Teesta Katte, Deepak Sayeeram, Saloni Bhatia, Anika Rachel Abraham, Kiran Rajeev, Anish Raju R. Amara, Sharadhi Siri, Kavitha Bommana, Avinash Arvind Rasalkar, Rajyalakshmi Malempati, Mohammed S. Mustak, Prathibha Narayanan, S. Divijendra Natha Reddy. Identification of novel biomarkers for lung squamous cell carcinoma. 3 Biotech 2023;13:72. [ DOI: 10.1007/s13205-023-03489-z] [Reference Citation Analysis]
121 Yu Q, Wang Y, Yi G, Yang W, Chen K, Tan X, Zhang X, Xu Z, Yang Z, Peng Y. BDNF is a prognostic biomarker involved in immune infiltration of lung adenocarcinoma and is associated with brain metastasis. Immunology 2023;168:320-30. [PMID: 36151890 DOI: 10.1111/imm.13581] [Reference Citation Analysis]
122 Sun K, Yao H, Zhang P, Sun Y, Ma J, Xia Q. Emerging landscape of circFNDC3B and its role in human malignancies. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1097956] [Reference Citation Analysis]
123 Ragusa D, Dijkhuis L, Pina C, Tosi S. Mechanisms associated with t(7;12) acute myeloid leukaemia: from genetics to potential treatment targets. Biosci Rep 2023;43:BSR20220489. [PMID: 36622782 DOI: 10.1042/BSR20220489] [Reference Citation Analysis]
124 Kokkali S, Kyriazoglou A, Mangou E, Economopoulou P, Panousieris M, Psyrri A, Ardavanis A, Vassos N, Boukovinas I. Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers. JCM 2023;12:1119. [DOI: 10.3390/jcm12031119] [Reference Citation Analysis]
125 Yang C, Shao Y, Wang X, Wang J, Wang P, Huang C, Wang W, Wang J. The Effect of the Histone Chaperones HSPA8 and DEK on Tumor Immunity in Hepatocellular Carcinoma. IJMS 2023;24:2653. [DOI: 10.3390/ijms24032653] [Reference Citation Analysis]
126 Tong J, Tan X, Hao S, Ermine K, Lu X, Liu Z, Jha A, Yu J, Zhang L. Inhibition of multiple CDKs potentiates colon cancer chemotherapy via p73-mediated DR5 induction. Oncogene 2023. [PMID: 36721000 DOI: 10.1038/s41388-023-02598-6] [Reference Citation Analysis]
127 Ozato Y, Kojima Y, Kobayashi Y, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Kagawa K, Goto Y, Utou M, Fukunaga M, Gamachi A, Imamura K, Kuze Y, Zenkoh J, Suzuki A, Niida A, Hirose H, Hayashi S, Koseki J, Oki E, Fukuchi S, Murakami K, Tobo T, Nagayama S, Uemura M, Sakamoto T, Oshima M, Doki Y, Eguchi H, Mori M, Iwasaki T, Oda Y, Shibata T, Suzuki Y, Shimamura T, Mimori K. Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer. Cell Rep 2023;42:111929. [PMID: 36656712 DOI: 10.1016/j.celrep.2022.111929] [Reference Citation Analysis]
128 Acquati C, Miller-sonet E, Zhang A, Ionescu E. Social Wellbeing in Cancer Survivorship: A Cross-Sectional Analysis of Self-Reported Relationship Closeness and Ambivalence from a Community Sample. Current Oncology 2023;30:1720-1732. [DOI: 10.3390/curroncol30020133] [Reference Citation Analysis]
129 Katleba KD, Tsamouri MM, Jathal M, Baek HB, Armenta RB, Tepper CG, Cortopassi G, Ghosh PM, Mudryj M. Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells. Sci Rep 2023;13:1762. [PMID: 36720985 DOI: 10.1038/s41598-023-28692-z] [Reference Citation Analysis]
130 Qian Y, Wang J, Bu W, Zhu X, Zhang P, Zhu Y, Fan X, Wang C. Targeted implementation strategies of precise photodynamic therapy based on clinical and technical demands. Biomater Sci 2023;11:704-18. [PMID: 36472233 DOI: 10.1039/d2bm01384c] [Reference Citation Analysis]
131 Yu J, Li G, Tian Y, Huo S. Establishment of a Lymph Node Metastasis-Associated Prognostic Signature for Lung Adenocarcinoma. Genetics Research 2023;2023:1-15. [DOI: 10.1155/2023/6585109] [Reference Citation Analysis]
132 Zhang C, Lu X, Liu X, Xu J, Li J, Qu T, Dai J, Guo R. Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer. Oxidative Medicine and Cellular Longevity 2023;2023:1-21. [DOI: 10.1155/2023/1367938] [Reference Citation Analysis]
133 Garg H, Whalen P, Marji H, Cooper R, Dursun F, Bhandari M, Khanna L, Jayakumar L, Liss MA, Svatek RS, Rodriguez R, Kaushik D, Pruthi DK. Patency outcomes of primary Inferior vena cava repair in radical nephrectomy & tumor thrombectomy. J Vasc Surg Venous Lymphat Disord 2023:S2213-333X(23)00055-0. [PMID: 36736700 DOI: 10.1016/j.jvsv.2023.01.004] [Reference Citation Analysis]
134 Cheng G, Guo J, Wang R, Yuan JM, Balbo S, Hecht SS. Quantitation by Liquid Chromatography-Nanoelectrospray Ionization-High-Resolution Tandem Mass Spectrometry of Multiple DNA Adducts Related to Cigarette Smoking in Oral Cells in the Shanghai Cohort Study. Chem Res Toxicol 2023. [PMID: 36719849 DOI: 10.1021/acs.chemrestox.2c00393] [Reference Citation Analysis]
135 Zhu S, Al-Mathkour M, Cao L, Khalafi S, Chen Z, Poveda J, Peng D, Lu H, Soutto M, Hu T, McDonald OG, Zaika A, El-Rifai W. CDK1 bridges NF-κB and β-catenin signaling in response to H. pylori infection in gastric tumorigenesis. Cell Rep 2023;42:112005. [PMID: 36681899 DOI: 10.1016/j.celrep.2023.112005] [Reference Citation Analysis]
136 Teke K, Erkut Avci I, Burak Cinar N, Abdullah Baynal E, Bosnali E, Polat S, Yilmaz H, Kara O, Dillioglugil O. Immune-inflammatory-nutritional status predicts oncologic outcomes after radical cystectomy for urothelial carcinoma of bladder. Actas Urol Esp (Engl Ed) 2023:S2173-5786(23)00003-3. [PMID: 36731820 DOI: 10.1016/j.acuroe.2023.01.001] [Reference Citation Analysis]
137 Kerdjoudj M, De La Torre RA, Arnouk H. Characterization of DJ-1, PTEN, and p-Akt as Prognostic Biomarkers in the Progression of Oral Squamous Cell Carcinoma. Cureus 2023. [DOI: 10.7759/cureus.34436] [Reference Citation Analysis]
138 Zhang J, Zhang Z, Mao N, Zhang H, Gao J, Wang B, Ren J, Liu X, Zhang B, Dou T, Li W, Wang Y, Jia H. Radiomics nomogram for predicting axillary lymph node metastasis in breast cancer based on DCE-MRI: A multicenter study. XST 2023. [DOI: 10.3233/xst-221336] [Reference Citation Analysis]
139 Jyoti K, Malik G, Chaudhary M, Madan J, Kamboj A. Hyaluronate decorated polyethylene glycol linked poly(lactide-co-glycolide) nanoparticles encapsulating MUC-1 peptide augmented mucosal immune response in Balb/c mice through inhalation route. Biochim Biophys Acta Gen Subj 2023;:130317. [PMID: 36731729 DOI: 10.1016/j.bbagen.2023.130317] [Reference Citation Analysis]
140 Han S, Jiang D, Zhang F, Li K, Jiao K, Hu J, Song H, Ma Q, Wang J. A new immune signature for survival prediction and immune checkpoint molecules in non-small cell lung cancer. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1095313] [Reference Citation Analysis]
141 Zhang H, Wang C, Liu Y, Hu H, Tang Q, Huang R, Wang M, Wang G. The optimal minimum lymph node count for carcinoembryonic antigen elevated colon cancer: a population-based study in the SEER set and External set. BMC Cancer 2023;23:100. [PMID: 36710327 DOI: 10.1186/s12885-023-10524-y] [Reference Citation Analysis]
142 Zhang B, Xu Z, Gu W, Zhou J, Tang N, Zhang S, Chen C, Zhang Z. Postoperative complications and short-term prognosis of laparoscopic pancreaticoduodenectomy vs. open pancreaticoduodenectomy for treating pancreatic ductal adenocarcinoma: a retrospective cohort study. World J Surg Oncol 2023;21:26. [PMID: 36710324 DOI: 10.1186/s12957-023-02909-x] [Reference Citation Analysis]
143 Lv Y, Du X, Tang W, Yang Q, Gao F. Exosomes: The Role in Tumor Tolerance and the Potential Strategy for Tumor Therapy. Pharmaceutics 2023;15:462. [DOI: 10.3390/pharmaceutics15020462] [Reference Citation Analysis]
144 Shingala K, Stavros S, Parag S, Tercek A, Makhani SS, Bouz A, Galbo A, Chung-bridges K. Racial Disparities in Survival Outcomes of Patients With Serous Epithelial Ovarian Cancer: A Retrospective Cohort Analysis. Cureus 2023. [DOI: 10.7759/cureus.34389] [Reference Citation Analysis]
145 Wang K, Chen Y, Zhang Y, Liu S, Ao M, Yang H, Li B. Exploration of Immunogenic Cell Death-Associated Genes for Predicting Prognosis and Immunological Characteristics in Cervical Squamous Cell Carcinoma. Journal of Oncology 2023;2023:1-13. [DOI: 10.1155/2023/1405635] [Reference Citation Analysis]
146 Yang J, Zhao B, Ling X, Li D, Zhao J, Lv Y, Wang G, Liu X, Li N, Yang J. Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China. BMC Cancer 2023;23:103. [PMID: 36717797 DOI: 10.1186/s12885-023-10568-0] [Reference Citation Analysis]
147 Xun X, Ai J, Feng F, Hong P, Rai S, Liu R, Zhang B, Zhou Y, Hu H. Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysis. Front Pharmacol 2023;14. [DOI: 10.3389/fphar.2023.1108772] [Reference Citation Analysis]
148 Feng K, Xu Z, Wang Y, Wu X, Xiong F, Ruan Y, Wu X, Ye L, Su D, Yu J, Sun X. Renal-clearable porous hollow copper iron oxide nanoparticles for trimodal chemodynamic-photothermal-chemo anti-tumor therapy. Nanoscale 2023. [PMID: 36723141 DOI: 10.1039/d2nr06224k] [Reference Citation Analysis]
149 Wu M, Gao H. A prediction model for in-hospital mortality in intensive care unit patients with metastatic cancer. Front Surg 2023;10. [DOI: 10.3389/fsurg.2023.992936] [Reference Citation Analysis]
150 Nerella SG, Singh P, Thacker PS, Arifuddin M, Supuran CT. PET radiotracers and fluorescent probes for imaging human carbonic anhydrase IX and XII in hypoxic tumors. Bioorg Chem 2023;133:106399. [PMID: 36731297 DOI: 10.1016/j.bioorg.2023.106399] [Reference Citation Analysis]
151 Zhou H, Jia W, Lu L, Han R. MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment. Cancers 2023;15:824. [DOI: 10.3390/cancers15030824] [Reference Citation Analysis]
152 Zou X, Liu Y, Lin X, Wang R, Dai Z, Chen Y, Ma M, Tasiheng Y, Yan Y, Wang X, Yu X, Cheng H, Liu C. Characterization of Estrogen Receptors in Pancreatic Adenocarcinoma with Tertiary Lymphoid Structures. Cancers 2023;15:828. [DOI: 10.3390/cancers15030828] [Reference Citation Analysis]
153 Laouali N, Benmarhnia T, Lanphear BP, Oulhote Y. Associations with Blood Lead and Urinary Cadmium Concentrations in Relation to Mortality in the US Population: A Causal Survival Analysis with G-Computation. Toxics 2023;11:133. [DOI: 10.3390/toxics11020133] [Reference Citation Analysis]
154 Wu S, Qin L, Yang J, Wang J, Shen Y. Association between F-box-only protein 43 overexpression and hepatocellular carcinoma pathogenesis and prognosis. Cancer Med 2023. [PMID: 36710413 DOI: 10.1002/cam4.5660] [Reference Citation Analysis]
155 Shewell LK, Day CJ, Hippolite T, De Bisscop X, Paton JC, Paton AW, Jennings MP. Serum Neu5Gc biomarkers are elevated in primary cutaneous melanoma. Biochem Biophys Res Commun 2023;642:162-6. [PMID: 36580827 DOI: 10.1016/j.bbrc.2022.12.053] [Reference Citation Analysis]
156 Ren J, Ren J, Wang K, Xu Y, Zhu M, Ren T, Guo Z, Li R, Huang J, Tan Q. The location of visceral pleural invasion in stage IB patients with non-small cell lung cancer: Comparison and prognosis. Eur J Surg Oncol 2023:S0748-7983(23)00088-4. [PMID: 36725457 DOI: 10.1016/j.ejso.2023.01.022] [Reference Citation Analysis]
157 Lu M, Luo Y, Wang Y, Yu J, Zheng H, Yang Z. Transrectal versus transperineal prostate biopsy in detection of prostate cancer: a retrospective study based on 452 patients. BMC Urol 2023;23:11. [PMID: 36709292 DOI: 10.1186/s12894-023-01176-y] [Reference Citation Analysis]
158 Wang X, Zhu W, Long Q, Chen E, Sun H, Li X, Xu H, Li W, Dong P, He L, Chen M, Deng W. The prognostic value and immune correlation of IL18 expression and promoter methylation in renal cell carcinoma. Clin Epigenetics 2023;15:14. [PMID: 36707882 DOI: 10.1186/s13148-023-01426-8] [Reference Citation Analysis]
159 Li W, Wu R, Zhang S, Zhao Y, Li L, Hu Z, Su Q, Mang Y, Zhang X, Dong Y, Zheng K, Ran J, Li L. Analysis of angiogenesis-related subtypes of hepatocellular carcinoma and tumor microenvironment infiltration feature in hepatocellular carcinoma. Clin Transl Oncol 2023. [PMID: 36708372 DOI: 10.1007/s12094-023-03084-x] [Reference Citation Analysis]
160 Mi YY, Ji Y, Zhang L, Sun CY, Wei BB, Yang DJ, Wan HY, Qi XW, Wu S, Zhu LJ. A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo. Cell Death Dis 2023;14:67. [PMID: 36709328 DOI: 10.1038/s41419-023-05606-5] [Reference Citation Analysis]
161 Saxena P, Goyal A, Bivi MA, Singh SK, Rashid M. Segmentation of Nucleus and Cytoplasm from H&E-Stained Follicular Lymphoma. Electronics 2023;12:651. [DOI: 10.3390/electronics12030651] [Reference Citation Analysis]
162 McClam M, Workman L, Dias EM, Walker TJ, Brandt HM, Craig DW, Gibson R, Lamont A, Weiner BJ, Wandersman A, Fernandez ME. Using cognitive interviews to improve a measure of organizational readiness for implementation. BMC Health Serv Res 2023;23:93. [PMID: 36707829 DOI: 10.1186/s12913-022-09005-y] [Reference Citation Analysis]
163 Liu C, Zhang M, Yan X, Ni Y, Gong Y, Wang C, Zhang X, Wan L, Yang H, Ge C, Li Y, Zou W, Huang R, Li X, Sun B, Liu B, Yue J, Yu J. Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression. Sci Adv 2023;9:eadd8977. [PMID: 36706185 DOI: 10.1126/sciadv.add8977] [Reference Citation Analysis]
164 Yang F, Xu K, Zhou YG, Ren T. Insight into autophagy in platinum resistance of cancer. Int J Clin Oncol 2023. [PMID: 36705869 DOI: 10.1007/s10147-023-02301-5] [Reference Citation Analysis]
165 Gao L, Ying F, Cai J, Peng M, Xiao M, Sun S, Zeng Y, Xiong Z, Cai L, Gao R, Wang Z. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer. J Ovarian Res 2023;16:27. [PMID: 36707884 DOI: 10.1186/s13048-022-01065-2] [Reference Citation Analysis]
166 Viergever B, Raats D, Geurts V, Mullenders J, Jonges T, Heijden M(VD, Es JV, Kranenburg O, Meijer R. Urine-derived bladder cancer organoids (urinoids) as tool for cancer longitudinal response monitoring and therapy adaptation.. [DOI: 10.21203/rs.3.rs-2499089/v1] [Reference Citation Analysis]
167 Kaya C, Chan F, Iwanaga K, Wu JR, Bezyak J. A Psychometric Validation of the Impact on Participation and Autonomy Questionnaire in a Sample of Turkish Cancer Survivors. Rehabilitation Counseling Bulletin 2023. [DOI: 10.1177/00343552221146160] [Reference Citation Analysis]
168 He K, Li J, Huang X, Zhao W, Wang K, Wang T, Chen J, Wang Z, Yi J, Zhao S, Zhao L. KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1090779] [Reference Citation Analysis]
169 Zheng M, Hu Y, Liu O, Li S, Wang Y, Li X, Liu J, Yang Q, Li X, Lin B. Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing. Oxidative Medicine and Cellular Longevity 2023;2023:1-22. [DOI: 10.1155/2023/1261039] [Reference Citation Analysis]
170 Iksen I, Witayateeraporn W, Wirojwongchai T, Suraphan C, Pornputtapong N, Singharajkomron N, Nguyen HM, Pongrakhananon V. Identifying molecular targets of Aspiletrein-derived steroidal saponins in lung cancer using network pharmacology and molecular docking-based assessments. Sci Rep 2023;13:1545. [PMID: 36707691 DOI: 10.1038/s41598-023-28821-8] [Reference Citation Analysis]
171 Haight PJ, Barrington DA, Graves SM, Piver RN, Baek J, Ardizzone M, Akinduro JA, Busho AC, Fadoju D, Pandit R, Stephens R, Strowder LM, Tadepalli S, VanNoy B, Sriram B, McLaughlin EM, Lightfoot MDS, Bixel KL, Cohn DE, Cosgrove CM, O'Malley D, Salani R, Nagel CI, Backes FJ. Safety and feasibility of same-day discharge following minimally invasive hysterectomy in the morbidly obese patient population. Gynecol Oncol 2023;170:203-9. [PMID: 36709661 DOI: 10.1016/j.ygyno.2023.01.013] [Reference Citation Analysis]
172 Wang Y, Robinson PS, Coorens THH, Moore L, Lee-Six H, Noorani A, Sanders MA, Jung H, Katainen R, Heuschkel R, Brunton-Sim R, Weston R, Read D, Nobbs B, Fitzgerald RC, Saeb-Parsy K, Martincorena I, Campbell PJ, Rushbrook S, Zilbauer M, Buczacki SJA, Stratton MR. APOBEC mutagenesis is a common process in normal human small intestine. Nat Genet 2023. [PMID: 36702998 DOI: 10.1038/s41588-022-01296-5] [Reference Citation Analysis]
173 Tang W, Ye H, Tang X, Su J, Xu K, Zhong W, Liang Y. Adjuvant immunotherapy in early-stage resectable non–small cell lung cancer: A new milestone. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1063183] [Reference Citation Analysis]
174 Ye Q, Liu Z, Zhang S, Wang G, Wen G, Dong M. Development of 99mTc-Hynic-Adh-1 Molecular Probe Specifically Targeting N-Cadherin and Its Preliminary Experimental Study in Monitoring Drug Resistance of Non-Small-Cell Lung Cancer. Cancers 2023;15:755. [DOI: 10.3390/cancers15030755] [Reference Citation Analysis]
175 Parida S, Siddharth S, Xia Y, Sharma D. Concomitant analyses of intratumoral microbiota and genomic features reveal distinct racial differences in breast cancer. NPJ Breast Cancer 2023;9:4. [PMID: 36702853 DOI: 10.1038/s41523-023-00505-6] [Reference Citation Analysis]
176 Wu L, Zhao X, Tian S, Zhang K, He C, Feng Y, Zhou J, Guo W, Ji Z, He X, Chen G, Wang J. Efficacy and toxicity of Iodine-125 seed implantation for lymph node recurrence secondary to esophageal cancer after radiotherapy: a multicenter retrospective study. Radiat Oncol 2023;18:18. [PMID: 36698157 DOI: 10.1186/s13014-022-02196-y] [Reference Citation Analysis]
177 Yao H, Lyu F, Ma J, Sun F, Tang G, Wu J, Zhou Z. PIMREG is a prognostic biomarker involved in immune microenvironment of clear cell renal cell carcinoma and associated with the transition from G1 phase to S phase. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1035321] [Reference Citation Analysis]
178 Kim H, Villareal LB, Liu Z, Haneef M, Falcon DM, Martin DR, Lee HJ, Dame MK, Attili D, Chen Y, Varani J, Spence JR, Kovbasnjuk O, Colacino JA, Lyssiotis CA, Lin HC, Shah YM, Xue X. Transferrin Receptor-Mediated Iron Uptake Promotes Colon Tumorigenesis. Adv Sci (Weinh) 2023;:e2207693. [PMID: 36703617 DOI: 10.1002/advs.202207693] [Reference Citation Analysis]
179 Angeli A, Micheli L, Carta F, Ferraroni M, Pirali T, Fernandez Carvajal A, Ferrer Montiel A, Di Cesare Mannelli L, Ghelardini C, Supuran CT. First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy. J Med Chem 2023;66:1616-33. [PMID: 36626645 DOI: 10.1021/acs.jmedchem.2c01911] [Reference Citation Analysis]
180 Alves ÂVF, Melo CR, Chagas-Neto JL, Amaral RG, Ambrósio SR, Moreira MR, Veneziani RCS, Cardoso JC, Severino P, Gondak RO, Souto EB, de Albuquerque-Júnior RLC. Ent-kaurenoic acid-enriched Mikania glomerata leaves-complexed β-cyclodextrin: Pharmaceutical development and in vivo antitumor activity in a sarcoma 180 mouse model. Int J Pharm 2023;631:122497. [PMID: 36529360 DOI: 10.1016/j.ijpharm.2022.122497] [Reference Citation Analysis]
181 Tucker SM, Zaihra T. Cytogenetic and survival analysis in 315 multiple myeloma patients; five with orbital and eight with extramedullary disease. Orbit 2023;:1-9. [PMID: 36697375 DOI: 10.1080/01676830.2023.2166082] [Reference Citation Analysis]
182 Piludu M, Pichiri G, Coni P, Piras M, Congiu T, Faa G, Lachowicz JI. Cell starvation increases uptake of extracellular Thymosin β4 and its complexes with calcium. Int Immunopharmacol 2023;116:109743. [PMID: 36706591 DOI: 10.1016/j.intimp.2023.109743] [Reference Citation Analysis]
183 Tange S, Hirano T, Idogawa M, Hirata E, Imoto I, Tokino T. MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle/c-Myc/mTORC1 pathway. BMC Cancer 2023;23:85. [PMID: 36698109 DOI: 10.1186/s12885-022-10433-6] [Reference Citation Analysis]
184 Sun Z, Jing C, Zhan H, Guo X, Suo N, Kong F, Tao W, Xiao C, Hu D, Wang H, Jiang S. Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1097472] [Reference Citation Analysis]
185 Xu F, Dong M, Wang Z, Cao L. Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1083069] [Reference Citation Analysis]
186 Xia L, Liu Y, Cai P, Feng Y, Yuan H, Tang S, Wang YW, Liu N, Chen Y, Zhou Z. Halogen Replacement on the Lysine Side Chain of Lys-Urea-Glu-Based PSMA Inhibitors Leads to Significant Changes in Targeting Properties. Mol Imaging Biol 2023. [PMID: 36695967 DOI: 10.1007/s11307-023-01804-x] [Reference Citation Analysis]
187 Chen G, Chen H, Xiao Q, Zhou X, Wang F, Chen S, Yu X, Luo F, Li L. UXT-V1 contributes to the malignant phenotypes of colorectal cancer via GSK3β by activating Wnt/β-catenin pathway.. [DOI: 10.21203/rs.3.rs-2392726/v1] [Reference Citation Analysis]
188 Chen X, Yong H, Chen M, Deng C, Wang P, Chu S, Li M, Hou P, Zheng J, Li Z, Bai J. TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability. J Exp Clin Cancer Res 2023;42:34. [PMID: 36694250 DOI: 10.1186/s13046-022-02583-z] [Reference Citation Analysis]
189 Liang Y, Wang PY, Li YJ, Liu ZY, Wang RR, Sun GB, Sun HF, Xie SY. Multistage O(2)-producing liposome for MRI-guided synergistic chemodynamic/chemotherapy to reverse cancer multidrug resistance. Int J Pharm 2023;631:122488. [PMID: 36521638 DOI: 10.1016/j.ijpharm.2022.122488] [Reference Citation Analysis]
190 Zheng S, Lin N, Wu Q, He H, Yang C. Prognostic model construction and validation of esophageal cancer cellular senescence-related genes and correlation with immune infiltration. Front Surg 2023;10. [DOI: 10.3389/fsurg.2023.1090700] [Reference Citation Analysis]
191 Guo X, Song X, Long X, Liu Y, Xie Y, Xie C, Ji B. New nomogram for predicting lymph node positivity in pancreatic head cancer. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1053375] [Reference Citation Analysis]
192 Budhathoki S, Diergaarde B, Liu G, Olshan A, Ness A, Waterboer T, Virani S, Basta P, Bender N, Brenner N, Dudding T, Hayes N, Hope A, Huang SH, Hueniken K, Kanterewicz B, McKay JD, Pring M, Thomas S, Wisniewski K, Thomas S, Brhane Y, Agudo A, Alemany L, Lagiou A, Barzan L, Canova C, Conway DI, Healy CM, Holcatova I, Lagiou P, Macfarlane GJ, Macfarlane TV, Polesel J, Richiardi L, Robinson M, Znaor A, Brennan P, Hung RJ. A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers. Int J Cancer 2023. [PMID: 36694401 DOI: 10.1002/ijc.34444] [Reference Citation Analysis]
193 Cianflone A, Savoia F, Parasole R, Mirabelli P. Pediatric biobanks to enhance clinical and translational research for children. Eur J Pediatr 2023;:1-10. [PMID: 36692622 DOI: 10.1007/s00431-023-04818-3] [Reference Citation Analysis]
194 Liede A, Sebby W, Miriyala AKR, Potluri R, Mazumder D, Ghosh A, Papademetriou E, Kilpatrick R, Tyczynski JE. Risk of seizures in a population of women with BRCA-positive metastatic breast cancer from an electronic health record database in the United States. BMC Cancer 2023;23:78. [PMID: 36690978 DOI: 10.1186/s12885-023-10554-6] [Reference Citation Analysis]
195 Fathy A, Ibrahim ABM, Elkhalik SA, Villinger A, Abbas SM. New iron(III) complexes with 2-formylpyridine thiosemicarbazones: Synthetic aspects, structural and spectral analyses and cytotoxicity screening against MCF-7 human cancer cells. Heliyon 2023;9:e13008. [PMID: 36711299 DOI: 10.1016/j.heliyon.2023.e13008] [Reference Citation Analysis]
196 Ming H, Li B, Jiang J, Qin S, Nice EC, He W, Lang T, Huang C. Protein degradation: expanding the toolbox to restrain cancer drug resistance. J Hematol Oncol 2023;16:6. [PMID: 36694209 DOI: 10.1186/s13045-023-01398-5] [Reference Citation Analysis]
197 Younginger BS, Mayba O, Reeder J, Nagarkar DR, Modrusan Z, Albert ML, Byrd AL. Enrichment of oral-derived bacteria in inflamed colorectal tumors and distinct associations of Fusobacterium in the mesenchymal subtype. Cell Rep Med 2023;:100920. [PMID: 36706753 DOI: 10.1016/j.xcrm.2023.100920] [Reference Citation Analysis]
198 Yan K, Auger S, Diaz A, Naman J, Vemulapalli R, Hasina R, Izumchenko E, Shogan B, Agrawal N. Microbial Changes Associated With Oral Cavity Cancer Progression. Otolaryngol --head neck surg 2023. [DOI: 10.1002/ohn.211] [Reference Citation Analysis]
199 Lin K, Huang L, Zhang Y, Chen M, Li Z, Yung KKL, Lv S, Pan Q, Zhang W, Fu J, Li W, Deng Q. The Antiangiogenic and Antitumor Effects of Scoparasin B in Non-Small-Cell Lung Cancer. J Nat Prod 2023. [PMID: 36692021 DOI: 10.1021/acs.jnatprod.2c00979] [Reference Citation Analysis]
200 Xie M, Su C. Microenvironment and the progress of immunotherapy in clinical practice of NSCLC brain metastasis. Front Oncol 2023;12. [DOI: 10.3389/fonc.2022.1006284] [Reference Citation Analysis]
201 Ning J, Wang S, Guo Y, Diao J, Bai X, Wang H, Hu K, Zhao Q. High Intensity Focused Ultrasound Ablation for Patients With Locally Advanced Pancreatic Adenocarcinoma: A Propensity Score-Matching Analysis. J Ultrasound Med 2023. [PMID: 36691925 DOI: 10.1002/jum.16181] [Reference Citation Analysis]
202 Fleischer JR, Schmitt AM, Haas G, Xu X, Zeisberg EM, Bohnenberger H, Küffer S, Teuwen LA, Karras PJ, Beißbarth T, Bleckmann A, Planque M, Fendt SM, Vermeulen P, Ghadimi M, Kalucka J, De Oliveira T, Conradi LC. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution. Mol Cancer 2023;22:17. [PMID: 36691028 DOI: 10.1186/s12943-023-01713-1] [Reference Citation Analysis]
203 Blackmur JP, Chew E, Trail M, Brodie K, Santoni N, Rodger F, Hamilton D, Gaba F, Randall S, Nalagatla S, Little B, Janjua K, Sweeney C, Martindale A, Qureshi K, Riddick A, O'Connor K, McNeill SA, Phipps S, Cutress ML, Mains EAA, Dunn I, Reid S, Stewart GD, Lamb G, Aslam MZ, Leung S, Clark R, Wilson I, Oades G, Chapman A, Laird A. Assessment of association between lower ureteric excision technique and oncological outcomes for upper urinary tract urothelial carcinoma: retrospective analysis from the Scottish Renal Cancer Consortium. World J Urol 2023. [PMID: 36692533 DOI: 10.1007/s00345-023-04283-5] [Reference Citation Analysis]
204 Wang Q, Wang J, Yan H, Li Z, Wang K, Kang F, Tian J, Zhao X, Yun SH. An ultra-small bispecific protein augments tumor penetration and treatment for pancreatic cancer. Eur J Nucl Med Mol Imaging 2023. [PMID: 36692541 DOI: 10.1007/s00259-023-06115-5] [Reference Citation Analysis]
205 Gianfredi V, Nucci D, Nardi M, Santangelo OE, Provenzano S. Using Google Trends and Wikipedia to Investigate the Global Public’s Interest in the Pancreatic Cancer Diagnosis of a Celebrity. IJERPH 2023;20:2106. [DOI: 10.3390/ijerph20032106] [Reference Citation Analysis]
206 Rupa R, Prema R, Popat PB, Manchanda S, Venkatesh K, Chandramohan A, Subbian A, Rangarajan B. Imaging Recommendations for Diagnosis, Staging, and Management of Ovarian and Fallopian Tube Cancers. Indian J Med Paediatr Oncol 2023. [DOI: 10.1055/s-0042-1759518] [Reference Citation Analysis]
207 Cheng S, Li J, Li B, Tang L, Yin T, Liu S. Atezolizumab versus Pembrolizumab for First-line Treatment in Non-small-cell Lung Cancer with High PD-L1 Expression: A Network Meta-analysis and Cost-effectiveness Analysis from Chinese Perspectives.. [DOI: 10.21203/rs.3.rs-2457024/v1] [Reference Citation Analysis]
208 Zhang Y, Zhang J, Zhang W, Wang M, Wang S, Xu Y, Zhao L, Li X, Li G. Mapping Multiple Factors-mediated Chromatin Interactions to Assess Dysregulation of Lung Cancer-related Genes. Genomics Proteomics Bioinformatics 2023:S1672-0229(23)00004-9. [PMID: 36702236 DOI: 10.1016/j.gpb.2023.01.004] [Reference Citation Analysis]
209 Yang L, Su J, Wang W, Zhou F. The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic pancreatic cancer: a retrospective study. World J Surg Oncol 2023;21:19. [PMID: 36691032 DOI: 10.1186/s12957-023-02896-z] [Reference Citation Analysis]
210 Zhu A, Liu Y, Li Z, He Y, Bai L, Wu Y, Zhang Y, Huang Y, Jiang P. Diagnosis and functional prediction of microbial markers in tumor tissues of sporadic colorectal cancer patients associated with the MLH1 protein phenotype. Front Oncol 2023;12. [DOI: 10.3389/fonc.2022.1116780] [Reference Citation Analysis]
211 Boscencu R, Radulea N, Manda G, Machado IF, Socoteanu RP, Lupuliasa D, Burloiu AM, Mihai DP, Ferreira LFV. Porphyrin Macrocycles: General Properties and Theranostic Potential. Molecules 2023;28:1149. [DOI: 10.3390/molecules28031149] [Reference Citation Analysis]
212 Brown SA, Chung BY, Doshi K, Hamid A, Pederson E, Maddula R, Hanna A, Choudhuri I, Sparapani R, Bagheri Mohamadi Pour M, Zhang J, Kothari AN, Collier P, Caraballo P, Noseworthy P, Arruda-Olson A; Cardio-Oncology Artificial Intelligence Informatics and Precision Equity (CAIPE) Research Team Investigators. Patient similarity and other artificial intelligence machine learning algorithms in clinical decision aid for shared decision-making in the Prevention of Cardiovascular Toxicity (PACT): a feasibility trial design. Cardiooncology 2023;9:7. [PMID: 36691060 DOI: 10.1186/s40959-022-00151-0] [Reference Citation Analysis]
213 Collarino A, Fuoco V, Garganese G, Pasciuto T, de Koster EJ, Florit A, Fragomeni SM, Zagaria L, Fragano A, Martinelli F, Ditto A, Seregni E, Scambia G, Raspagliesi F, Rufini V, Maccauro M. Lymphatic mapping and sentinel node biopsy in vulvar melanoma: the first multicenter study and systematic review. Gynecol Oncol 2023;170:153-9. [PMID: 36696819 DOI: 10.1016/j.ygyno.2023.01.011] [Reference Citation Analysis]
214 Yang L, Ding Y, Zhang D, Yang G, Dong X, Zhang Z, Zhang C, Zhang W, Dai Y, Li Z. Predictive value of enhanced CT and pathological indicators in lymph node metastasis in patients with gastric cancer based on GEE model.. [DOI: 10.21203/rs.3.rs-2478877/v1] [Reference Citation Analysis]
215 Zhang Y, Liu JB, Liu J, Liu M, Liu HL, Zhang J. UCHL3 promotes cervical cancer development and metastasis by stabilizing NRF2 via deubiquitination. Biochem Biophys Res Commun 2023;641:132-8. [PMID: 36527747 DOI: 10.1016/j.bbrc.2022.11.065] [Reference Citation Analysis]
216 Chen J, Li T, Ye C, Zhong J, Huang J, Ke Y, Sun H. The Lung Microbiome: A New Frontier for Lung and Brain Disease. IJMS 2023;24:2170. [DOI: 10.3390/ijms24032170] [Reference Citation Analysis]
217 Liu P, Wang W, Wang F, Fan J, Guo J, Wu T, Lu D, Zhou Q, Liu Z, Wang Y, Shang Z, Chan FL, Yang W, Li X, Zhao SC, Zheng Q, Wang F, Wu D. Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer. J Transl Med 2023;21:40. [PMID: 36681849 DOI: 10.1186/s12967-022-03860-3] [Reference Citation Analysis]
218 Li D, Xia L, Huang P, Wang Z, Guo Q, Huang C, Leng W, Qin S. Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2/FGFR1/PI3K/AKT axis. Cell Death Discov 2023;9:17. [PMID: 36681667 DOI: 10.1038/s41420-023-01336-x] [Reference Citation Analysis]
219 Chen J, Luo J, He J, Jiang X, Jiang N, Yang C, Zhong S. Cell Cycle-Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer. Biomed Res Int 2023;2023:1733100. [PMID: 36718148 DOI: 10.1155/2023/1733100] [Reference Citation Analysis]
220 Kase AM, George DJ, Ramalingam S. Clear Cell Renal Cell Carcinoma: From Biology to Treatment. Cancers 2023;15:665. [DOI: 10.3390/cancers15030665] [Reference Citation Analysis]
221 Saxena P, Goyal A. Computer-assisted grading of follicular lymphoma: a classification based on SVM, machine learning, and transfer learning approaches. The Imaging Science Journal 2023. [DOI: 10.1080/13682199.2022.2162663] [Reference Citation Analysis]
222 Sadeghi S, Quinn D, Dorff T, Pal S, Groshen S, Tsao-Wei D, Parikh R, Devitt M, Parikh M, Jackovich A, Ruel N, Vogelzang N, Burgess E, Siddiqi I, Gill IS, Lara PN, Dreicer R, Gill PS. EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma. J Clin Oncol 2023;41:640-50. [PMID: 35984996 DOI: 10.1200/JCO.21.02923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 Timofeeva AA, Minina VI, Astafeva EA. Polymorphism of folate metabolism genes in breast cancer patients. HERALD of North-Western State Medical University named after I I Mechnikov 2023;14:5-16. [DOI: 10.17816/mechnikov108505] [Reference Citation Analysis]
224 Konstantinopoulos PA, Lee EK, Xiong N, Krasner C, Campos S, Kolin DL, Liu JF, Horowitz N, Wright AA, Bouberhan S, Penson RT, Yeku O, Bowes B, Needham H, Hayes M, Sawyer H, Polak M, Shea M, Cheng SC, Castro C, Matulonis UA. A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer. J Clin Oncol 2023;41:599-608. [PMID: 36174113 DOI: 10.1200/JCO.22.00628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
225 Schleicher E, McAuley E, Courneya KS, Anton P, Ehlers DK, Phillips SM, Brown NI, Oster RA, Pekmezi D, Rogers LQ. Breast Cancer Survivors' Exercise Preferences Change During an Exercise Intervention and are associated with Post-Intervention Physical Activity. Res Sq 2023:rs. [PMID: 36711885 DOI: 10.21203/rs.3.rs-2488848/v1] [Reference Citation Analysis]
226 Cen D, Zheng Q, Zheng B, Zhou R, Xiao X, Zhang T, Huang Z, Yan T, Yu J, Li X, Deng R, Cai X. A Near‐Infrared Light‐Responsive ROS Cascade Nanoplatform for Synergistic Therapy Potentiating Antitumor Immune Responses. Adv Funct Materials 2023. [DOI: 10.1002/adfm.202211402] [Reference Citation Analysis]
227 Liang Y, Wu G, Luo T, Xie H, Zuo Q, Huang P, Li H, Chen L, Lu H, Chen Q. 10-Gingerol Enhances the Effect of Taxol in Triple-Negative Breast Cancer via Targeting ADRB2 Signaling. Drug Des Devel Ther 2023;17:129-42. [PMID: 36712945 DOI: 10.2147/DDDT.S390602] [Reference Citation Analysis]
228 Morris VK, Kennedy EB, Baxter NN, Benson AB 3rd, Cercek A, Cho M, Ciombor KK, Cremolini C, Davis A, Deming DA, Fakih MG, Gholami S, Hong TS, Jaiyesimi I, Klute K, Lieu C, Sanoff H, Strickler JH, White S, Willis JA, Eng C. Treatment of Metastatic Colorectal Cancer: ASCO Guideline. J Clin Oncol 2023;41:678-700. [PMID: 36252154 DOI: 10.1200/JCO.22.01690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
229 Yin X, Jiang K, Zhou Z, Yu H, Yan D, He X, Yan S. Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer. Oxid Med Cell Longev 2023;2023:3878796. [PMID: 36713030 DOI: 10.1155/2023/3878796] [Reference Citation Analysis]
230 Wang G, Li L, Zang J, Hong H, Zhu L, Kung HF, Zhu Z. Head-to-Head Comparison of 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT in Patients With Primary Prostate Cancer: A Pilot Study. Clin Nucl Med 2023. [PMID: 36727866 DOI: 10.1097/RLU.0000000000004566] [Reference Citation Analysis]
231 Ju Y, Wang L, Cheng F, Huang F, Chen X, Song Q, Xiao J, Zhu X, Jia H. Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy. BMC Endocr Disord 2023;23:19. [PMID: 36670396 DOI: 10.1186/s12902-022-01261-7] [Reference Citation Analysis]
232 von den Driesch J, Flöttmann J, Prall F, Mullins CS, Linnebacher M, Bürtin F. HROP68: A rare case of medullary pancreatic cancer—characterization and chemosensitivity of the first patient-derived cell line. Front Oncol 2023;12. [DOI: 10.3389/fonc.2022.1082927] [Reference Citation Analysis]
233 Li F, Zhou C, Li S, Wang J, Li M, Mu H. Bioinformatic analysis of differentially expressed profiles of lncRNAs and miRNAs with their related ceRNA network in endometrial cancer. Medicine (Baltimore) 2023;102:e32573. [PMID: 36701720 DOI: 10.1097/MD.0000000000032573] [Reference Citation Analysis]
234 Saeed A, Park R, Dai J, Al-Rajabi R, Kasi A, Baranda J, Williamson S, Saeed A, Ripp J, Collins Z, Mulvaney K, Shugrue M, Firth-Braun J, Godwin AK, Madan R, Phadnis M, Sun W. Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results. Cell Rep Med 2023;:100916. [PMID: 36702123 DOI: 10.1016/j.xcrm.2023.100916] [Reference Citation Analysis]
235 Wang S, Zhou L, Tian H, Li B, Su M, Li Q, Nice EC, Huang C, Shao J, He T. Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapy. J Nanobiotechnology 2023;21:24. [PMID: 36670444 DOI: 10.1186/s12951-023-01779-5] [Reference Citation Analysis]
236 Flory A, McLennan L, Peet B, Kroll M, Stuart D, Brown D, Stuebner K, Phillips B, Coomber BL, Woods JP, Miller M, Tripp CD, Wolf-Ringwall A, Kruglyak KM, McCleary-Wheeler AL, Phelps-Dunn A, Wong LK, Warren CD, Brandstetter G, Rosentel MC, DiMarzio LR, O'Kell AL, Cohen TA, Grosu DS, Chibuk J, Tsui DWY, Chorny I, Rafalko JM. Cancer detection in clinical practice and using blood-based liquid biopsy: A retrospective audit of over 350 dogs. J Vet Intern Med 2023;37:258-67. [PMID: 36661398 DOI: 10.1111/jvim.16616] [Reference Citation Analysis]
237 Li Y, Na F, Pei J. Construction and characterization of a cuproptosis- and immune checkpoint-based LncRNAs signature for breast cancer risk stratification. Breast Cancer 2023. [PMID: 36662399 DOI: 10.1007/s12282-023-01434-9] [Reference Citation Analysis]
238 Tian Y, Dong D, Wu L, Park JY, Wei GH, Wang L; PRACTICAL/ELLIPSE consortium. Combined CRISPR and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression. bioRxiv 2023:2023. [PMID: 36711639 DOI: 10.1101/2023.01.18.524405] [Reference Citation Analysis]
239 Fatima S, Shaikh IN, Kaler AK. CHEK2 gene in metastatic prostate cancer: A cordial check on DNA damage repair pathway. IJMIO 2023;0:1-4. [DOI: 10.25259/ijmio_25_2022] [Reference Citation Analysis]
240 Yi M, He T, Wang K, Wei Y. Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non‑small‑cell lung cancer: A meta analysis. Clinics (Sao Paulo) 2023;78:100152. [PMID: 36681071 DOI: 10.1016/j.clinsp.2022.100152] [Reference Citation Analysis]
241 Chat V, Dagayev S, Moran U, Snuderl M, Weber J, Ferguson R, Osman I, Kirchhoff T. A genome-wide association study of germline variation and melanoma prognosis. Front Oncol 2022;12:1050741. [PMID: 36741706 DOI: 10.3389/fonc.2022.1050741] [Reference Citation Analysis]
242 Zhang JH, Starr SL, Chamie K. Contemporary Systemic Therapies in Urothelial Carcinoma. Urology 2023:S0090-4295(23)00048-1. [PMID: 36682700 DOI: 10.1016/j.urology.2023.01.007] [Reference Citation Analysis]
243 Agochukwu-Mmonu N, Qin Y, Kaufman S, Oerline M, Vince R, Makarov D, Caram MV, Chapman C, Ravenell J, Hollenbeck BK, Skolarus TA. Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities. JCO Oncol Pract 2023;:OP2200147. [PMID: 36657098 DOI: 10.1200/OP.22.00147] [Reference Citation Analysis]
244 Yang M, Yan Q, Luo Y, Wang B, Deng S, Luo H, Ye B, Wang X. Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technology. Front Pharmacol 2023;14. [DOI: 10.3389/fphar.2023.1016967] [Reference Citation Analysis]
245 Feng Y, Han X, Zhang Z, Qiao H, Tang H. ABI3BP is a prognosis biomarker related with clinicopathological features and immunity infiltration of lung tumor. Front Genet 2023;13. [DOI: 10.3389/fgene.2022.1085785] [Reference Citation Analysis]
246 Broséus J, Hergalant S, Vogt J, Tausch E, Kreuz M, Mottok A, Schneider C, Dartigeas C, Roos-Weil D, Quinquenel A, Moulin C, Ott G, Blanchet O, Tomowiak C, Lazarian G, Rouyer P, Chteinberg E, Bernhart SH, Tournilhac O, Gauchotte G, Lomazzi S, Chapiro E, Nguyen-Khac F, Chery C, Davi F, Hunault M, Houlgatte R, Rosenwald A, Delmer A, Meyre D, Béné MC, Thieblemont C, Lichter P, Ammerpohl O, Guéant JL, Guièze R, Martin-Subero JI, Cymbalista F, Feugier P, Siebert R, Stilgenbauer S; ICGC MMML-Seq Consortium. Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis. Nat Commun 2023;14:309. [PMID: 36658118 DOI: 10.1038/s41467-022-34642-6] [Reference Citation Analysis]
247 Liu Y, Xia L, Cai P, Wang Y, Feng Y, Zhang W, Liu N, Chen Y, Zhou Z. In vitro and in vivo comparative study of 68Ga-labeled DOTA-, NOTA-, and HBEDCC-chelated radiotracers targeting prostate-specific membrane antigen. J Radioanal Nucl Chem 2023. [DOI: 10.1007/s10967-022-08731-1] [Reference Citation Analysis]
248 Peng Y, Tang R, Ding L, Zheng R, Liu Y, Yin L, Fu Y, Deng T, Li X. Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation. Eur J Pharmacol 2023;942:175522. [PMID: 36681316 DOI: 10.1016/j.ejphar.2023.175522] [Reference Citation Analysis]
249 Suh DH, Ha HI, Lee YJ, Lim J, Won YJ, Lim MC. Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry. J Gynecol Oncol 2023. [PMID: 36731896 DOI: 10.3802/jgo.2023.34.e39] [Reference Citation Analysis]
250 Yang L, Liu Y, Zhang B, Yu M, Huang F, Zeng J, Lu Y, Yang C. CEACAM1 Is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Clear Cell Renal Cell Carcinoma. Dis Markers 2023;2023:3606362. [PMID: 36712923 DOI: 10.1155/2023/3606362] [Reference Citation Analysis]
251 Pestana RC, Serrano C. Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE database. Front Oncol 2022;12:1079909. [PMID: 36741731 DOI: 10.3389/fonc.2022.1079909] [Reference Citation Analysis]
252 Cheng X, Yi X. RNA modification writers pattern in relation to tumor microenvironment and prognosis in prostate cancer. Front Genet 2023;13. [DOI: 10.3389/fgene.2022.1065424] [Reference Citation Analysis]
253 Zhang M, Li R, Zhang J, Wang Y, Wang Y, Guo Y. Development and validation of a nomogram for predicting overall survival in patients with early-onset endometrial cancer.. [DOI: 10.21203/rs.3.rs-2435017/v1] [Reference Citation Analysis]
254 Ikenaga N, Nakata K, Hayashi M, Nakamura S, Abe T, Ideno N, Murakami M, Fujimori N, Fujita N, Isoda T, Baba S, Ishigami K, Oda Y, Nakamura M. Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. J Gastrointest Surg 2023. [PMID: 36652179 DOI: 10.1007/s11605-023-05591-2] [Reference Citation Analysis]
255 Liu YL, Manning-Geist BL, Knezevic A, Deng L, Bromberg M, Funt SA, Meisel JL, Zivanovic O, Roche KL, Sonoda Y, Gardner GJ, Grisham RN, O'Cearbhaill RE, Tew WP, Abu-Rustum NR, Chi DS, Aghajanian C, Feldman DR. Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management. Gynecol Oncol 2023;170:93-101. [PMID: 36669327 DOI: 10.1016/j.ygyno.2022.12.022] [Reference Citation Analysis]
256 McGregor B, Geynisman DM, Burotto M, Porta C, Suarez C, Bourlon MT, Del Tejo V, Du EX, Yang X, Sendhil SR, Betts KA, Huo S. Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma. Oncologist 2023;28:72-9. [PMID: 36124890 DOI: 10.1093/oncolo/oyac186] [Reference Citation Analysis]
257 Liu X, Song J, Zhang H, Liu X, Zuo F, Zhao Y, Zhao Y, Yin X, Guo X, Wu X, Zhang H, Xu J, Hu J, Jing J, Ma X, Shi H. Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. Cancer Cell 2023:S1535-6108(23)00001-6. [PMID: 36706761 DOI: 10.1016/j.ccell.2023.01.001] [Reference Citation Analysis]
258 Xu DZ, Sun XY, Liang YX, Huang HW, Liu R, Lu ZL, He L. Esterase-Responsive Polymeric Micelles Containing Tetraphenylethene and Poly(ethylene glycol) Moieties for Efficient Doxorubicin Delivery and Tumor Therapy. Bioconjug Chem 2023;34:248-56. [PMID: 36621834 DOI: 10.1021/acs.bioconjchem.2c00545] [Reference Citation Analysis]
259 Tan Q, Xu L, Zhang J, Ning L, Jiang Y, He T, Luo J, Chen J, Lv Q, Yang X, Xie H. Breast cancer cells interact with tumor-derived extracellular matrix in a molecular subtype-specific manner. Biomater Adv 2023;146:213301. [PMID: 36709629 DOI: 10.1016/j.bioadv.2023.213301] [Reference Citation Analysis]
260 Nakamura S, Ohuchida K, Ohtsubo Y, Yamada Y, Tsutsumi C, Okuda S, Hisano K, Mochida Y, Shinkawa T, Iwamoto C, Torata N, Mizuuchi Y, Shindo K, Nakata K, Moriyama T, Torisu T, Nagai E, Morisaki T, Kitazono T, Oda Y, Nakamura M. Single-cell transcriptome analysis reveals functional changes in tumour-infiltrating B lymphocytes after chemotherapy in oesophageal squamous cell carcinoma. Clin Transl Med 2023;13:e1181. [PMID: 36650114 DOI: 10.1002/ctm2.1181] [Reference Citation Analysis]
261 Feng HM, Zhao Y, Yan WJ, Li B. Genomic and immunogenomic analysis of three prognostic signature genes in LUAD. BMC Bioinformatics 2023;24:19. [PMID: 36650426 DOI: 10.1186/s12859-023-05137-y] [Reference Citation Analysis]
262 Chen J, Yuan Y, Fang M, Zhu Y, Sun X, Lou Y, Xin Y, Zhou F. Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A systematic review and meta-analysis. Front Endocrinol (Lausanne) 2022;13:1074540. [PMID: 36733800 DOI: 10.3389/fendo.2022.1074540] [Reference Citation Analysis]
263 Jin J, Zhu X, Deng Z, Zhang P, Xiao Y, Han H, Li Y, Li H. Protein-energy malnutrition and worse outcomes after major cancer surgery: A nationwide analysis. Front Oncol 2023;13:970187. [PMID: 36733308 DOI: 10.3389/fonc.2023.970187] [Reference Citation Analysis]
264 Moyers JT, Pestana RC, Roszik J, Hong DS, Naing A, Fu S, Piha-Paul S, Yap TA, Karp D, Rodon J, Livingston A, Zarzour MA, Ravi V, Patel S, Benjamin RS, Ludwig J, Herzog C, Ratan R, Somaiah N, Conley A, Gorlick R, Meric-Bernstam F, Subbiah V. Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102). Clin Cancer Res 2023;29:401-9. [PMID: 36288393 DOI: 10.1158/1078-0432.CCR-22-2509] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Lee CY, Kaza E, Harris TC, O'Farrell DA, King MT, Dyer MA, Cormack RA, Buzurovic I. Catheter reconstruction and dosimetric verification of MRI-only treatment planning (MRTP) for interstitial HDR brachytherapy using PETRA sequence. Phys Med Biol 2023;68. [PMID: 36584396 DOI: 10.1088/1361-6560/acaf48] [Reference Citation Analysis]
266 Shen Y, Li D, Liang Q, Yang M, Pan Y, Li H. Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma. Front Immunol 2022;13:1029092. [PMID: 36733399 DOI: 10.3389/fimmu.2022.1029092] [Reference Citation Analysis]
267 Jiang A, Ye J, Zhou Y, Zhu B, Lu J, Ge S, Qu L, Xiao J, Wang L, Cai C. Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma. Cells 2023;12:349. [DOI: 10.3390/cells12030349] [Reference Citation Analysis]
268 Wang Q, Xu J, Wang A, Chen Y, Wang T, Chen D, Zhang J, Brismar TB. Systematic review of machine learning-based radiomics approach for predicting microsatellite instability status in colorectal cancer. Radiol Med 2023. [PMID: 36648615 DOI: 10.1007/s11547-023-01593-x] [Reference Citation Analysis]
269 Nagarajan K, Krishnakumar V, Parimala K. Spectroscopic and computational characterizations, Hirshfeld surface investigations, anticancer studies and molecular docking analysis of novel NLO 3-hydroxy-3′,4′,5,7-tetramethoxyflavone. Bull Mater Sci 2023;46:12. [DOI: 10.1007/s12034-022-02841-y] [Reference Citation Analysis]
270 Li B, Ren B, Ma G, Cai F, Wang P, Zeng Y, Liu Y, Zhang L, Yang Y, Liang H, Zhang R, Deng J. Inactivation of ZSCAN18 by promoter hypermethylation drives the proliferation via attenuating TP53INP2-mediated autophagy in gastric cancer cells. Clin Epigenetics 2023;15:10. [PMID: 36650573 DOI: 10.1186/s13148-023-01425-9] [Reference Citation Analysis]
271 Han L, Dai W, Luo W, Ye L, Fang H, Mo S, Li Q, Xu Y, Wang R, Cai G. Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer. Cancers 2023;15:562. [DOI: 10.3390/cancers15030562] [Reference Citation Analysis]
272 Herzog AE, Somayaji R, Nör JE. Bmi-1: A master regulator of head and neck cancer stemness. Front Oral Health 2023;4:1080255. [PMID: 36726797 DOI: 10.3389/froh.2023.1080255] [Reference Citation Analysis]
273 Du R, Wang C, Liu J, Wang K, Dai L, Shen W. Phosphorylation of TGIF2 represents a therapeutic target that drives EMT and metastasis of lung adenocarcinoma. BMC Cancer 2023;23:52. [PMID: 36647029 DOI: 10.1186/s12885-023-10535-9] [Reference Citation Analysis]
274 Ou GC, Luo W, Zhang WS, Wang SH, Zhao J, Zhao HM, Qiu R. Gefitinib improves severe bronchorrhea and prolongs the survival of a patient with lung invasive mucinous adenocarcinoma: A case report. World J Clin Cases 2023; 11(2): 441-448 [PMID: 36686363 DOI: 10.12998/wjcc.v11.i2.441] [Reference Citation Analysis]
275 Khadela A, Chavda VP, Postwala H, Ephraim R, Apostolopoulos V, Shah Y. Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer. Cancers (Basel) 2023;15. [PMID: 36672492 DOI: 10.3390/cancers15020543] [Reference Citation Analysis]
276 Luo M, Zhang Y, Xu Z, Lv S, Wei Q, Dang Q. Experimental analysis of bladder cancer-associated mutations in EP300 identifies EP300-R1627W as a driver mutation. Mol Med 2023;29:7. [PMID: 36647005 DOI: 10.1186/s10020-023-00608-7] [Reference Citation Analysis]
277 Song J, You G, Yin X, Zhu G, Wang W, Yu Y, Zhu J. Overexpression of YTHDC2 contributes to the progression of prostate cancer and predicts poor outcomes in patients with prostate cancer. J Biochem Mol Toxicol 2023;:e23308. [PMID: 36644951 DOI: 10.1002/jbt.23308] [Reference Citation Analysis]
278 Zhao M, Li W. Metabolism-associated molecular classification of uterine corpus endometrial carcinoma. Front Genet 2023;14:955466. [PMID: 36726804 DOI: 10.3389/fgene.2023.955466] [Reference Citation Analysis]
279 Bhatia A, Burtness B. Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update. Drugs 2023. [PMID: 36645621 DOI: 10.1007/s40265-023-01835-2] [Reference Citation Analysis]
280 Huang W, Su D, Liao X, Yang T, Lu Y, Zhang Z. Prognostic costimulatory molecule-related signature risk model correlates with immunotherapy response in colon cancer. Sci Rep 2023;13:789. [PMID: 36646765 DOI: 10.1038/s41598-023-27826-7] [Reference Citation Analysis]
281 Wang Z, Zhang J, Dai F, Li B, Cheng Y. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unveils heterogeneity and establishes a novel signature for prognosis and tumor immune microenvironment in ovarian cancer. J Ovarian Res 2023;16:12. [PMID: 36642706 DOI: 10.1186/s13048-022-01074-1] [Reference Citation Analysis]
282 O'Reilly M, Linehan A, Krstic A, Kolch W, Sheahan K, Winter DC, Mc Dermott R. Oncotherapeutic Strategies in Early Onset Colorectal Cancer. Cancers (Basel) 2023;15. [PMID: 36672501 DOI: 10.3390/cancers15020552] [Reference Citation Analysis]
283 Mondal P, Patel NS, Bailey K, Aravind S, Cartwright SB, Hollingsworth MA, Lazenby AJ, Carlson MA. Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig. Dis Model Mech 2023;16. [PMID: 36579622 DOI: 10.1242/dmm.049699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
284 Li J, Yin J, Li W, Wang H, Ni B. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma. Cancer Cell Int 2023;23:7. [PMID: 36647100 DOI: 10.1186/s12935-022-02836-z] [Reference Citation Analysis]
285 Bhaswant M, Shanmugam DK, Miyazawa T, Abe C, Miyazawa T. Microgreens-A Comprehensive Review of Bioactive Molecules and Health Benefits. Molecules 2023;28. [PMID: 36677933 DOI: 10.3390/molecules28020867] [Reference Citation Analysis]
286 Hu R, Dai C, Dai X, Dong C, Huang H, Song X, Feng W, Ding L, Chen Y, Zhang B. Topology regulation of nanomedicine for autophagy-augmented ferroptosis and cancer immunotherapy. Sci Bull (Beijing) 2023;68:77-94. [PMID: 36621435 DOI: 10.1016/j.scib.2022.12.030] [Reference Citation Analysis]
287 Khan MIH, Mahdi F, Penfornis P, Akins NS, Hossain MI, Kim SJ, Sulochana SP, Adam AT, Tran TD, Tan C, Paolo Claudio P, Paris JJ, Le HV. Synthesis and biological evaluation of tert-butyl ester and ethyl ester prodrugs of L-γ-methyleneglutamic acid amides for cancer. Bioorg Med Chem 2023;78:117137. [PMID: 36603398 DOI: 10.1016/j.bmc.2022.117137] [Reference Citation Analysis]
288 Qiu J, Guo Y, Wang S, Ren Q, Dong Z, Gao M, Ma J, Chen S, Liu S. Newly identified lncRNA-45 promotes breast cancer metastasis through activating the mTOR signaling pathway. Biochem Biophys Res Commun 2023;640:40-9. [PMID: 36502630 DOI: 10.1016/j.bbrc.2022.11.099] [Reference Citation Analysis]
289 Li X, Liu X, Lu N, Chen Y, Zhang X, Guo C, Xiao W, Xue X, Sun K, Wang M, Gao S, Shen Y, Zhang M, Wu J, Que R, Yu J, Bai X, Liang T. Normalization of tumor markers and a clear resection margin affect progression-free survival of patients with unresectable pancreatic cancer who have undergone conversion surgery. BMC Cancer 2023;23:49. [PMID: 36641427 DOI: 10.1186/s12885-023-10529-7] [Reference Citation Analysis]
290 Mosiane KS, Nweke EE, Balogun M, Fru PN. Polyethyleneglycol-Betulinic Acid (PEG-BA) Polymer-Drug Conjugate Induces Apoptosis and Antioxidation in a Biological Model of Pancreatic Cancer. Polymers (Basel) 2023;15. [PMID: 36679328 DOI: 10.3390/polym15020448] [Reference Citation Analysis]
291 Jiang W, Ouyang X, Ji Z, Shi W, Wu Y, Yao Q, Wang Y, Yang W, Xiang L, Yang H. The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer. Cancer Lett 2023;556:216064. [PMID: 36646410 DOI: 10.1016/j.canlet.2023.216064] [Reference Citation Analysis]
292 Zhang X, Chen Q, He Y, Shi Q, Yin C, Xie Y, Yu H, Bao Y, Wang X, Tang C, Dong Z. STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent. J Exp Clin Cancer Res 2023;42:19. [PMID: 36639675 DOI: 10.1186/s13046-022-02573-1] [Reference Citation Analysis]
293 Huang H, Cao W, Long Z, Kuang L, Li X, Feng Y, Wu Y, Zhao Y, Chen Y, Sun P, Peng P, Zhang J, Yuan L, Li T, Hu H, Li G, Yang L, Zhang X, Hu F, Sun X, Hu D. DNA methylation-based patterns for early diagnostic prediction and prognostic evaluation in colorectal cancer patients with high tumor mutation burden. Front Oncol 2022;12:1030335. [PMID: 36713578 DOI: 10.3389/fonc.2022.1030335] [Reference Citation Analysis]
294 Chai X, Hu XP, Wang XY, Wang HT, Pang JP, Zhou WF, Liao JN, Shan LH, Xu XH, Xu L, Xia HG, Hou TJ, Li D. Computationally guided discovery of novel non-steroidal AR-GR dual antagonists demonstrating potency against antiandrogen resistance. Acta Pharmacol Sin 2023. [PMID: 36639570 DOI: 10.1038/s41401-022-01038-7] [Reference Citation Analysis]
295 Yang J, Xin C, Yin G, Li J. Taraxasterol suppresses the proliferation and tumor growth of prostate cancer cells through the FGFR2-PI3K/AKT signaling pathway.. [DOI: 10.21203/rs.3.rs-2437423/v1] [Reference Citation Analysis]
296 Coppo R, Kondo J, Iida K, Okada M, Onuma K, Tanaka Y, Kamada M, Ohue M, Kawada K, Obama K, Inoue M. Distinct but interchangeable subpopulations of colorectal cancer cells with different growth fates and drug sensitivity. iScience 2023;26:105962. [PMID: 36718360 DOI: 10.1016/j.isci.2023.105962] [Reference Citation Analysis]
297 Orso F, Virga F, Dettori D, Dalmasso A, Paradzik M, Savino A, Pomatto MAC, Quirico L, Cucinelli S, Coco M, Mareschi K, Fagioli F, Salmena L, Camussi G, Provero P, Poli V, Mazzone M, Pandolfi PP, Taverna D. Stroma-derived miR-214 coordinates tumor dissemination. J Exp Clin Cancer Res 2023;42:20. [PMID: 36639824 DOI: 10.1186/s13046-022-02553-5] [Reference Citation Analysis]
298 Massanova M, Vere R, Robertson S, Crocetto F, Barone B, Dutto L, Ahmad I, Underwood M, Salmond J, Patel A, Celentano G, Bhatt JR. Clinical and prostate multiparametric magnetic resonance imaging findings as predictors of general and clinically significant prostate cancer risk: A retrospective single-center study. Curr Urol 2023;Publish Ahead of Print. [DOI: 10.1097/cu9.0000000000000173] [Reference Citation Analysis]
299 Jiang S, Zou J, Dong J, Shi H, Chen J, Li Y, Duan X, Li W. Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC. Cell Commun Signal 2023;21:9. [PMID: 36639771 DOI: 10.1186/s12964-022-01023-x] [Reference Citation Analysis]
300 Yu J, Chen Y, Li T, Sheng B, Zhen Z, Liu C, Zhang J, Yan Q, Zhu P. High and low inferior mesenteric artery ligation in laparoscopic low anterior rectal resections: A retrospective study. Front Surg 2022;9:1027034. [PMID: 36713667 DOI: 10.3389/fsurg.2022.1027034] [Reference Citation Analysis]
301 Wang H, Tian RF, Liang X, Fan J, Duan ZC, Fan XY, Zhang JJ, Yao DS, Chen ZN, Li L. A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma. Front Oncol 2022;12:1015042. [PMID: 36713541 DOI: 10.3389/fonc.2022.1015042] [Reference Citation Analysis]
302 Zhang Y, Wang X, Wang S, Liu J, Li R, Li X, Zhang R. Circ-ERBB2 knockdown sensitized colorectal cancer cells to 5-FU via miR-181a-5p/PTEN/Akt pathway. J Biochem Mol Toxicol 2023;:e23297. [PMID: 36639866 DOI: 10.1002/jbt.23297] [Reference Citation Analysis]
303 Haston JC, O'Laughlin K, Matteson K, Roy S, Qvarnstrom Y, Ali IKM, Cope JR. The Epidemiology and Clinical Features of Non-Keratitis Acanthamoeba Infections in the United States, 1956-2020. Open Forum Infect Dis 2023;10:ofac682. [PMID: 36655187 DOI: 10.1093/ofid/ofac682] [Reference Citation Analysis]
304 Lin F, Li Q, Wang Z, Shi Y, Ma H, Zhang H, Zhang K, Yang P, Zhang R, Duan S, Gu Y, Mao N, Xie H. Intratumoral and peritumoral radiomics for preoperatively predicting the axillary non-sentinel lymph node metastasis in breast cancer on the basis of contrast-enhanced mammography: a multicenter study. Br J Radiol 2023;:20220068. [PMID: 36542866 DOI: 10.1259/bjr.20220068] [Reference Citation Analysis]
305 Liao M, Wang Z, Yao J, Xing H, Hao Y, Qiu B. Identification of potential biomarkers for papillary thyroid carcinoma by comprehensive bioinformatics analysis. Mol Cell Biochem 2023. [PMID: 36635603 DOI: 10.1007/s11010-022-04606-x] [Reference Citation Analysis]
306 Mukherjee A, Wiener HW, Griffin RL, Lenneman C, Chatterjee A, Nabell LM, Lewis CE, Shrestha S. Traditional risk factors and cancer-related factors associated with cardiovascular disease risk in head and neck cancer patients. Front Cardiovasc Med 2022;9:1024846. [PMID: 36712282 DOI: 10.3389/fcvm.2022.1024846] [Reference Citation Analysis]
307 Li D, Deng C, Fu F, Bai J, Li Y, Zhang Y, Chen H. Impact of Prior Cancer History on Outcomes of Resected Lung Cancer. Ann Surg Oncol 2023. [PMID: 36635522 DOI: 10.1245/s10434-022-12597-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
308 Kaje KC, Dsilva F, Sanal TS, Latha T, Kumar S, D’souza C. Effect of Yoga Intervention on Inflammatory Biomarkers among Women with Breast Cancer – A Systematic Review. IJPC 2023;0:1-11. [DOI: 10.25259/ijpc_125_2022] [Reference Citation Analysis]
309 Xu FL, Wu XH, Chen C, Wang K, Huang LY, Xia J, Liu Y, Shan XF, Tang N. SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase. Cell Death Dis 2023;14:22. [PMID: 36635256 DOI: 10.1038/s41419-023-05558-w] [Reference Citation Analysis]
310 Fang Y, Zheng X, Zou X, Ye Z, Liu J, Lei J, Li Z. Genetic and clinical profiles of 160 papillary thyroid cancers with lateral neck lymph node metastasis. Front Oncol 2022;12:1057532. [PMID: 36713542 DOI: 10.3389/fonc.2022.1057532] [Reference Citation Analysis]
311 Wang H, Yang D, Lv Y, Lin J, Wang H. Operative versus Nonoperative Treatment in Patients with Advanced Non-Small-Cell Lung Cancer: Recommended for Surgery. Can Respir J 2023;2023:4119541. [PMID: 36687390 DOI: 10.1155/2023/4119541] [Reference Citation Analysis]
312 Yang X, Su X, Wang Z, Yu Y, Wu Z, Zhang D. ULBP2 is a biomarker related to prognosis and immunity in colon cancer. Mol Cell Biochem 2023. [PMID: 36633827 DOI: 10.1007/s11010-022-04647-2] [Reference Citation Analysis]
313 Li J, Tan Y, Li K, Hui AM, Wu Z, Han P, Wei Z, Qiu J, Diao L, Wang X. Effect of Food (Low and High Fat) on Pharmacokinetics of FCN-159, a Selective MEK Inhibitor, in Healthy Chinese Males. Adv Ther 2023. [PMID: 36627544 DOI: 10.1007/s12325-022-02375-z] [Reference Citation Analysis]
314 Peng Y, Zhang W, Chen Y, Zhang L, Shen H, Wang Z, Tian S, Yang X, Cui D, He Y, Chang X, Feng Z, Tang Q, Mao Y. Engineering c-Met-CAR NK-92 cells as a promising therapeutic candidate for lung adenocarcinoma. Pharmacol Res 2023;188:106656. [PMID: 36640859 DOI: 10.1016/j.phrs.2023.106656] [Reference Citation Analysis]
315 You D, Kim H, Jeong Y, Yoon SY, Lo E, Kim S, Lee JE. Tumorigenicity of EGFR- and/or HER2-Positive Breast Cancers Is Mediated by Recruitment of Tumor-Associated Macrophages. Int J Mol Sci 2023;24. [PMID: 36674955 DOI: 10.3390/ijms24021443] [Reference Citation Analysis]
316 Suhail M, Rehan M, Tarique M, Tabrez S, Husain A, Zughaibi TA. Targeting a transcription factor NF-κB by green tea catechins using in silico and in vitro studies in pancreatic cancer. Front Nutr 2022;9:1078642. [PMID: 36712528 DOI: 10.3389/fnut.2022.1078642] [Reference Citation Analysis]
317 Shrode RL, Knobbe JE, Cady N, Yadav M, Hoang J, Cherwin C, Curry M, Garje R, Vikas P, Sugg S, Phadke S, Filardo E, Mangalam AK. Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria. Sci Rep 2023;13:526. [PMID: 36631533 DOI: 10.1038/s41598-023-27436-3] [Reference Citation Analysis]
318 Zou Y, Zhang G, Li C, Long H, Chen D, Li Z, Ouyang G, Zhang W, Zhang Y, Wang Z. Discovery of Tryptanthrin and Its Derivatives and Its Activities against NSCLC In Vitro via Both Apoptosis and Autophagy Pathways. Int J Mol Sci 2023;24. [PMID: 36674964 DOI: 10.3390/ijms24021450] [Reference Citation Analysis]
319 Chen X, Yu L, Zhou J, Ren J, Wang S, Tan Y, Ding Y. Inhibition of p62 and/or NFE2L2 induced autophagy impaires esophageal squamous cell cancer metastasis by reversing EMT. Gene 2023;858:147194. [PMID: 36641074 DOI: 10.1016/j.gene.2023.147194] [Reference Citation Analysis]
320 Li J, Shi S, Liu J, Liang C, Hua J, Meng Q, Xu H, Wei M, Zhang B, Xu J, Wang W, Yu X. Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resectable body and tail pancreatic adenocarcinoma: protocol of a multicenter, prospective, randomized phase III control trial (CSPAC-3).. [DOI: 10.21203/rs.3.rs-2331879/v1] [Reference Citation Analysis]
321 Mosavi Z, Bashi Zadeh Fakhar H, Rezaei-Tavirani M, Akbari ME, Rostami F. Proteome profiling of ductal carcinoma in situ. Breast Dis 2022;41:513-20. [PMID: 36641653 DOI: 10.3233/BD-220017] [Reference Citation Analysis]
322 Hanžek A, Ducongé F, Siatka C, Duc AE. Identification and Characterization of Aptamers Targeting Ovarian Cancer Biomarker Human Epididymis Protein 4 for the Application in Urine. Cancers (Basel) 2023;15. [PMID: 36672400 DOI: 10.3390/cancers15020452] [Reference Citation Analysis]
323 Yi X, Zhang C, Liu B, Gao G, Tang Y, Lu Y, Pan Z, Wang G, Feng W. Ribosomal protein L22-like1 promotes prostate cancer progression by activating PI3K/Akt/mTOR signalling pathway. J Cell Mol Med 2023;27:403-11. [PMID: 36625246 DOI: 10.1111/jcmm.17663] [Reference Citation Analysis]
324 Thongsom S, Racha S, Ei ZZ, Petsri K, Aksorn N, Chamni S, Panpuang V, Zou H, Chanvorachote P. N,N'-Diarylurea Derivatives (CTPPU) Inhibited NSCLC Cell Growth and Induced Cell Cycle Arrest through Akt/GSK-3β/c-Myc Signaling Pathway. Int J Mol Sci 2023;24. [PMID: 36674871 DOI: 10.3390/ijms24021357] [Reference Citation Analysis]
325 Liu Y, Shen Z, Zhu T, Lu W, Fu Y. Curcumin enhances the anti-cancer efficacy of paclitaxel in ovarian cancer by regulating the miR-9-5p/BRCA1 axis. Front Pharmacol 2022;13:1014933. [PMID: 36703740 DOI: 10.3389/fphar.2022.1014933] [Reference Citation Analysis]
326 Wu LL, Liang SH, Jiang F, Qiu LH, Chen X, Yu WJ, Li CW, Qian JY, Huang YY, Lin P, Long H, Li ZX, Li K, Ma GW, Xie D. The postoperative prognosis of skip-N2 metastasis is favorable in small-cell lung carcinoma patients with pathological N2 classification: a propensity-score-adjusted retrospective multicenter study. Ther Adv Med Oncol 2023;15:17588359221146134. [PMID: 36643656 DOI: 10.1177/17588359221146134] [Reference Citation Analysis]
327 Lo YC, Liu Y, Kammersgaard M, Koladiya A, Keyes TJ, Davis KL. Single-cell technologies uncover intra-tumor heterogeneity in childhood cancers. Semin Immunopathol 2023. [PMID: 36625902 DOI: 10.1007/s00281-022-00981-1] [Reference Citation Analysis]
328 Boys E, Gao B, Hui R, da Silva I, Hau E, Gee H, Nagrial A. Use of durvalumab in stage III non-small-cell lung cancer based on eligibility for the PACIFIC study. Thorac Cancer 2023. [PMID: 36627112 DOI: 10.1111/1759-7714.14780] [Reference Citation Analysis]
329 Li N, Wan Z, Lu D, Chen R, Ye X. Long-term benefit of immunotherapy in a patient with squamous lung cancer exhibiting mismatch repair deficient/high microsatellite instability/high tumor mutational burden: A case report and literature review. Front Immunol 2022;13:1088683. [PMID: 36703977 DOI: 10.3389/fimmu.2022.1088683] [Reference Citation Analysis]
330 Zheng P, Long Z, Gao A, Lu J, Wang S, Zhong C, Lai H, Guo Y, Wang K, Fang C, Mao X. A five-pseudouridylation-associated-LncRNA classifier for primary prostate cancer prognosis prediction. Front Genet 2022;13:1110799. [PMID: 36704346 DOI: 10.3389/fgene.2022.1110799] [Reference Citation Analysis]
331 Wang X, Zhang H, Zong R, Yu W, Wu F, Li Y. Novel models for early prediction and prevention of acute respiratory distress syndrome in patients following hepatectomy: A clinical translational study based on 1,032 patients. Front Med (Lausanne) 2022;9:1025764. [PMID: 36698796 DOI: 10.3389/fmed.2022.1025764] [Reference Citation Analysis]
332 Benson KK, Sheel A, Rahman S, Esnakula A, Manne A. Understanding the Clinical Significance of MUC5AC in Biliary Tract Cancers. Cancers (Basel) 2023;15. [PMID: 36672382 DOI: 10.3390/cancers15020433] [Reference Citation Analysis]
333 Kraft T, Grützmann K, Meinhardt M, Meier F, Westphal D, Seifert M. Patient-specific identification of genome-wide DNA-methylation differences between intracranial and extracranial melanoma metastases. Sci Rep 2023;13:444. [PMID: 36624125 DOI: 10.1038/s41598-022-24940-w] [Reference Citation Analysis]
334 Six KA, Wadhwa A, York JM, Adams K, Henneberg H, Bhatia S, Landier W. The New Oncologic Diagnosis Discussion: Perspectives of Pediatric Oncologists. JCO Oncol Pract 2023;:OP2200558. [PMID: 36623244 DOI: 10.1200/OP.22.00558] [Reference Citation Analysis]
335 Li Y, Lih TM, Dhanasekaran SM, Mannan R, Chen L, Cieslik M, Wu Y, Lu RJ, Clark DJ, Kołodziejczak I, Hong R, Chen S, Zhao Y, Chugh S, Caravan W, Naser Al Deen N, Hosseini N, Newton CJ, Krug K, Xu Y, Cho KC, Hu Y, Zhang Y, Kumar-Sinha C, Ma W, Calinawan A, Wyczalkowski MA, Wendl MC, Wang Y, Guo S, Zhang C, Le A, Dagar A, Hopkins A, Cho H, Leprevost FDV, Jing X, Teo GC, Liu W, Reimers MA, Pachynski R, Lazar AJ, Chinnaiyan AM, Van Tine BA, Zhang B, Rodland KD, Getz G, Mani DR, Wang P, Chen F, Hostetter G, Thiagarajan M, Linehan WM, Fenyö D, Jewell SD, Omenn GS, Mehra R, Wiznerowicz M, Robles AI, Mesri M, Hiltke T, An E, Rodriguez H, Chan DW, Ricketts CJ, Nesvizhskii AI, Zhang H, Ding L; Clinical Proteomic Tumor Analysis Consortium. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer Cell 2023;41:139-163.e17. [PMID: 36563681 DOI: 10.1016/j.ccell.2022.12.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
336 Nolan MB, Piasecki TM, Smith SS, Baker TB, Fiore MC, Adsit RT, Bolt DM, Conner KL, Bernstein SL, Eng OD, Lazuk D, Gonzalez A, Hayes-Birchler T, Jorenby DE, D'Angelo H, Kirsch JA, Williams BS, Kent S, Kim H, Lubanski SA, Yu M, Suk Y, Cai Y, Kashyap N, Mathew J, McMahan G, Rolland B, Tindle HA, Warren GW, Abu-El-Rub N, An LC, Boyd AD, Brunzell DH, Carrillo VA, Chen LS, Davis JM, Deshmukh VG, Dilip D, Goldstein AO, Ha PK, Iturrate E, Jose T, Khanna N, King A, Klass E, Lui M, Mermelstein RJ, Poon C, Tong E, Wilson KM, Theobald WE, Slutske WS. Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin. Cancer Epidemiol Biomarkers Prev 2023;32:12-21. [PMID: 35965473 DOI: 10.1158/1055-9965.EPI-22-0500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
337 Lin Y, Tan H, Yu G, Zhan M, Xu B. Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer. Int J Mol Sci 2023;24. [PMID: 36674820 DOI: 10.3390/ijms24021305] [Reference Citation Analysis]
338 Liu S, Zhen L, Zhang S, Cai Y, Lin Y, Chen F, Li X, You Q, Lai X, Lai H, Zheng X, Yi H. Comparison of prognosis of patients with endometrial cancer after hysteroscopy versus dilatation and curettage: A multicenter retrospective study. Front Med (Lausanne) 2022;9:1097133. [PMID: 36698830 DOI: 10.3389/fmed.2022.1097133] [Reference Citation Analysis]
339 Aibel C, Coll De Peña A, Tripathi A. An Optimized CoBRA Method for the Microfluidic Electrophoresis Detection of Breast Cancer Associated RASSF1 Methylation. BioTech (Basel) 2023;12:7. [PMID: 36648833 DOI: 10.3390/biotech12010007] [Reference Citation Analysis]
340 Wang X, Zhang C, Song H, Yuan J, Zhang L, He J. CircCCDC66: Emerging roles and potential clinical values in malignant tumors. Front Oncol 2022;12:1061007. [PMID: 36698408 DOI: 10.3389/fonc.2022.1061007] [Reference Citation Analysis]
341 Song H, Su Q, Nie Y, Zhang C, Huang P, Shi S, Liu Q, Wang W. Supramolecular assembly of a trivalent peptide hydrogel vaccine for cancer immunotherapy. Acta Biomater 2023:S1742-7061(22)00887-X. [PMID: 36632876 DOI: 10.1016/j.actbio.2022.12.070] [Reference Citation Analysis]
342 Zhou B, Zang R, Song P, Zhang M, Bie F, Bai G, Li Y, Huai Q, Han Y, Gao S. Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study. J Transl Med 2023;21:10. [PMID: 36624443 DOI: 10.1186/s12967-022-03857-y] [Reference Citation Analysis]
343 Trinidad-Calderón PA, Varela-Chinchilla CD, García-Lara S. Depsipeptides Targeting Tumor Cells: Milestones from In Vitro to Clinical Trials. Molecules 2023;28. [PMID: 36677728 DOI: 10.3390/molecules28020670] [Reference Citation Analysis]
344 Guo L, Kong D, Liu J, Zhan L, Luo L, Zheng W, Zheng Q, Chen C, Sun S. Breast cancer heterogeneity and its implication in personalized precision therapy. Exp Hematol Oncol 2023;12:3. [PMID: 36624542 DOI: 10.1186/s40164-022-00363-1] [Reference Citation Analysis]
345 Ohlsen TJD, Doody DR, Mueller BA, Desai AD, Chow EJ. Population-Based Impact of Rurality and Neighborhood-Level Socioeconomic Disadvantage on Pediatric Cancer Mortality in Washington State. Cancer Epidemiol Biomarkers Prev 2023;32:141-8. [PMID: 36343539 DOI: 10.1158/1055-9965.EPI-22-0897] [Reference Citation Analysis]
346 Akinyemiju T, Chen Q, Wilson LE, Previs RA, Joshi A, Liang M, Pisu M, Ward KC, Berchuck A, Schymura MJ, Huang B. Healthcare Access Domains Mediate Racial Disparities in Ovarian Cancer Treatment Quality in a US Patient Cohort: A Structural Equation Modelling Analysis. Cancer Epidemiol Biomarkers Prev 2023;32:74-81. [PMID: 36306380 DOI: 10.1158/1055-9965.EPI-22-0650] [Reference Citation Analysis]
347 Tsochantaridis I, Roupas A, Mohlin S, Pappa A, Voulgaridou GP. The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression. Life (Basel) 2023;13. [PMID: 36676146 DOI: 10.3390/life13010197] [Reference Citation Analysis]
348 Christopher CN, Matthews CE, Saint-Maurice PF, Keadle SK. Impact of Moderate-Vigorous Physical Activity Trajectories on Colon Cancer Risk over the Adult Life Course. Cancer Epidemiol Biomarkers Prev 2023;32:30-6. [PMID: 36306403 DOI: 10.1158/1055-9965.EPI-22-0768] [Reference Citation Analysis]
349 Zaffaroni N, Beretta GL. The Therapeutic Potential of Pyroptosis in Melanoma. Int J Mol Sci 2023;24. [PMID: 36674798 DOI: 10.3390/ijms24021285] [Reference Citation Analysis]
350 Zhang Y, Liu YL, Nie K, Zhou J, Chen Z, Chen JH, Wang X, Kim B, Parajuli R, Mehta RS, Wang M, Su MY. Deep Learning-based Automatic Diagnosis of Breast Cancer on MRI Using Mask R-CNN for Detection Followed by ResNet50 for Classification. Acad Radiol 2023:S1076-6332(22)00695-X. [PMID: 36631349 DOI: 10.1016/j.acra.2022.12.038] [Reference Citation Analysis]
351 Steel H, Park SY, Lim T, Stram DO, Boushey CJ, Hébert JR, Le Marchand L, Wu AH, Setiawan VW. Diet Quality and Pancreatic Cancer Incidence in the Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev 2023;32:123-31. [PMID: 36306381 DOI: 10.1158/1055-9965.EPI-22-0564] [Reference Citation Analysis]
352 Zhang H, Chen B, Waliullah ASM, Aramaki S, Ping Y, Takanashi Y, Zhang C, Zhai Q, Yan J, Oyama S, Kahyo T, Setou M. A New Potential Therapeutic Target for Cancer in Ubiquitin-Like Proteins-UBL3. Int J Mol Sci 2023;24. [PMID: 36674743 DOI: 10.3390/ijms24021231] [Reference Citation Analysis]
353 Almetrek MA, Mahjari AA, Aldharman SS, Amer KA, Balobaid MF, Madkhali A, Alsayary AM, Alsubaie SF. Surgical Intervention for Spinal Lesions Due to Multiple Myeloma: A Case Report. Cureus 2023. [DOI: 10.7759/cureus.33505] [Reference Citation Analysis]
354 Lauria G, Curcio R, Lunetti P, Tiziani S, Coppola V, Dolce V, Fiermonte G, Ahmed A. Role of Mitochondrial Transporters on Metabolic Rewiring of Pancreatic Adenocarcinoma: A Comprehensive Review. Cancers (Basel) 2023;15. [PMID: 36672360 DOI: 10.3390/cancers15020411] [Reference Citation Analysis]
355 Di Costanzo F, Di Costanzo F, Antonuzzo L, Mazza E, Giommoni E. Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine. Cancers (Basel) 2023;15. [PMID: 36672366 DOI: 10.3390/cancers15020416] [Reference Citation Analysis]
356 Ke C, Dai S, Xu F, Yuan J, Fan S, Chen Y, Yang L, Li Y. Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma. BMC Cancer 2023;23:25. [PMID: 36611155 DOI: 10.1186/s12885-022-10461-2] [Reference Citation Analysis]
357 Yu C, Wang S, Lai WF, Zhang D. The Progress of Chitosan-Based Nanoparticles for Intravesical Bladder Cancer Treatment. Pharmaceutics 2023;15. [PMID: 36678840 DOI: 10.3390/pharmaceutics15010211] [Reference Citation Analysis]
358 Ni L, Chen K, Phuong C, Sabbagh AR, Wong AC, Mohamad O, Hsu IC. Outcomes of salvage high dose-rate brachytherapy with or without pelvic external beam radiotherapy in patients with palpable local recurrence of prostate cancer after radical prostatectomy. Brachytherapy 2023:S1538-4721(22)00386-5. [PMID: 36623988 DOI: 10.1016/j.brachy.2022.12.002] [Reference Citation Analysis]
359 Wu Y, Xu S, Cheng S, Yang J, Wang Y. Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status. J Ovarian Res 2023;16:6. [PMID: 36611214 DOI: 10.1186/s13048-023-01094-5] [Reference Citation Analysis]
360 Wang Z, Cheng S, Liu Y, Zhao R, Zhang J, Zhou X, Shu W, Feng D, Wang H. Gene signature and prognostic value of ubiquitination-related genes in endometrial cancer. World J Surg Oncol 2023;21:3. [PMID: 36611207 DOI: 10.1186/s12957-022-02875-w] [Reference Citation Analysis]
361 Tian Y, Pang Y, Yang P, Guo H, Liu Y, Zhang Z, Ding P, Zheng T, Li Y, Fan L, Zhang Z, Zhao X, Tan B, Wang D, Zhao Q. The safety and efficacy of carbon nanoparticle suspension injection versus indocyanine green tracer-guided lymph node dissection during radical gastrectomy (FUTURE-01): A single-center randomized controlled trial protocol. Front Oncol 2022;12:1044854. [PMID: 36686792 DOI: 10.3389/fonc.2022.1044854] [Reference Citation Analysis]
362 Gattoni G, de la Haba RR, Martín J, Reyes F, Sánchez-Porro C, Feola A, Zuchegna C, Guerrero-Flores S, Varcamonti M, Ricca E, Selem-Mojica N, Ventosa A, Corral P. Genomic study and lipidomic bioassay of Leeuwenhoekiella parthenopeia: A novel rare biosphere marine bacterium that inhibits tumor cell viability. Front Microbiol 2022;13:1090197. [PMID: 36687661 DOI: 10.3389/fmicb.2022.1090197] [Reference Citation Analysis]
363 Yuan S, He SH, Li LY, Xi S, Weng H, Zhang JH, Wang DQ, Guo MM, Zhang H, Wang SY, Ming DJ, Liu MY, Hu H, Zeng XT. A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m(6)A reader YTHDC1. Cell Death Dis 2023;14:7. [PMID: 36609444 DOI: 10.1038/s41419-022-05544-8] [Reference Citation Analysis]
364 Mao W, Qu J, Zhong S, Wu X, Mao K, Liao K, jin H. Associations between urinary parabens and lung cancer.. [DOI: 10.21203/rs.3.rs-2303735/v1] [Reference Citation Analysis]
365 Ren Z, Yang J, Liang J, Xu Y, Lu G, Han Y, Zhu J, Tan H, Xu T, Ren M. Monitoring of postoperative neutrophil-to-lymphocyte ratio, D-dimer, and CA153 in: Diagnostic value for recurrent and metastatic breast cancer. Front Surg 2022;9:927491. [PMID: 36684341 DOI: 10.3389/fsurg.2022.927491] [Reference Citation Analysis]
366 Lin J, Nousome D, Jiang J, Chesnut GT, Shriver CD, Zhu K. Five-year survival of patients with late-stage prostate cancer: comparison of the Military Health System and the U.S. general population. Br J Cancer 2023. [PMID: 36609596 DOI: 10.1038/s41416-022-02136-3] [Reference Citation Analysis]
367 Sutandyo N, Hanafi AR, Jayusman AM, Kurniawati SA, Hanif MA. Overweight and Obesity are Associated with Poorer Survival Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemotherapy. Int J Gen Med 2023;16:85-93. [PMID: 36636716 DOI: 10.2147/IJGM.S382577] [Reference Citation Analysis]
368 Wang W, Huang Q, Liao Z, Zhang H, Liu Y, Liu F, Chen X, Zhang B, Chen Y, Zhu P. ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner. Exp Hematol Oncol 2023;12:1. [PMID: 36609413 DOI: 10.1186/s40164-022-00370-2] [Reference Citation Analysis]
369 Mirza S, Bhadresha K, Mughal MJ, McCabe M, Shahbazi R, Ruff P, Penny C. Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet? Front Oncol 2022;12:1023565. [PMID: 36686736 DOI: 10.3389/fonc.2022.1023565] [Reference Citation Analysis]
370 Wu S, Ma X, Zhang X, Yang C, Wang Y, Liu Y. Survival outcomes of autologous breast reconstruction after mastectomy: A matched case-control study. Front Oncol 2022;12:1022925. [PMID: 36686843 DOI: 10.3389/fonc.2022.1022925] [Reference Citation Analysis]
371 Gu Z, Zheng Z, Zhang W, Mao S, Wang S, Geng J, Yao X. The development and assessment of a predicting nomogram for the recovery of immediate urinary continence following laparoscopic radical prostatectomy. Front Surg 2022;9:1071093. [PMID: 36684134 DOI: 10.3389/fsurg.2022.1071093] [Reference Citation Analysis]
372 Voss JK, Ebner DW, Burger KN, Mahoney DW, Devens ME, Lowrie KL, Kisiel JB. Multitarget Stool DNA Testing Has High Positive Predictive Value for Colorectal Neoplasia on the Second Round of Testing. Clin Gastroenterol Hepatol 2023:S1542-3565(23)00004-6. [PMID: 36621751 DOI: 10.1016/j.cgh.2022.12.026] [Reference Citation Analysis]
373 Li J, Wang SR, Li QL, Zhu T, Zhu PS, Chen M, Cui XW. Diagnostic value of multiple ultrasound diagnostic techniques for axillary lymph node metastases in breast cancer: A systematic analysis and network meta-analysis. Front Oncol 2022;12:1043185. [PMID: 36686798 DOI: 10.3389/fonc.2022.1043185] [Reference Citation Analysis]
374 Chang L, Hung S, Chen C, Li J, Chiu K, Wang S, Yang C, Lu K, Chen C, Wang S, Lin C, Cheng C, Ou Y, Yang S. Geriatric Nutritional Risk Index as a Prognostic Marker for Patients with Upper Tract Urothelial Carcinoma Receiving Radical Nephroureterectomy.. [DOI: 10.21203/rs.3.rs-2431529/v1] [Reference Citation Analysis]
375 Gromowski T, Lukacs-Kornek V, Cisowski J. Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination. Cancer Cell Int 2023;23:3. [PMID: 36609378 DOI: 10.1186/s12935-022-02843-0] [Reference Citation Analysis]
376 Yang M, Ji W, Xu N, Zong C, Gu J, Guo X, Zhang L. Association of vitamin D receptor polymorphisms with colorectal cancer susceptibility: A systematic meta-analysis. Medicine (Baltimore) 2023;102:e32575. [PMID: 36607855 DOI: 10.1097/MD.0000000000032575] [Reference Citation Analysis]
377 Kang X, Wang Y, Liu P, Huang B, Zhou B, Lu S, Geng W, Tang H. Progresses, Challenges, and Prospects of CRISPR/Cas9 Gene-Editing in Glioma Studies. Cancers (Basel) 2023;15. [PMID: 36672345 DOI: 10.3390/cancers15020396] [Reference Citation Analysis]
378 Schuch LF, Viana KSS, Arruda JAA, Abreu LG, Aguiar MCF, Bernardes VF. Effects of tobacco on the DNA of smokers and non-smokers affected by OSCC: systematic review and meta-analysis. Braz Oral Res 2023;37:e008. [PMID: 36629591 DOI: 10.1590/1807-3107bor-2023.vol37.0008] [Reference Citation Analysis]
379 Patra T, Cunningham DM, Meyer K, Toth K, Ray RB, Heczey A, Ray R. Targeting Lin28 axis enhances glypican-3-CAR T cell efficacy against hepatic tumor initiating cell population. Mol Ther 2023:S1525-0016(23)00002-3. [PMID: 36609146 DOI: 10.1016/j.ymthe.2023.01.002] [Reference Citation Analysis]
380 Wang G, Sun X, Li T, Xu M, Guo M, Liu C, Xie M. Study of the short-term quality of life of patients with esophageal cancer after inflatable videoassisted mediastinoscopic transhiatal esophagectomy. Front Surg 2022;9:981576. [PMID: 36684129 DOI: 10.3389/fsurg.2022.981576] [Reference Citation Analysis]
381 Wang L, Zhu L, Yan J, Qin W, Wang C, Xi W, Xu Z, Chen Y, Jiang J, Huang S, Yan C, Zhang H, Pan Z, Zhang J. CT-Based Radiomic Score: A Risk Stratifier in Far-Advanced Gastric Cancer Patients. Acad Radiol 2023:S1076-6332(22)00688-2. [PMID: 36610930 DOI: 10.1016/j.acra.2022.12.034] [Reference Citation Analysis]
382 Xiang Q, Li D, Cheng C, Xu K, Zuo C. (68)Ga-HBED-CC-WL-12 PET in Diagnosing and Differentiating Pancreatic Cancers in Murine Models. Pharmaceuticals (Basel) 2023;16. [PMID: 36678577 DOI: 10.3390/ph16010080] [Reference Citation Analysis]
383 Chowdhury S, Ramchandran R, Palecek SP, Acevedo-Acevedo S, Bishop E. Sucrose Nonfermenting-Related Kinase Expression Is Related to a Metabolic Switch in Ovarian Cancer Cells That Results in Increased Fatty Acid Oxidation. Cancer Invest 2023;:1-15. [PMID: 36227231 DOI: 10.1080/07357907.2022.2136376] [Reference Citation Analysis]
384 Ma H, Wang X, Zhao J, Ma R, Wang Q, Liu J, Qiao J, Wu J, An J, Liu Y, Xing Y, Ma X, Wu Q, Wang H, Su Z. Prognostic Biomarkers Based On GUF1, EFTUD2 and GSPT1 Targets Affecting Migration of Gastric Cancer Cells.. [DOI: 10.21203/rs.3.rs-2407964/v1] [Reference Citation Analysis]
385 Hua Q, Lu Y, Wang D, Da J, Peng W, Sun G, Gu K, Wang H, Zhu Y. KIAA1199 promotes oxaliplatin resistance and epithelial mesenchymal transition of colorectal cancer via protein O-GlcNAcylation. Transl Oncol 2023;28:101617. [PMID: 36610242 DOI: 10.1016/j.tranon.2023.101617] [Reference Citation Analysis]
386 Liu T, Li M, Cheng W, Yao Q, Xue Y, Wang X, Jin H. A clinical prognostic model for patients with esophageal squamous cell carcinoma based on circulating tumor DNA mutation features. Front Oncol 2022;12:1025284. [PMID: 36686833 DOI: 10.3389/fonc.2022.1025284] [Reference Citation Analysis]
387 Zidan ASA, Ibrahim ABM, Aly AAM, Mosbah HK, Mayer P, Saber SH. Synthesis, Solid State Structure, and Cytotoxic Activity of a Complex Dimer of Yttrium with Anthranilic Acid against Cancer Cells. Biol Trace Elem Res 2023. [PMID: 36602747 DOI: 10.1007/s12011-022-03545-4] [Reference Citation Analysis]
388 Baban F, Auen T, Eschbacher KL, Swanson AA, Hartley CP. Invasive urothelial carcinoma with squamous differentiation and associated high-risk human papilloma virus infection: Clinical, cytologic, and histologic features of a rare entity. Ann Diagn Pathol 2023;63:152103. [PMID: 36640642 DOI: 10.1016/j.anndiagpath.2022.152103] [Reference Citation Analysis]
389 Yu X, Luo B, Lin J, Zhu Y. Alternative splicing event associated with immunological features in bladder cancer. Front Oncol 2022;12:966088. [PMID: 36686818 DOI: 10.3389/fonc.2022.966088] [Reference Citation Analysis]
390 Shang R, Chen J, Gao Y, Chen J, Han G. TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP. Dis Markers 2023;2023:5899662. [PMID: 36644609 DOI: 10.1155/2023/5899662] [Reference Citation Analysis]
391 Zeng XL, Heneghan MB, Badawy SM. Adherence to Oral Chemotherapy in Acute Lymphoblastic Leukemia during Maintenance Therapy in Children, Adolescents, and Young Adults: A Systematic Review. Curr Oncol 2023;30:720-48. [PMID: 36661705 DOI: 10.3390/curroncol30010056] [Reference Citation Analysis]
392 Abidoye O, Cho YM, Bhushan S, Adewunmi C, Choudhury H. Trends in pancreatic cancer incidence and mortality in the United States from 2000 to 2019; a SEER based study. F1000Res 2023;12:15. [DOI: 10.12688/f1000research.122872.1] [Reference Citation Analysis]
393 Wang F, Gu Z, Zhao X, Chen Z, Zhang Z, Sun S, Han M. Metabolic characteristics of the various incision margins for breast cancer conservation surgery. Front Oncol 2022;12:959454. [PMID: 36686765 DOI: 10.3389/fonc.2022.959454] [Reference Citation Analysis]
394 Pan LF, Chang R, Hsu CY, Tsui KH. Older veterans associated with reduced risk of cancer: Retrospective nationwide matched cohort study in Taiwan. Front Med (Lausanne) 2022;9:931565. [PMID: 36687435 DOI: 10.3389/fmed.2022.931565] [Reference Citation Analysis]
395 Hua H, Xie H, Zheng J, Lei L, Deng Z, Yu C. RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway. Oxid Med Cell Longev 2023;2023:1728463. [PMID: 36644576 DOI: 10.1155/2023/1728463] [Reference Citation Analysis]
396 Pan Y, Lu X, Shu G, Cen J, Lu J, Zhou M, Huang K, Dong J, Li J, Lin H, Song H, Xu Q, Han H, Chen Z, Chen W, Luo J, Wei J, Zhang J. Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma. Cancer Res 2023;83:103-16. [PMID: 36264173 DOI: 10.1158/0008-5472.CAN-21-3432] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
397 Shu X, Liu Y, Qiao X, Ai G, Liu L, Liao J, Deng Z, He X. Radiomic-based machine learning model for the accurate prediction of prostate cancer risk stratification. Br J Radiol 2023;:20220238. [PMID: 36475858 DOI: 10.1259/bjr.20220238] [Reference Citation Analysis]
398 Chen G, Song Y, Zheng Z, Ai Y, Lv X. RNA Binding Protein-related bioinformatics analysis reveals that PCF11 is a prognostic biomarker in oral squamous cell carcinoma.. [DOI: 10.21203/rs.3.rs-2390648/v1] [Reference Citation Analysis]
399 Li Q, Tong D, Jing X, Ma P, Li F, Jiang Q, Zhang J, Wen H, Cui M, Huang C, Zhang M. MAD2L1 is transcriptionally regulated by TEAD4 and promotes cell proliferation and migration in colorectal cancer. Cancer Gene Ther 2023. [PMID: 36599972 DOI: 10.1038/s41417-022-00586-8] [Reference Citation Analysis]
400 Zhu L, Lu W, Wang F, Wang Y, Wu PY, Zhou J, Liu H. Study of T2 mapping in quantifying and discriminating uterine lesions under different magnetic field strengths: 1.5 T vs. 3.0 T. BMC Med Imaging 2023;23:1. [PMID: 36600192 DOI: 10.1186/s12880-022-00960-w] [Reference Citation Analysis]
401 Shen X, Shang L, Han J, Zhang Y, Niu W, Liu H, Shi H. Immune-related gene signature associates with immune landscape and predicts prognosis accurately in patients with skin cutaneous melanoma. Front Genet 2022;13:1095867. [PMID: 36685954 DOI: 10.3389/fgene.2022.1095867] [Reference Citation Analysis]
402 Kola P, Nagesh PKB, Roy PK, Deepak K, Reis RL, Kundu SC, Mandal M. Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo- and radioresistances. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2023;:e1876. [PMID: 36600447 DOI: 10.1002/wnan.1876] [Reference Citation Analysis]
403 Yang J, Liu Q, Bai Y, Zhao H, He T, Zhao Z, Huang M, Jiang M, Zhang R, Zhang M. Prognostic value of lymph node micrometastasis in esophageal cancer: A systematic review and meta-analysis. Front Oncol 2022;12:1025855. [PMID: 36686727 DOI: 10.3389/fonc.2022.1025855] [Reference Citation Analysis]
404 Muley H, Valencia K, Casas J, Moreno B, Botella L, Lecanda F, Fadó R, Casals N. Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer. Int J Mol Sci 2023;24. [PMID: 36674468 DOI: 10.3390/ijms24020946] [Reference Citation Analysis]
405 Chen JL, Pan CK, Lin LC, Tsai CY, Kuo CY, Huang YS, Lin YL. Therapeutic efficacy of cyclin-dependent kinase inhibition in combination with ionizing radiation for lung cancer. Int J Radiat Biol 2023;:1-10. [PMID: 36598432 DOI: 10.1080/09553002.2023.2161658] [Reference Citation Analysis]
406 Wu Q, Zhao S, Huang Y, Wang J, Tang W, Zhou L, Qi L, Zhang Z, Xie Y, Zhang J, Li H, Wu N. Correlation between lung cancer probability and number of pulmonary nodules in baseline computed tomography lung cancer screening: A retrospective study based on the Chinese population. Front Oncol 2022;12:1061242. [PMID: 36686791 DOI: 10.3389/fonc.2022.1061242] [Reference Citation Analysis]
407 Sakellakis M, Chalkias A. The Role οf Ion Channels in the Development and Progression of Prostate Cancer. Mol Diagn Ther 2023. [PMID: 36600143 DOI: 10.1007/s40291-022-00636-9] [Reference Citation Analysis]
408 Chen Q, Zhu S, Jiao N, Zhang Z, Gao G, Zheng W, Feng G, Han W. Improvement in the performance of an autoantibody panel in combination with heat shock protein 90a for the detection of early‑stage lung cancer. Exp Ther Med 2023;25:82. [PMID: 36741915 DOI: 10.3892/etm.2023.11781] [Reference Citation Analysis]
409 Chhaya S, Watts I, Ng K, Mustapha R, Powles T, Sharma A, Vasdev N. Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer. Oncol Ther 2023. [PMID: 36595203 DOI: 10.1007/s40487-022-00218-z] [Reference Citation Analysis]
410 Mehrabian A, Dadpour S, Mashreghi M, Zarqi J, Askarizadeh A, Badiee A, Arabi L, Moosavian SA, Jaafari MR. The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre-insertion and post-insertion methods for brain delivery in normal mice. IET Nanobiotechnol 2023. [PMID: 36594666 DOI: 10.1049/nbt2.12111] [Reference Citation Analysis]
411 Huang Y, Chen M, Zhang Y, Chen X, Zhang L, Dong C. Finding family resilience in adversity: A grounded theory of families with children diagnosed with leukaemia. J Clin Nurs 2023. [PMID: 36597215 DOI: 10.1111/jocn.16615] [Reference Citation Analysis]
412 Liu YM, Ge JY, Chen YF, Liu T, Chen L, Liu CC, Ma D, Chen YY, Cai YW, Xu YY, Shao ZM, Yu KD. Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination. Adv Sci (Weinh) 2023;:e2205395. [PMID: 36594618 DOI: 10.1002/advs.202205395] [Reference Citation Analysis]
413 Mobley EM, Guerrier C, Tfirn I, Gutter MS, Vigal K, Pather K, Braithwaite D, Nataliansyah MM, Tsai S, Baskovich B, Awad ZT, Parker AS. Impact of Medicaid Expansion on Stage at Diagnosis for US Adults with Pancreatic Cancer: a Population-Based Study. J Racial Ethn Health Disparities 2023. [PMID: 36596980 DOI: 10.1007/s40615-022-01459-4] [Reference Citation Analysis]
414 Ilovaisky AI, Scherbakov AM, Merkulova VM, Chernoburova EI, Shchetinina MA, Andreeva OE, Salnikova DI, Zavarzin IV, Terent'ev AO. Secosteroid-quinoline hybrids as new anticancer agents. J Steroid Biochem Mol Biol 2023;228:106245. [PMID: 36608906 DOI: 10.1016/j.jsbmb.2022.106245] [Reference Citation Analysis]
415 Okuno K, Xu C, Pascual-Sabater S, Tokunaga M, Takayama T, Han H, Fillat C, Kinugasa Y, Goel A. Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma. Biomedicines 2023;11. [PMID: 36672630 DOI: 10.3390/biomedicines11010119] [Reference Citation Analysis]
416 Bhuimali M, Munshi S, Hapa K, Kadu PK, Kale PP. Evaluation of liposomes for targeted drug delivery in lung cancer treatment. International Journal of Polymeric Materials and Polymeric Biomaterials 2023. [DOI: 10.1080/00914037.2022.2163639] [Reference Citation Analysis]
417 Lidström T, Cumming J, Gaur R, Frängsmyr L, Pateras IS, Mickert MJ, Franklin O, Forsell MNE, Arnberg N, Dongre M, Patthey C, Öhlund D. Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer. Cancer Immunol Res 2023;11:72-92. [PMID: 36478037 DOI: 10.1158/2326-6066.CIR-21-1088] [Reference Citation Analysis]
418 Mashayekhi M, Asadi M, Hashemzadeh S, Vahedi A, Shanehbandi D, Al-Omar AF, Akbari M, Raeisi M. Promoter methylation levels of RASSF1 and ATIC genes are associated with lung cancer in Iranian patients. Horm Mol Biol Clin Investig 2023. [PMID: 36584330 DOI: 10.1515/hmbci-2022-0007] [Reference Citation Analysis]
419 Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, López-Vacas R, Zapater-Moros A, López-Camacho E, Lumbreras-Herrera MI, Soriano V, Garicano F, Lecumberri MJ, Rodríguez de la Borbolla M, Majem M, Pérez-Ruiz E, González-Cao M, Oramas J, Magdaleno A, Fra J, Martín-Carnicero A, Corral M, Puértolas T, Ramos R, Fresno Vara JÁ, Espinosa E. Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma. Int J Mol Sci 2023;24. [PMID: 36614248 DOI: 10.3390/ijms24010801] [Reference Citation Analysis]
420 Zhao Q, Wang Y, Huo T, Li F, Zhou L, Feng Y, Wei Z. Exploration of Risk Factors for Pancreatic Cancer and Development of a Clinical High-Risk Group Rating Scale. J Clin Med 2023;12. [PMID: 36615158 DOI: 10.3390/jcm12010358] [Reference Citation Analysis]
421 Wang Y, Li M, Zhang X, Ji H, Wang W, Han N, Li H, Xu X, Lan X. (18)F-5-FPN: A Specific Probe for Monitoring Photothermal Therapy Response in Malignant Melanoma. Mol Pharm 2023;20:572-81. [PMID: 36382713 DOI: 10.1021/acs.molpharmaceut.2c00742] [Reference Citation Analysis]
422 Fwelo P, Adzrago D, Adekunle AD, Adekunle TE, Akinlo A, Perkinson WB. Relationship between mental health disorder symptoms and negative cancer perceptions among U.S. adults. Cancer Causes Control 2023. [PMID: 36593424 DOI: 10.1007/s10552-022-01665-9] [Reference Citation Analysis]
423 Aguiar JA, Li EV, Siddiqui MR, Soliman MA, Kumar SKSR, Schaeffer EM, Keeter MK, Brown CH, Szymaniak BM, Ross AE. Utilization of genetic testing in men with advanced prostate cancer. Prostate 2023. [PMID: 36591888 DOI: 10.1002/pros.24480] [Reference Citation Analysis]
424 Dai J, Liu X, Li J, Qu T, Cui Y, Jin S, Zhang E, Guo R. Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR-TKIs in advanced non-small cell lung cancer: A systematic review and network meta-analysis. Thorac Cancer 2023. [PMID: 36594109 DOI: 10.1111/1759-7714.14783] [Reference Citation Analysis]
425 Ponce S, Zhang H. Developing quantitative assays for six urinary glycoproteins using parallel reaction monitoring, data-independent acquisition, and TMT-based data-dependent acquisition. Proteomics 2023;:e2200072. [PMID: 36592098 DOI: 10.1002/pmic.202200072] [Reference Citation Analysis]
426 Meireles S, Dias N, Martins D, Dias C, Gonçalves M, Silva J, Silva CM, Oliveira PD, Soares P, Lopes JM. Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma. Diagnostics (Basel) 2023;13. [PMID: 36611446 DOI: 10.3390/diagnostics13010153] [Reference Citation Analysis]
427 Mato AR, Hess LM, Chen Y, Abada PB, Konig H, Pagel JM, Walgren RA. Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database Study. Clin Lymphoma Myeloma Leuk 2023;23:57-67. [PMID: 36335022 DOI: 10.1016/j.clml.2022.09.007] [Reference Citation Analysis]
428 Li J, Shen C, Qiu H, Wang J, Yue X, Dai L, Huang Y, Li T, Fang Q, Zhi Y, Shi C, Li W. Intravesical IR-780 instillation prevents radiation cystitis by protecting urothelial integrity. Neurourol Urodyn 2023;42:40-8. [PMID: 36208109 DOI: 10.1002/nau.25056] [Reference Citation Analysis]
429 Yuan X, Lau H, Shen Y, Huang Q, Huang H, Zhang M, Tao L, Hsueh C, Gong H, Zhou L. Tumour microbiota structure predicts hypopharyngeal carcinoma recurrence and metastasis. Journal of Oral Microbiology 2023;15. [DOI: 10.1080/20002297.2022.2146378] [Reference Citation Analysis]
430 He J, Liu Y, Liu C, Hu H, Sun L, Xu D, Li J, Wang J, Chen X, Lin R, Jiang Y, Zhang Y, Zhang W, Cheng Y, Wu X, Fang M, Li E, Xu Y, Chen Y, Li J, Cui Y, Pan Z, Zhang S, Yuan Y, Ding K. A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol. Technol Cancer Res Treat 2023;22:15330338231152350. [PMID: 36727222 DOI: 10.1177/15330338231152350] [Reference Citation Analysis]
431 Arzmi MH, P. P. Abdul Majeed A, Muazu Musa R, Mohd Razman MA, Gan H, Mohd Khairuddin I, Ab. Nasir AF. Epidemiology, Detection and Management of Cancer: An Overview. Deep Learning in Cancer Diagnostics 2023. [DOI: 10.1007/978-981-19-8937-7_1] [Reference Citation Analysis]
432 He Y, Li H, Wang K, Wang J, Zhu Y, Ni S, Liu S. Fourteen years old as the best age cutoff to differentiate prepubertal from pubertal papillary thyroid carcinoma. Head Neck 2023;45:85-94. [PMID: 36200593 DOI: 10.1002/hed.27208] [Reference Citation Analysis]
433 Zhu L, Gao H, Huang S, Cao T, Zhai X, Hu J, Wang T, Dong J, Liu Z, Chen J, Liu J, Zhang Z, Zhou Q. Combination of STING agonist and CXCR3 antagonist disrupts immune tolerance to overcome anti-PD-L1 resistance in lung adenocarcinoma under oxidative stress. Gene 2023;851:146962. [DOI: 10.1016/j.gene.2022.146962] [Reference Citation Analysis]
434 Okugawa K, Yahata H, Ohgami T, Yasunaga M, Asanoma K, Kobayashi H, Kato K. An update of oncologic and obstetric outcomes after abdominal trachelectomy using the FIGO 2018 staging system for cervical cancer: a single-institution retrospective analysis. J Gynecol Oncol 2023;34. [DOI: 10.3802/jgo.2023.34.e41] [Reference Citation Analysis]
435 Üstünsoy S. Resistin as a Biomarker and Applications to Prediabetes. Biomarkers in Diabetes 2023. [DOI: 10.1007/978-3-031-08014-2_4] [Reference Citation Analysis]
436 Park AK, Davidoff C, Bancroft K, Kaplan NM. Pain Management in Lung Cancer Rehabilitation. Lung Cancer Rehabilitation 2023. [DOI: 10.1016/b978-0-323-83404-9.00004-9] [Reference Citation Analysis]
437 Boulenger A, Luo Y, Zhang C, Zhao C, Gao Y, Xiao M, Zhu Q, Tang J. Deep learning-based system for automatic prediction of triple-negative breast cancer from ultrasound images. Med Biol Eng Comput 2023;61:567-78. [PMID: 36542320 DOI: 10.1007/s11517-022-02728-4] [Reference Citation Analysis]
438 Guo S, Xiu J, Kong L, Kong X, Wang H, Lü Z, Xu F, Li J, Ji T, Wang F, Liu H. Micro-tomographic and infrared spectral data mining for breast cancer diagnosis. Optics and Lasers in Engineering 2023;160:107305. [DOI: 10.1016/j.optlaseng.2022.107305] [Reference Citation Analysis]
439 Mo S, Dai W, Wang H, Lan X, Ma C, Su Z, Xiang W, Han L, Luo W, Zhang L, Wang R, Zhang Y, Zhang W, Yang L, Lu R, Guo L, Zheng Y, Huang M, Xu Y, Liang L, Cai S, Cai G. Early detection and prognosis prediction for colorectal cancer by circulating tumour DNA methylation haplotypes: A multicentre cohort study. eClinicalMedicine 2023;55:101717. [DOI: 10.1016/j.eclinm.2022.101717] [Reference Citation Analysis]
440 Velev M, Dalban C, Chevreau C, Gravis G, Negrier S, Laguerre B, Gross-goupil M, Ladoire S, Borchiellini D, Geoffrois L, Joly F, Priou F, Barthelemy P, Laramas M, Narciso B, Thiery-vuillemin A, Berdah J, Ferrari V, Dominique Thomas Q, Mione C, Curcio H, Oudard S, Tantot F, Escudier B, Chabaud S, Albiges L, Thibault C. Efficacy And Safety Of Nivolumab In Bone Metastases From Renal Cell Carcinoma: Results Of The Getug — Afu 26 Nivoren Multicenter Phase Ii Study. European Journal of Cancer 2023. [DOI: 10.1016/j.ejca.2022.12.028] [Reference Citation Analysis]
441 Liu J, Jing W, Wang T, Hu Z, Lu H. Functional metabolomics revealed the dual-activation of cAMP-AMP axis is a novel therapeutic target of pancreatic cancer. Pharmacol Res 2023;187:106554. [PMID: 36379357 DOI: 10.1016/j.phrs.2022.106554] [Reference Citation Analysis]
442 Zhang J, Liu P, Chen J, Yao D, Liu Q, Zhang J, Zhang HW, Leung EL, Yao XJ, Liu L. Upgrade of chrysomycin A as a novel topoisomerase II inhibitor to curb KRAS-mutant lung adenocarcinoma progression. Pharmacol Res 2023;187:106565. [PMID: 36414124 DOI: 10.1016/j.phrs.2022.106565] [Reference Citation Analysis]
443 Hu R, Li Y, Guo Y, Li X, Du S, Liao M, Hou H, Sun H, Zhao S, Su J, Chen X, Yin M. BRD4 inhibitor suppresses melanoma metastasis via the SPINK6/EGFR-EphA2 pathway. Pharmacol Res 2023;187:106609. [PMID: 36516883 DOI: 10.1016/j.phrs.2022.106609] [Reference Citation Analysis]
444 Liu Q, Liu H, Huang X, Fan X, Xiao Z, Yan R, Yao J, An G, Ge Y, Miao J, Liu J. A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer. Cancer Gene Ther 2023;30:192-208. [PMID: 36151333 DOI: 10.1038/s41417-022-00538-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
445 Shan T, Ran X, Li H, Feng G, Zhang S, Zhang X, Zhang L, Lu L, An L, Fu R, Sun K, Wang S, Chen R, Li L, Chen W, Wei W, Zeng H, He J. Disparities in stage at diagnosis for liver cancer in China. Journal of the National Cancer Center 2023. [DOI: 10.1016/j.jncc.2022.12.002] [Reference Citation Analysis]
446 Hossen MB, Islam MA, Reza MS, Kibria MK, Horaira MA, Tuly KF, Faruqe MO, Kabir F, Mollah MNH. Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer. Comput Biol Med 2023;152:106411. [PMID: 36502691 DOI: 10.1016/j.compbiomed.2022.106411] [Reference Citation Analysis]
447 Ibrahim FM, Helal DS, Ali DA, Abd-Ellatif RN, Elkady AM, Sharshar R, Gharib F, Abo Elnasr M, El-Guindy DM. Prognostic role of annexin A2 and cancer-associated fibroblasts in advanced non-small cell lung cancer: Implication in epithelial-mesenchymal transition and gefitinib resistance. Pathol Res Pract 2023;241:154293. [PMID: 36586309 DOI: 10.1016/j.prp.2022.154293] [Reference Citation Analysis]
448 Sun X, Li Y, Lan H, Jiang T, Wan X, Cheng Y. Identification of KCNK1 as a potential prognostic biomarker and therapeutic target of breast cancer. Pathol Res Pract 2023;241:154286. [PMID: 36566598 DOI: 10.1016/j.prp.2022.154286] [Reference Citation Analysis]
449 Li G, Li T, Fu W, Lei C, Hu S. Sym004 anti-EGFR antibody mixture overcomes resistance to anti-EGFR antibodies in metastatic colorectal cancer. Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies 2023. [DOI: 10.1016/b978-0-12-821584-5.00026-2] [Reference Citation Analysis]
450 Wang S, Bei Y, Tian Q, He J, Wang R, Wang Q, Sun L, Ke J, Xie C, Shen P. PFKFB4 facilitates palbociclib resistance in oestrogen receptor-positive breast cancer by enhancing stemness. Cell Prolif 2023;56:e13337. [PMID: 36127291 DOI: 10.1111/cpr.13337] [Reference Citation Analysis]
451 Wang Y, Xia H, Chen B, Wang Y. Rethinking nanoparticulate polymer-drug conjugates for cancer theranostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2023;15:e1828. [PMID: 35734967 DOI: 10.1002/wnan.1828] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
452 Parraga CB, Singh R, Lin R, Tamariz L, Palacio A. Colorectal Cancer Screening disparities among race: A zip code level analysis. Clinical Colorectal Cancer 2023. [DOI: 10.1016/j.clcc.2023.01.001] [Reference Citation Analysis]
453 Garcia-Recio S, Hinoue T, Wheeler GL, Kelly BJ, Garrido-Castro AC, Pascual T, De Cubas AA, Xia Y, Felsheim BM, McClure MB, Rajkovic A, Karaesmen E, Smith MA, Fan C, Ericsson PIG, Sanders ME, Creighton CJ, Bowen J, Leraas K, Burns RT, Coppens S, Wheless A, Rezk S, Garrett AL, Parker JS, Foy KK, Shen H, Park BH, Krop I, Anders C, Gastier-Foster J, Rimawi MF, Nanda R, Lin NU, Isaacs C, Marcom PK, Storniolo AM, Couch FJ, Chandran U, Davis M, Silverstein J, Ropelewski A, Liu MC, Hilsenbeck SG, Norton L, Richardson AL, Symmans WF, Wolff AC, Davidson NE, Carey LA, Lee AV, Balko JM, Hoadley KA, Laird PW, Mardis ER, King TA, Perou CM; AURORA US Network. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nat Cancer 2023;4:128-47. [PMID: 36585450 DOI: 10.1038/s43018-022-00491-x] [Reference Citation Analysis]
454 Hill CS, Herman JM. The Current Role of Radiation in Pancreatic Cancer and Future Directions. Clinical Colorectal Cancer 2023. [DOI: 10.1016/j.clcc.2023.01.002] [Reference Citation Analysis]
455 Wang Y, Ji H, Zhu B, Xing Q, Xie H. Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma. Eur J Immunol 2023;53:e2250105. [PMID: 36367018 DOI: 10.1002/eji.202250105] [Reference Citation Analysis]
456 Stevens VL, Carter BD, Jacobs EJ, McCullough ML, Teras LR, Wang Y. A prospective case-cohort analysis of plasma metabolites and breast cancer risk. Breast Cancer Res 2023;25:5. [PMID: 36650550 DOI: 10.1186/s13058-023-01602-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
457 Farnum A, Parnas M, Hoque Apu E, Cox E, Lefevre N, Contag CH, Saha D. Harnessing insect olfactory neural circuits for detecting and discriminating human cancers. Biosensors and Bioelectronics 2023;219:114814. [DOI: 10.1016/j.bios.2022.114814] [Reference Citation Analysis]
458 Liu H, Li Z, Han X, Li Z, Zhao Y, Liu F, Zhu Z, Lv Y, Liu Z, Zhang N. The prognostic impact of tumor-infiltrating B lymphocytes in patients with solid malignancies: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2023;181:103893. [PMID: 36481308 DOI: 10.1016/j.critrevonc.2022.103893] [Reference Citation Analysis]
459 Boyd LN, Ali M, Leeflang MM, Treglia G, de Vries R, Le Large TY, Besselink MG, Giovannetti E, van Laarhoven HW, Kazemier G. Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data. eClinicalMedicine 2023;55:101747. [DOI: 10.1016/j.eclinm.2022.101747] [Reference Citation Analysis]
460 Shen H, Hu X, Yang X, Chen J, Fu Y, He H, Shi Y, Zeng R, Chang W, Zheng S. Inhibition of BRD4 enhanced the tumor suppression effect of dasatinib in gastric cancer. Med Oncol 2022;40:9. [PMID: 36352160 DOI: 10.1007/s12032-022-01831-8] [Reference Citation Analysis]
461 Lue K, Chen Y, Wu Y, Liu S. Influence of the methodological aspects of the dichotomization of total metabolic tumor volume measured through baseline fluorine-18 fluorodeoxyglucose PET on survival prediction in lymphoma. Nuclear Medicine Communications 2023;44:74-80. [DOI: 10.1097/mnm.0000000000001640] [Reference Citation Analysis]
462 Chen D, Zhou X, Yan P, Yang C, Li Y, Han L, Ren X. Lipid metabolism reprogramming in colorectal cancer. J Cell Biochem 2023;124:3-16. [PMID: 36334309 DOI: 10.1002/jcb.30347] [Reference Citation Analysis]
463 Zhang C, Zhao J, Wang W, Geng H, Wang Y, Gao B. Current advances in the application of nanomedicine in bladder cancer. Biomed Pharmacother 2023;157:114062. [PMID: 36469969 DOI: 10.1016/j.biopha.2022.114062] [Reference Citation Analysis]
464 Pearson J, Jacobson C, Ugochukwu N, Asare E, Kan K, Pace N, Han J, Wan N, Schonberger R, Andreae M. Geospatial analysis of patients' social determinants of health for health systems science and disparity research. Int Anesthesiol Clin 2023;61:49-62. [PMID: 36480649 DOI: 10.1097/AIA.0000000000000389] [Reference Citation Analysis]
465 Yang F, Liu Y, Xiao J, Li B, Chen Y, Hu A, Zeng J, Liu Z, Liu H. Circ-CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15. Cell Prolif 2023;56:e13344. [PMID: 36181462 DOI: 10.1111/cpr.13344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
466 Sharma AE, Moran A, Somasegar S, Steinhardt G, Chapel DB, Lastra RR, Lee NK, Ritterhouse LL, Bennett JA. Clinicopathologic Evaluation and Molecular Profiling of Recurrent Stage IA Endometrial Endometrioid Carcinoma: A Case-control Study. Int J Gynecol Pathol 2023;42:26-34. [PMID: 35125405 DOI: 10.1097/PGP.0000000000000856] [Reference Citation Analysis]
467 Brodowsky EC, Sood A, Butaney M, Majdalany SE, Stephens A, Corsi N, Piontkowski AJ, Rakic I, Jamil M, Dalela D, Peabody JO, Rogers CG, Abdollah F. Time to second biochemical recurrence as a prognostic indicator in postprostatectomy patients who undergo salvage radiation therapy: An RTOG 9601 based post hoc analysis. Prostate 2023;83:64-70. [PMID: 36120850 DOI: 10.1002/pros.24436] [Reference Citation Analysis]
468 Cho E, Dietrich MS, Friedman DL, Gilmer MJ, Gerhardt CA, Given BA, Hendricks-Ferguson VL, Hinds PS, Akard TF. Effects of a Web-Based Pediatric Oncology Legacy Intervention on the Coping of Children With Cancer. Am J Hosp Palliat Care 2023;40:34-42. [PMID: 35535490 DOI: 10.1177/10499091221100809] [Reference Citation Analysis]
469 Wang L, Mei X, Liu X, Guo L, Yang B, Chen R. The Interleukin-33/ST2 Axis Enhances Lung-Resident CD14+ Monocyte Function in Patients with Non-Small Cell Lung Cancer. Immunol Invest 2023;52:67-82. [PMID: 36218388 DOI: 10.1080/08820139.2022.2130075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
470 Goswami P. Impact of advance care planning and end-of-life conversations on patients with cancer: An integrative review of literature. J Nurs Scholarsh 2023;55:272-90. [PMID: 35946931 DOI: 10.1111/jnu.12804] [Reference Citation Analysis]
471 Doersch KM, Tabayoyong WB, Bandari J. Evaluation of toxicities for intravesical drugs in phase 1 bladder cancer trials. Cancer 2023;129:39-48. [PMID: 36262086 DOI: 10.1002/cncr.34508] [Reference Citation Analysis]
472 Guo RQ, Peng JZ, Li YM, Li XG. Microwave ablation combined with anti-PD-1/CTLA-4 therapy induces an antitumor immune response to renal cell carcinoma in a murine model. Cell Cycle 2023;22:242-54. [PMID: 35980140 DOI: 10.1080/15384101.2022.2112007] [Reference Citation Analysis]
473 Zhang Y, Tang S, Feng X, Li X, Yang J, Liu Q, Li M, Chai Y, Yang C, Lin S, Liu J. Tumor-targeting gene-photothermal synergistic therapies based on multifunctional polydopamine nanoparticles. Chemical Engineering Journal 2023. [DOI: 10.1016/j.cej.2023.141315] [Reference Citation Analysis]
474 Rahimi G, Yousefnia S, Angnes L, Negahdary M. Design a PEGylated nanocarrier containing lemongrass essential oil (LEO), a drug delivery system: Application as a cytotoxic agent against breast cancer cells. Journal of Drug Delivery Science and Technology 2023. [DOI: 10.1016/j.jddst.2023.104183] [Reference Citation Analysis]
475 Liu T, Du Y, Yan Y, Song S, Qi J, Xia X, Hu X, Chen Q, Liu J, Zeng X, Zhao H. pH-responsive dual-functional hydrogel integrating localized delivery and anti-cancer activities for highly effective therapy in PDX of OSCC. Materials Today 2023. [DOI: 10.1016/j.mattod.2022.12.009] [Reference Citation Analysis]
476 Ikenaga N, Miyasaka Y, Ohtsuka T, Nakata K, Adachi T, Eguchi S, Nishihara K, Inomata M, Kurahara H, Hisaka T, Baba H, Nagano H, Ueki T, Noshiro H, Tokunaga S, Ishigami K, Nakamura M; Kyushu Study Group of Treatment for Pancreatobiliary Cancer. A Prospective Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial Involvement. Ann Surg Oncol 2023;30:193-202. [PMID: 36207481 DOI: 10.1245/s10434-022-12566-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
477 Diaz M, Symonette D, Appel HR, Cristian A. Nutritional Considerations in Lung Cancer Rehabilitation. Lung Cancer Rehabilitation 2023. [DOI: 10.1016/b978-0-323-83404-9.00021-9] [Reference Citation Analysis]
478 Bazarbashi S, Badran A, Gad AM, Aljubran A, Alzahrani A, Alshibani A, Alrakaf R, Elhassan T, Alsuhaibani A, Elshenawy MA. Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer: A Comparative Nonrandomized Study. Ann Surg Oncol 2023;30:426-32. [PMID: 36042103 DOI: 10.1245/s10434-022-12467-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
479 El-tanani M, Al Khatib AO, Al-najjar BO, Shakya AK, El-tanani Y, Lee Y, Serrano-aroca Á, Mishra V, Mishra Y, Aljabali AA, Goyal R, Negi P, Farani MR, Binabaj MM, Gholami A, Binabaj MM, Charbe NB, Tambuwala MM. Cellular and molecular basis of therapeutic approaches to breast cancer. Cellular Signalling 2023;101:110492. [DOI: 10.1016/j.cellsig.2022.110492] [Reference Citation Analysis]
480 Herout R, Baunacke M, Flegar L, Borkowetz A, Reicherz A, Koch R, Kraywinkel K, Thomas C, Groeben C, Huber J. Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019. World J Urol 2023;41:127-33. [PMID: 36445373 DOI: 10.1007/s00345-022-04219-5] [Reference Citation Analysis]
481 Du M, Zhang S, Liu X, Xu C, Zhang X. Ploidy Status of Ovarian Cancer Cell Lines and Their Association with Gene Expression Profiles. Biomolecules 2023;13. [PMID: 36671477 DOI: 10.3390/biom13010092] [Reference Citation Analysis]
482 Zheng Y, Luo J. Extension-contraction transformation network for pancreas segmentation in abdominal CT scans. Comput Biol Med 2023;152:106410. [PMID: 36516578 DOI: 10.1016/j.compbiomed.2022.106410] [Reference Citation Analysis]
483 Figueroa-valverde L, Rosas-nexticapa M, Alvarez-ramirez M, Lopez-ramos M, Mateu-armand V, Lopez-gutierrez T. Statistical Data (1978-2020) on Prostate Cancer in the Southern Population of Mexico. Clin Cancer Investig J 2023;12:7-10. [DOI: 10.51847/lkyjt987fn] [Reference Citation Analysis]
484 Xia SH, Zhou D, Ge F, Sun M, Chen X, Zhang H, Miao C. Influence of Perioperative Anesthesia on Cancer Recurrence: from Basic Science to Clinical Practice. Curr Oncol Rep 2023;25:63-81. [PMID: 36512273 DOI: 10.1007/s11912-022-01342-9] [Reference Citation Analysis]
485 Gemini-piperni S, Ricci-junior E, İlem-özdemir D, da Silva Batista B, Alencar LMR, Rossi AM, Santos-oliveira R. Nano-Hydroxyapatite Radiolabeled with Radium Dichloride [223Ra] RaCl2 for Bone Cancer Targeted Alpha Therapy: In vitro Assay and Radiation Effect on the Nanostructure. Colloids and Surfaces B: Biointerfaces 2023. [DOI: 10.1016/j.colsurfb.2023.113174] [Reference Citation Analysis]
486 Desmarais T, Yang J, Narezkina A, Fernandes T. Etiology of pulmonary hypertension in multiple myeloma: A case series and literature review. Respir Med 2023;206:107071. [PMID: 36508985 DOI: 10.1016/j.rmed.2022.107071] [Reference Citation Analysis]
487 Cao Q, Ma J, Li W, Hong P, Shen T, Tong M. Guanine nucleotide-binding protein 2, GNBP2, accelerates the progression of clear cell renal cell carcinoma via regulation of STAT3 signaling transduction pathway. Genes Genomics 2023;45:1-11. [PMID: 36346541 DOI: 10.1007/s13258-022-01334-w] [Reference Citation Analysis]
488 Cass I, Roberts JNT, Benoit PR, Jensen NV. Multidisciplinary considerations in the maintenance treatment of poly(ADP-ribose) polymerase inhibitors for homologous recombination-proficient, advanced-stage epithelial ovarian cancer. CA Cancer J Clin 2023;73:8-16. [PMID: 36369877 DOI: 10.3322/caac.21764] [Reference Citation Analysis]
489 Foster JM, Zhang C, Rehman S, Sharma P, Alexander HR. The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future. CA Cancer J Clin 2023;73:49-71. [PMID: 35969103 DOI: 10.3322/caac.21749] [Reference Citation Analysis]
490 Dick A, Perri T, Kogan L, Brandt B, Meyer R, Levin G. Sentinel lymph node mapping in endometrial cancer: A comparison of main national and international guidelines. Int J Gynaecol Obstet 2022. [PMID: 35700068 DOI: 10.1002/ijgo.14307] [Reference Citation Analysis]
491 Liang Z, Luo K, Wang Y, Zeng Q, Ling X, Wang S, Dragomir MP, Li Q, Yang H, Xi M, Chen B. Clinical and Dosimetric Predictors for Postoperative Cardiopulmonary Complications in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy and Surgery. Ann Surg Oncol 2023;30:529-38. [PMID: 36127527 DOI: 10.1245/s10434-022-12526-9] [Reference Citation Analysis]
492 Adlard K, Brown C, Hayward S, Barrows J, MacLean L. Pilot Randomized Trial of a Three Times Weekly Heparin Flushing Intervention in Children, Adolescents, and Young Adults With Cancer With Tunneled Central Venous Catheters. J Pediatr Hematol Oncol Nurs 2023;40:24-33. [PMID: 35611518 DOI: 10.1177/27527530221090479] [Reference Citation Analysis]
493 Wu X, Xu LY, Li EM, Dong G. Molecular dynamics simulation study on the structures of fascin mutants. J Mol Recognit 2023;36:e2998. [PMID: 36225126 DOI: 10.1002/jmr.2998] [Reference Citation Analysis]
494 Furtado FS, Suarez-weiss KE, Amorim BJ, Clark JW, Picchio M, Harisinghani M, Catalano OA. Gastrointestinal imaging. Clinical PET/MRI 2023. [DOI: 10.1016/b978-0-323-88537-9.00015-5] [Reference Citation Analysis]
495 Katipally RR, Spurr LF, Gutiontov SI, Turchan WT, Connell P, Juloori A, Malik R, Binkley MS, Jiang AL, Rouhani SJ, Chervin CS, Wanjari P, Segal JP, Ng V, Loo BW, Gomez DR, Bestvina CM, Vokes EE, Ferguson MK, Donington JS, Diehn M, Pitroda SP. STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer. JCO Precis Oncol 2023;7:e2200273. [PMID: 36603171 DOI: 10.1200/PO.22.00273] [Reference Citation Analysis]
496 Wang G, Li L, Li Y, Zhang LH. Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway. Phytomedicine 2023;109:154571. [PMID: 36610147 DOI: 10.1016/j.phymed.2022.154571] [Reference Citation Analysis]
497 Zhu J, Jiang Z, Xie B, Fu C, Xiao W, Li Y. Comparison of oncologic outcomes between pancreaticoduodenectomy and total pancreatectomy for pancreatic adenocarcinoma. Surg Endosc 2023;37:109-19. [PMID: 35851818 DOI: 10.1007/s00464-022-09441-1] [Reference Citation Analysis]
498 Guo W, Chen Z, Li Z, Huang H, Ren Y, Li Z, Zhao B, Li G, Hu Y. Cancer cell membrane biomimetic mesoporous silica nanotheranostics for enhanced Ferroptosis-mediated immuogenic cell death on Gastric cancer. Chemical Engineering Journal 2023;455:140868. [DOI: 10.1016/j.cej.2022.140868] [Reference Citation Analysis]
499 Liu F, Xu J, Yang R, Liu S, Hu S, Yan M, Han F. New light on treatment of cervical cancer: Chinese medicine monomers can be effective for cervical cancer by inhibiting the PI3K/Akt signaling pathway. Biomed Pharmacother 2023;157:114084. [PMID: 36481407 DOI: 10.1016/j.biopha.2022.114084] [Reference Citation Analysis]
500 Wu J, Wang D, Zhou J, Li J, Xie R, Li Y, Huang J, Liu B, Qiu J. Gambogenic acid induces apoptosis and autophagy through ROS-mediated endoplasmic reticulum stress via JNK pathway in prostate cancer cells. Phytother Res 2023;37:310-28. [PMID: 36086867 DOI: 10.1002/ptr.7614] [Reference Citation Analysis]
501 Venugopal A, Sreelekshmi V, Nair JJ. Ensemble Deep Learning Model for Breast Histopathology Image Classification. ICT Infrastructure and Computing 2023. [DOI: 10.1007/978-981-19-5331-6_51] [Reference Citation Analysis]
502 Ramirez AG, Trapido EJ. Advancing the Science of Cancer in Latinos. Advancing the Science of Cancer in Latinos 2023. [DOI: 10.1007/978-3-031-14436-3_1] [Reference Citation Analysis]
503 Jiang R, Luo S, Zhang M, Lan Q, Zhao X, Wang W, Zhuo S, Wang X, Jiang X. Jianpiyiqi decoction inhibits proliferation and invasion by suppressing the Caspase-1/IRAKs/NF-κB signalling pathway in hepatoma Huh-7 cells. European Journal of Integrative Medicine 2023. [DOI: 10.1016/j.eujim.2023.102230] [Reference Citation Analysis]
504 Huang GS, Tymon-Rosario J, Santin AD. What role does adjuvant therapy play in the management of endometrial cancer? Expert Opin Pharmacother 2023;24:7-10. [PMID: 36594708 DOI: 10.1080/14656566.2022.2157207] [Reference Citation Analysis]
505 Liu Y, Sun L, Guo H, Zhou S, Wang C, Ji C, Meng F, Liang S, Zhang B, Yuan Y, Ma K, Li X, Guo X, Cui T, Zhang N, Wang J, Liu Y, Liu L. Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib. Oncogene 2023;42:374-88. [PMID: 36473908 DOI: 10.1038/s41388-022-02551-z] [Reference Citation Analysis]
506 Wang Y, Liu F, Sun L, Jia Y, Yang P, Guo D, Shi M, Wang A, Chen GC, Zhang Y, Zhu Z. Association between human blood metabolome and the risk of breast cancer. Breast Cancer Res 2023;25:9. [PMID: 36694207 DOI: 10.1186/s13058-023-01609-4] [Reference Citation Analysis]
507 Ge X, Li X, Liu B, Wang S, Li J. MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6. Chin J Physiol 2023;0:0. [DOI: 10.4103/cjop.cjop-d-22-00071] [Reference Citation Analysis]
508 Song CH, Kim N, Nam RH, Choi SI, Jang JY, Lee HN. Changes in Gut Microbiome upon Orchiectomy and Testosterone Administration in AOM/DSS-Induced Colon Cancer Mouse Model. Cancer Res Treat 2023;55:196-218. [PMID: 35790194 DOI: 10.4143/crt.2022.080] [Reference Citation Analysis]
509 Miquelotti LB, Sari MHM, Ferreira LM. Immunotherapy in Cancer Management: A Literature Review of Clinical Efficacy of Pembrolizumab in the Non-small Cell Lung Cancer Treatment. Adv Pharm Bull 2023;13:88-95. [PMID: 36721805 DOI: 10.34172/apb.2023.007] [Reference Citation Analysis]
510 Shobeiri P, Seyedmirzaei H, Kalantari A, Mohammadi E, Rezaei N, Hanaei S. The Epidemiology of Brain and Spinal Cord Tumors. Adv Exp Med Biol 2023;1394:19-39. [PMID: 36587379 DOI: 10.1007/978-3-031-14732-6_2] [Reference Citation Analysis]
511 Ehret F, Hofmann T, Fürweger C, Kufeld M, Staehler M, Muacevic A, Haidenberger A. Single-fraction prostate-specific membrane antigen positron emission tomography- and multiparametric magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer local recurrences. BJU Int 2023;131:101-8. [PMID: 36114771 DOI: 10.1111/bju.15894] [Reference Citation Analysis]
512 Tonse R, Tom MC, Kotecha R. Systemic Therapy and Radiation Therapy in Lung Cancer. Lung Cancer Rehabilitation 2023. [DOI: 10.1016/b978-0-323-83404-9.00011-6] [Reference Citation Analysis]
513 Gundersen AI, Knowlton SE. Functional Outcomes in Lung Cancer Rehabilitation. Lung Cancer Rehabilitation 2023. [DOI: 10.1016/b978-0-323-83404-9.00015-3] [Reference Citation Analysis]
514 Manning-geist B, Gordhandas S, Ramalingam P, Zivanovic O. Ovarian clear cell carcinoma. Diagnosis and Treatment of Rare Gynecologic Cancers 2023. [DOI: 10.1016/b978-0-323-82938-0.00004-5] [Reference Citation Analysis]
515 Pahouja G, Patel HD, Desai S, Rac G, Cheng T, Okabe Y, Gorbonos A, Quek ML, Flanigan RC, Picken MM, Gupta GN. The rising incidence of ductal adenocarcinoma and intraductal carcinoma of the prostate: Diagnostic accuracy of biopsy, MRI-visibility, and outcomes. Urologic Oncology: Seminars and Original Investigations 2023;41:48.e11-48.e18. [DOI: 10.1016/j.urolonc.2022.09.025] [Reference Citation Analysis]
516 Botwin AL, Herold A, Poetsch N, Lee SI, Catalano OA, Del Carmen M. Gynecologic imaging. Clinical PET/MRI 2023. [DOI: 10.1016/b978-0-323-88537-9.00013-1] [Reference Citation Analysis]
517 Fayanju OM, Edmonds CE, Reyes SA, Arciero C, Bea VJ, Crown A, Joseph KA. The Landmark Series-Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women. Ann Surg Oncol 2023;30:58-67. [PMID: 36192515 DOI: 10.1245/s10434-022-12535-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
518 Erasmus JJ, Nguyen Q, Stewart DJ, Swisher SG. Lung Cancer. Oncologic Imaging : a Multidisciplinary Approach 2023. [DOI: 10.1016/b978-0-323-69538-1.00007-0] [Reference Citation Analysis]
519 Jiang Y, Yu L, Hu Q, Kang Y, You J, Huang C, Xu X, Chen L. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma. Mol Immunol 2023;153:226-37. [PMID: 36563642 DOI: 10.1016/j.molimm.2022.12.008] [Reference Citation Analysis]
520 Nabil R, Hassan NM, Abdellateif MS, Gawdat RM, Elshazly SS. The prognostic role of C-KIT, TET1 and TET2 gene expression in Acute Myeloid Leukemia. Mol Biol Rep 2023;50:641-53. [PMID: 36371552 DOI: 10.1007/s11033-022-08000-0] [Reference Citation Analysis]
521 Wang M, Liu L, Dai Q, Jin M, Huang G. Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC. J Cancer Res Clin Oncol 2023;149:247-61. [PMID: 36565319 DOI: 10.1007/s00432-022-04545-6] [Reference Citation Analysis]
522 Broach V, Hedrick Ellenson L. Other rare vulvovaginal cancers: Verrucous carcinoma, aggressive angiomyxoma, vulvar yolk sac tumor. Diagnosis and Treatment of Rare Gynecologic Cancers 2023. [DOI: 10.1016/b978-0-323-82938-0.00020-3] [Reference Citation Analysis]
523 Kikuchi M, Johnson MK, Lee JY, Kim J. Head and neck imaging. Clinical PET/MRI 2023. [DOI: 10.1016/b978-0-323-88537-9.00006-4] [Reference Citation Analysis]
524 de Galiza Barbosa F, Galgano SJ, Botwin AL, Lara Gongora AB, Sawaya G, Baroni RH, Queiroz MA. Genitourinary imaging. Clinical PET/MRI 2023. [DOI: 10.1016/b978-0-323-88537-9.00012-x] [Reference Citation Analysis]
525 Berta J, Rózsás A, Megyesfalvi Z, Ostoros G, Döme B. Thoracic irradiation as consolidation therapy in patients with extensive-stage small cell lung cancer. Curr Opin Oncol 2023;35:54-60. [PMID: 36420570 DOI: 10.1097/CCO.0000000000000911] [Reference Citation Analysis]
526 Kc M, Oral E, Rung AL, Trapido E, Rozek LS, Fontham ETH, Bensen JT, Farnan L, Steck SE, Song L, Mohler JL, Khan S, Vohra S, Peters ES. Prostate cancer aggressiveness and financial toxicity among prostate cancer patients. Prostate 2023;83:44-55. [PMID: 36063402 DOI: 10.1002/pros.24434] [Reference Citation Analysis]
527 Li C, Mi J, Wang Y, Zhang Z, Guo X, Zhou J, Hu Z, Tian J. New and effective EGFR-targeted fluorescence imaging technology for intraoperative rapid determination of lung cancer in freshly isolated tissue. Eur J Nucl Med Mol Imaging 2023;50:494-507. [PMID: 36207638 DOI: 10.1007/s00259-022-05975-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
528 Haeny AM, Gibbons FX, Fleischli ME, Gerrard M, Lopez J, Beach SRH. Racial centrality mediates the association between adolescent racial discrimination and adult cigarette smoking outcomes among Black Americans. Soc Sci Med 2023;316:115225. [PMID: 35931591 DOI: 10.1016/j.socscimed.2022.115225] [Reference Citation Analysis]
529 Broach V, Lawson B. Bartholin gland carcinomas. Diagnosis and Treatment of Rare Gynecologic Cancers 2023. [DOI: 10.1016/b978-0-323-82938-0.00018-5] [Reference Citation Analysis]
530 Song L, Wang H, Wang ZJ. Decoupling multi-task causality for improved skin lesion segmentation and classification. Pattern Recognition 2023;133:108995. [DOI: 10.1016/j.patcog.2022.108995] [Reference Citation Analysis]
531 Ou W, Lei J, Li M, Zhang X, Liang R, Long L, Wang C, Chen L, Chen J, Zhang J, Wang Z. Ultrasound-based radiomics score for pre-biopsy prediction of prostate cancer to reduce unnecessary biopsies. Prostate 2023;83:109-18. [PMID: 36207777 DOI: 10.1002/pros.24442] [Reference Citation Analysis]
532 Kong Q, Yang J, Li D, Ding Y, Hu Y, Xue X, Shi M, Jiang B, Zhou Y, Zhang M, Hu J, Guo C, Chen J, Han Y. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo. Journal of Ethnopharmacology 2023;300:115728. [DOI: 10.1016/j.jep.2022.115728] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
533 Zhao C, Gong J, Bai Y, Yin T, Zhou M, Pan S, Liu Y, Gao Y, Zhang Z, Shi Y, Zhu F, Zhang H, Wang M, Qin R. A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma. Cell Death Differ 2023;30:1-15. [PMID: 35906484 DOI: 10.1038/s41418-022-01040-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
534 Zhang H, Zhong A, Chen J. Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: A systemic review and meta-analysis. Skin Res Technol 2023;29:e13229. [PMID: 36329570 DOI: 10.1111/srt.13229] [Reference Citation Analysis]
535 Deng H, Chen Y, Li P, Hang Q, Zhang P, Jin Y, Chen M. PI3K/AKT/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancer. Cancer Pathogenesis and Therapy 2023;1:56-66. [DOI: 10.1016/j.cpt.2022.09.001] [Reference Citation Analysis]
536 Qin X, Wang X, Tian M, Dong Z, Wang J, Wang C, Huang Q. The role of Andrographolide in the prevention and treatment of liver diseases. Phytomedicine 2023;109:154537. [PMID: 36610122 DOI: 10.1016/j.phymed.2022.154537] [Reference Citation Analysis]
537 Wu F, Liu Y, Hu S, Lu C. Ribosomal protein L31 (RPL31) inhibits the proliferation and migration of gastric cancer cells. Heliyon 2023. [DOI: 10.1016/j.heliyon.2023.e13076] [Reference Citation Analysis]
538 Chiang RS, Desai A, Glover MJ, Hui G, Ramchandran KJ, Wakelee H, Lythgoe MP, Khaki AR. Racial Diversity and Reporting in United States Food and Drug Administration Registration Trials for Thoracic Malignancies from 2006 to 2020. Cancer Invest 2023;41:43-7. [PMID: 36197034 DOI: 10.1080/07357907.2022.2131808] [Reference Citation Analysis]
539 Lin W, Pan X, Zhang C, Ye B, Song J. Impact of Age at Diagnosis of Bladder Cancer on Survival: A Surveillance, Epidemiology, and End Results-Based Study 2004-2015. Cancer Control 2023;30:10732748231152322. [PMID: 36662642 DOI: 10.1177/10732748231152322] [Reference Citation Analysis]
540 Lv D, Wang Y, Li S, Shao X, Jin Q. Activation of MYO1G by lncRNA MNX1-AS1 Drives the Progression in Lung Cancer. Mol Biotechnol 2023;65:72-83. [PMID: 35819746 DOI: 10.1007/s12033-022-00531-y] [Reference Citation Analysis]
541 Yu L, Xu J, Qiao R, Han B, Zhong H, Zhong R. Pathological Stage N1 Limited-Stage Small-Cell Lung Cancer Patients Can Benefit From Surgical Resection. Clin Lung Cancer 2023;24:e1-8. [PMID: 36085281 DOI: 10.1016/j.cllc.2022.08.006] [Reference Citation Analysis]
542 黎 金. Expression and Immune Infiltration of LIX1 in Prostate Cancer Based on Bioinformatics. ACM 2023;13:152-162. [DOI: 10.12677/acm.2023.131024] [Reference Citation Analysis]
543 Wang H, Liang P, Zhang L, Shi L, Ge Y, Zhang L, Qiao X. A soluble pH-responsive host-guest-based nanosystem for homogeneous exosomes capture with high-efficiency. Chinese Chemical Letters 2023. [DOI: 10.1016/j.cclet.2023.108129] [Reference Citation Analysis]
544 Nishino H, Turner MA, Amirfakhri S, Lwin TM, Hosseini M, Singer BB, Hoffman RM, Bouvet M. Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse Model. Ann Surg Oncol 2023;30:618-25. [PMID: 36057899 DOI: 10.1245/s10434-022-12466-4] [Reference Citation Analysis]
545 Reid HW, Selvan B, Montes de Oca MK, Falkovic M, Malone S, Fish LJ, Wheeler S, Davidson BA. "You start feeling comfortable, you just start sharing:" A qualitative study of patient distress screening in Black and White patients with endometrial cancer. Gynecol Oncol 2023;168:166-75. [PMID: 36502783 DOI: 10.1016/j.ygyno.2022.11.008] [Reference Citation Analysis]
546 Ali W, Jacobs D, Zhen S, Diamond AM, Kajdacsy-Balla A. Associations of selenoprotein expression and gene methylation with the outcome of clear cell renal carcinoma. Arch Biochem Biophys 2023;733:109470. [PMID: 36442530 DOI: 10.1016/j.abb.2022.109470] [Reference Citation Analysis]
547 Visvanathan K, Mondul AM, Zeleniuch-Jacquotte A, Wang M, Gail MH, Yaun SS, Weinstein SJ, McCullough ML, Eliassen AH, Cook NR, Agnoli C, Almquist M, Black A, Buring JE, Chen C, Chen Y, Clendenen T, Dossus L, Fedirko V, Gierach GL, Giovannucci EL, Goodman GE, Goodman MT, Guénel P, Hallmans G, Hankinson SE, Horst RL, Hou T, Huang WY, Jones ME, Joshu CE, Kaaks R, Krogh V, Kühn T, Kvaskoff M, Lee IM, Mahamat-Saleh Y, Malm J, Manjer J, Maskarinec G, Millen AE, Mukhtar TK, Neuhouser ML, Robsahm TE, Schoemaker MJ, Sieri S, Sund M, Swerdlow AJ, Thomson CA, Ursin G, Wactawski-Wende J, Wang Y, Wilkens LR, Wu Y, Zoltick E, Willett WC, Smith-Warner SA, Ziegler RG. Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts. Eur J Epidemiol 2023;38:11-29. [PMID: 36593337 DOI: 10.1007/s10654-022-00921-1] [Reference Citation Analysis]
548 Takeshita H, Yoshida R, Inoue J, Ishikawa K, Shinohara K, Hirayama M, Oyama T, Kubo R, Yamana K, Nagao Y, Gohara S, Sakata J, Nakashima H, Matsuoka Y, Nakamoto M, Hirayama M, Kawahara K, Takahashi N, Hirosue A, Kuwahara Y, Fukumoto M, Toya R, Murakami R, Nakayama H. FOXM1-mediated regulation of reactive oxygen species and radioresistance in oral squamous cell carcinoma cells. Laboratory Investigation 2023. [DOI: 10.1016/j.labinv.2022.100060] [Reference Citation Analysis]
549 Gram IT, Park SY, Wilkens LR, Le Marchand L, Setiawan VW. Smoking and pancreatic cancer: a sex-specific analysis in the Multiethnic Cohort study. Cancer Causes Control 2023;34:89-100. [PMID: 36253659 DOI: 10.1007/s10552-022-01637-z] [Reference Citation Analysis]
550 Koike H, Ashizawa K, Tsutsui S, Fukuda M, Okano S, Matsumoto K, Nagayasu T, Honda S, Uetani M. Surgically resected lung adenocarcinoma: do heterogeneous GGNs and part-solid nodules on thin-section CT show different prognosis? Jpn J Radiol 2023;41:164-71. [PMID: 36219310 DOI: 10.1007/s11604-022-01345-3] [Reference Citation Analysis]
551 Zhang W, Qian W, Gu J, Gong M, Zhang W, Zhang S, Zhou C, Jiang Z, Jiang J, Han L, Wang X, Wu Z, Ma Q, Wang Z. Mutant p53 driven-LINC00857, a protein scaffold between FOXM1 and deubiquitinase OTUB1, promotes the metastasis of pancreatic cancer. Cancer Letters 2023;552:215976. [DOI: 10.1016/j.canlet.2022.215976] [Reference Citation Analysis]
552 Munshi F, Marthi S, Hyams E. Obesity and prostate cancer. The Link Between Obesity and Cancer 2023. [DOI: 10.1016/b978-0-323-90965-5.00013-1] [Reference Citation Analysis]
553 Beaudry RI, Akins JD, Richey RE, Brothers RM, Nelson MD, Sarma S, Tucker WJ, Haykowsky MJ. Exercise Leg Blood Flow Is Preserved in Long-term Breast Cancer Survivors Previously Treated With Anthracycline Chemotherapy. J Cardiopulm Rehabil Prev 2023;43:61-5. [PMID: 36223443 DOI: 10.1097/HCR.0000000000000718] [Reference Citation Analysis]
554 Rehman A, Butt MA, Zaman M. Attention Res-UNet. International Journal of Decision Support System Technology 2023;15:1-17. [DOI: 10.4018/ijdsst.315756] [Reference Citation Analysis]
555 Aruchamy B, Drago C, Russo V, Pitari GM, Ramani P, Aneesh TP, Benny S, Vishnu VR. Imidazole-pyridine hybrids as potent anti-cancer agents. Eur J Pharm Sci 2023;180:106323. [PMID: 36336277 DOI: 10.1016/j.ejps.2022.106323] [Reference Citation Analysis]
556 Huang J, Li H, Wang X, Liang X, Zhao T, Hu J, Bai H, Ge J, Sun S, He J. Impacts of ezetimibe on risks of various types of cancers: a meta-analysis and systematic review. Eur J Cancer Prev 2023;32:89-97. [PMID: 35352704 DOI: 10.1097/CEJ.0000000000000750] [Reference Citation Analysis]
557 Lam AY, Lee JK. The New Kids on the Block: Emerging Complementary Colonoscopy Quality Metrics. Clin Gastroenterol Hepatol 2023;21:26-8. [PMID: 35552014 DOI: 10.1016/j.cgh.2022.04.028] [Reference Citation Analysis]
558 Lauer RC, Barry M, Smith TL, Thomas AM, Wu J, Du R, Lee JH, Rao A, Dobroff AS, Arap MA, Nunes DN, Silva IT, Dias-Neto E, Chen I, McCance DJ, Cavenee WK, Pasqualini R, Arap W. Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts. Elife 2023;12. [PMID: 36645410 DOI: 10.7554/eLife.81929] [Reference Citation Analysis]
559 Tang Y, Ge S, Zheng X, Zheng J. High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma. Diagn Pathol 2022;17:100. [PMID: 36585741 DOI: 10.1186/s13000-022-01274-9] [Reference Citation Analysis]
560 García-Martínez S, González-Gamo D, Tesolato SE, Barabash A, de la Serna SC, Domínguez-Serrano I, Dziakova J, Rivera D, Torres AJ, Iniesta P. Telomere Length and Telomerase Activity in Subcutaneous and Visceral Adipose Tissues from Obese and Non-Obese Patients with and without Colorectal Cancer. Cancers (Basel) 2022;15. [PMID: 36612269 DOI: 10.3390/cancers15010273] [Reference Citation Analysis]
561 Fang Q, Lin J, Gao L, Pan R, Zheng X. Targeting mitochondrial tyrosyl-tRNA synthetase YARS2 suppresses colorectal cancer progression. Cancer Biol Ther 2022;23:1-8. [PMID: 36154909 DOI: 10.1080/15384047.2022.2127603] [Reference Citation Analysis]
562 Luo H, Wang X, Song S, Wang Y, Dan Q, Ge H. Targeting stearoyl-coa desaturase enhances radiation induced ferroptosis and immunogenic cell death in esophageal squamous cell carcinoma. OncoImmunology 2022;11:2101769. [DOI: 10.1080/2162402x.2022.2101769] [Reference Citation Analysis]
563 Geng H, Wang Y, Wang S. Blood MALT1 deficiency is common and relates to unfavorable induction therapy response and survival profile in acute myeloid leukemia patients. Hematology 2022;27:1176-1183. [DOI: 10.1080/16078454.2022.2139909] [Reference Citation Analysis]
564 Cuttano R, Colangelo T, Guarize J, Dama E, Cocomazzi MP, Mazzarelli F, Melocchi V, Palumbo O, Marino E, Belloni E, Montani F, Vecchi M, Barberis M, Graziano P, Pasquier A, Sanz-Ortega J, Montuenga LM, Carbonelli C, Spaggiari L, Bianchi F. miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response. J Hematol Oncol 2022;15:178. [PMID: 36587234 DOI: 10.1186/s13045-022-01394-1] [Reference Citation Analysis]
565 Pei J, Zhang S, Yang X, Han C, Pan Y, Li J, Wang Z, Sun C, Zhang J. Epigenetic regulator KDM4A activates Notch1-NICD-dependent signaling to drive tumorigenesis and metastasis in breast cancer. Transl Oncol 2023;28:101615. [PMID: 36592610 DOI: 10.1016/j.tranon.2022.101615] [Reference Citation Analysis]
566 Baker S, Gilhen-Baker M, Roviello GN. The Role of Nutrition and Forest-Bathing in the Physical Rehabilitation of Physically Inactive Patients: From the Molecular Aspects to New Nature-Inspired Techniques. Int J Environ Res Public Health 2022;20. [PMID: 36613115 DOI: 10.3390/ijerph20010793] [Reference Citation Analysis]
567 Liu Z, Wang D, Cao Q, Li J. The treatment efficacy of three-layered functional polymer materials as drug carrier for orthotopic colon cancer. Drug Delivery 2022;29:2971-83. [DOI: 10.1080/10717544.2022.2122633] [Reference Citation Analysis]
568 Banda A, Privé BM, Allach Y, Uijen MJM, Peters SMB, Loeff CC, Gotthardt M, Muselaers CHJ, Witjes JA, van Oort IM, Sedelaar JPM, Westdorp H, Mehra N, Khreish F, Ezziddin S, Sabet A, Kreissl MC, Winkens T, Seifert P, Janssen MJR, van Gemert WAM, Nagarajah J. PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study. Cancers (Basel) 2022;15. [PMID: 36612293 DOI: 10.3390/cancers15010297] [Reference Citation Analysis]
569 Koizumi T, Nishino Y, Takiguchi T, Kanda S, Otsuki K, Tanaka Y, Tomita R, Araki T, Hayashi R, Yasumoto K, Uramoto H, Hirono Y, Makino T, Nakada M, Yano S. Epidemiological and Therapeutic Analyses in Lung Cancer Patients Over 80 Years Old in the Hokushin Region: A Retrospective Hospital Administrative Database Study. Clin Lung Cancer 2022:S1525-7304(22)00284-4. [PMID: 36639281 DOI: 10.1016/j.cllc.2022.12.001] [Reference Citation Analysis]
570 Zhao M, Zhang Y, Shen S. A novel regulator in cancer initiation and progression: long noncoding RNA SHNG9. Clin Transl Oncol 2022. [PMID: 36586065 DOI: 10.1007/s12094-022-03060-x] [Reference Citation Analysis]
571 Huang J, Su R, Chen Z, Jiang S, Chen M, Yuan Y, Hu H, Fu C, Huang Z, Wang Z, Zheng B, Li C, Wang Z, Bao Y, Cai M, Guo J, Wei Q, Xue W. The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapy. OncoImmunology 2022;11:2124691. [DOI: 10.1080/2162402x.2022.2124691] [Reference Citation Analysis]
572 Lee J, Kim SJ, Kim SW, Song HY, Seo GS, Kim DH, Myung DS, Kim HS, Joo YE, Kim SY. Comparison of optimal bowel cleansing effects of 1L polyethylene glycol with ascorbic acid versus sodium picosulfate with magnesium citrate: A randomized controlled study. PLoS One 2022;17:e0279631. [PMID: 36584216 DOI: 10.1371/journal.pone.0279631] [Reference Citation Analysis]
573 Wu X, Zhang K, Zhong X, Huo X, Zhang J, Tian W, Yang X, Zhang Y, Wang Y. Androgens in endometrial carcinoma: the killer or helper? J Endocrinol Invest 2022. [PMID: 36583833 DOI: 10.1007/s40618-022-01916-1] [Reference Citation Analysis]
574 Sorayaie Azar A, Babaei Rikan S, Naemi A, Bagherzadeh Mohasefi J, Pirnejad H, Bagherzadeh Mohasefi M, Wiil UK. Application of machine learning techniques for predicting survival in ovarian cancer. BMC Med Inform Decis Mak 2022;22:345. [PMID: 36585641 DOI: 10.1186/s12911-022-02087-y] [Reference Citation Analysis]
575 Ying T, Wang X, Yao Y, Yuan J, Chen S, Wen L, Chen Z, Wang X, Luo C, Sheng J, Wang W, Teng L. Integrative Methylome and Transcriptome Characterization Identifies SERINC2 as a Tumor-Driven Gene for Papillary Thyroid Carcinoma. Cancers (Basel) 2022;15. [PMID: 36612238 DOI: 10.3390/cancers15010243] [Reference Citation Analysis]
576 Stasiak F, Seitlinger J, Streit A, Wollbrett C, Piccoli J, Siat J, Gauchotte G, Renaud S. Sentinel Lymph Node in Non-Small Cell Lung Cancer: Assessment of Feasibility and Safety by Near-Infrared Fluorescence Imaging and Clinical Consequences. J Pers Med 2022;13. [PMID: 36675751 DOI: 10.3390/jpm13010090] [Reference Citation Analysis]
577 Lan H, Yuan J, Zhang R, Jiang B, Li Q, Huang Z, Chen P, Xiang H, Zeng X, Xiao S. Pancancer analysis of SKA1 mutation and its association with the diagnosis and prognosis of human cancers. Genomics 2022;115:110554. [PMID: 36587749 DOI: 10.1016/j.ygeno.2022.110554] [Reference Citation Analysis]
578 Chen Y, Qian FJ, Ye ZQ, Xie WX, He YD, Huang JR, Tian L, Gu DN. Anticancer Benefit of Metformin in Patients With Early-Stage Pancreatic Cancer: A Retrospective Cohort Study. Technol Cancer Res Treat 2022;21:15330338221138208. [PMID: 36583563 DOI: 10.1177/15330338221138208] [Reference Citation Analysis]
579 Al-Odat OS, Guirguis DA, Schmalbach NK, Yao G, Budak-Alpdogan T, Jonnalagadda SC, Pandey MK. Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma. Int J Mol Sci 2022;24. [PMID: 36614089 DOI: 10.3390/ijms24010644] [Reference Citation Analysis]
580 Knull E, Park CKS, Bax J, Tessier D, Fenster A. Toward mechatronic MRI-guided focal laser ablation of the prostate: Robust registration for improved needle delivery. Med Phys 2022. [PMID: 36583505 DOI: 10.1002/mp.16190] [Reference Citation Analysis]
581 Vosough P, Khatami SH, Hashemloo A, Tajbakhsh A, Karimi-Fard F, Taghvimi S, Taheri-Anganeh M, Soltani Fard E, Savardashtaki A, Movahedpour A. Exosomal lncRNAs in gastrointestinal cancer. Clin Chim Acta 2022;540:117216. [PMID: 36592922 DOI: 10.1016/j.cca.2022.117216] [Reference Citation Analysis]
582 Gibson C, O'Connor M, White R, Jackson M, Baxi S, Sheppard D, Halkett GKB. Return to valued activities: Survivors' experiences of adaptation and growth after treatment for head and neck cancer. Psychooncology 2022. [PMID: 36582171 DOI: 10.1002/pon.6086] [Reference Citation Analysis]
583 Luo H, Wang L, Zhang D, Sun Y, Wang S, Song S, Ge H. HA15 inhibits binding immunoglobulin protein and enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma. Cancer Sci 2022. [PMID: 36582172 DOI: 10.1111/cas.15712] [Reference Citation Analysis]
584 Bellerba F, Chatziioannou AC, Jasbi P, Robinot N, Keski-Rahkonen P, Trolat A, Vozar B, Hartman SJ, Scalbert A, Bonanni B, Johansson H, Sears DD, Gandini S. Metabolomic profiles of metformin in breast cancer survivors: a pooled analysis of plasmas from two randomized placebo-controlled trials. J Transl Med 2022;20:629. [PMID: 36581893 DOI: 10.1186/s12967-022-03809-6] [Reference Citation Analysis]
585 Malik JA, Ahmed S, Momin SS, Shaikh S, Alafnan A, Alanazi J, Said Almermesh MH, Anwar S. Drug Repurposing: A New Hope in Drug Discovery for Prostate Cancer. ACS Omega 2023;8:56-73. [PMID: 36643505 DOI: 10.1021/acsomega.2c05821] [Reference Citation Analysis]
586 Chang VT, Sandifer C, Zhong F. GI Symptoms in Pancreatic Cancer. Clin Colorectal Cancer 2022:S1533-0028(22)00135-9. [PMID: 36623952 DOI: 10.1016/j.clcc.2022.12.002] [Reference Citation Analysis]
587 Hintelmann K, Petersen C, Borgmann K. Radiotherapeutic Strategies to Overcome Resistance of Breast Cancer Brain Metastases by Considering Immunogenic Aspects of Cancer Stem Cells. Cancers (Basel) 2022;15. [PMID: 36612206 DOI: 10.3390/cancers15010211] [Reference Citation Analysis]
588 Wang Z, Liu H, Gong Y, Cheng Y. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer. Eur J Med Res 2022;27:317. [PMID: 36581948 DOI: 10.1186/s40001-022-00924-4] [Reference Citation Analysis]
589 Lin Q, Zheng S, Yu X, Chen M, Zhou Y, Zhou Q, Hu C, Gu J, Xu Z, Wang L, Liu Y, Liu Q, Wang M, Li G, Cheng H, Zhou D, Liu G, Fu Z, Long Y, Li Y, Wang W, Qin R, Li Z, Chen R. Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial. Cancer Commun (Lond) 2022. [PMID: 36579790 DOI: 10.1002/cac2.12399] [Reference Citation Analysis]
590 Xu Z, Chen Y, Yu Y, Yu T, Wang Y, Chen T, Zhu L, Shu Y. A ferroptosis-related lncRNAs signature for prognosis prediction and its relationship with immune microenvironment in colon adenocarcinoma.. [DOI: 10.21203/rs.3.rs-2265866/v1] [Reference Citation Analysis]
591 Petric J, Handshin S, Bright T, Watson DI. Planned oesophagectomy after chemoradiotherapy versus salvage oesophagectomy following definitive chemoradiotherapy: a systematic review and meta-analysis. ANZ J Surg 2022. [PMID: 36582046 DOI: 10.1111/ans.18225] [Reference Citation Analysis]
592 Lin X, Wu Q, Lei W, Wu D, Sheng J, Liang G, Hou G, Fan D. miR-3154 promotes glioblastoma proliferation and metastasis via targeting TP53INP1.. [DOI: 10.21203/rs.3.rs-2344155/v1] [Reference Citation Analysis]
593 Gregory SN, Ryan CE, Hernandez JM, Sonke GS, Aronson SL, Zivanovic O, van Driel WJ; OVHIPEC-2 Study Group. Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2). Ann Surg Oncol 2022. [PMID: 36581719 DOI: 10.1245/s10434-022-12957-4] [Reference Citation Analysis]
594 Hao Z, Yu Y, Yang S. The impact of omentectomy on cause-specific survival of Stage I-IIIA epithelial ovarian cancer: A PSM-IPTW analysis based on the SEER database. Front Surg 2022;9:1052788. [PMID: 36644529 DOI: 10.3389/fsurg.2022.1052788] [Reference Citation Analysis]
595 Tafuri A, Panunzio A, Gozzo A, Ornaghi PI, Di Filippo G, Mazzucato G, Soldano A, De Maria N, Cianflone F, Artibani W, Porcaro AB, Pagliarulo V, Cerruto MA, Antonelli A. Impact of functional impairment and cognitive status on perioperative outcomes and costs after radical cystectomy: The role of Barthel Index. Int J Urol 2022. [PMID: 36575971 DOI: 10.1111/iju.15134] [Reference Citation Analysis]
596 Yang C, Zhang L, Hao X, Tang M, Zhou B, Hou J. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification. Curr Oncol 2022;30:430-48. [PMID: 36661684 DOI: 10.3390/curroncol30010035] [Reference Citation Analysis]
597 Wu C, Sun G, Wang F, Chen J, Zhan F, Lian X, Wang J, Weng F, Li B, Tang W, Quan J, Xiang D. DYRK2 downregulation in colorectal cancer leads to epithelial-mesenchymal transition induction and chemoresistance. Sci Rep 2022;12:22496. [PMID: 36577753 DOI: 10.1038/s41598-022-25053-0] [Reference Citation Analysis]
598 Gaál Z. Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies. Biomolecules 2022;13. [PMID: 36671446 DOI: 10.3390/biom13010061] [Reference Citation Analysis]
599 Shi L, Xu Y, Feng M. Role of Gut Microbiome in Immune Regulation and Immune Checkpoint Therapy of Colorectal Cancer. Dig Dis Sci 2022. [PMID: 36575326 DOI: 10.1007/s10620-022-07689-0] [Reference Citation Analysis]
600 Guo C, Xie B, Liu Q. Weighted gene co-expression network analysis combined with machine learning validation to identify key hub biomarkers in colorectal cancer. Funct Integr Genomics 2022;23:24. [PMID: 36576616 DOI: 10.1007/s10142-022-00949-2] [Reference Citation Analysis]
601 Kiritani S, Ono Y, Takamatsu M, Oba A, Sato T, Ito H, Inoue Y, Takahashi Y. Diabetogenic liver metastasis from pancreatic cancer: a case report. Surg Case Rep 2022;8:224. [PMID: 36576596 DOI: 10.1186/s40792-022-01582-8] [Reference Citation Analysis]
602 Shuwen H, Yinhang W, Xingming Z, Jing Z, Jinxin L, Wei W, Kefeng D. Using whole-genome sequencing (WGS) to plot colorectal cancer-related gut microbiota in a population with varied geography. Gut Pathog 2022;14:50. [PMID: 36578080 DOI: 10.1186/s13099-022-00524-x] [Reference Citation Analysis]
603 Jia R, Guo X, Liu H, Zhao F, Fan Z, Wang M, Sui J, Yin B, Wang Z, Wang Z. Analysis of Staged Features of Gastritis-Cancer Transformation and Identification of Potential Biomarkers in Gastric Cancer. J Inflamm Res 2022;15:6857-68. [PMID: 36597437 DOI: 10.2147/JIR.S390448] [Reference Citation Analysis]
604 Cabrera-Rivera LT, Sweetser B, Fuster-Soler JL, Ramis R, López-Hernández FA, Pérez-Martínez A, Ortega-García JA. Looking Towards 2030: Strengthening the Environmental Health in Childhood-Adolescent Cancer Survivor Programs. Int J Environ Res Public Health 2022;20. [PMID: 36612765 DOI: 10.3390/ijerph20010443] [Reference Citation Analysis]
605 Roshan Zamir M, Ariafar A, Ghaderi A, Amirzargar A. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer. Immunobiology 2022;228:152319. [PMID: 36599262 DOI: 10.1016/j.imbio.2022.152319] [Reference Citation Analysis]
606 Do MH, Thanh HD, To PK, Kim MS, Moon C, Jung C. CD46 protects the bladder cancer cells from cetuximab-mediated cytotoxicity. Sci Rep 2022;12:22420. [PMID: 36575233 DOI: 10.1038/s41598-022-27107-9] [Reference Citation Analysis]
607 Liang JX, Chen Q, Gao W, Chen D, Qian XY, Bi JQ, Lin XC, Han BB, Liu JS. A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma. BMC Bioinformatics 2022;23:562. [PMID: 36575396 DOI: 10.1186/s12859-022-05109-8] [Reference Citation Analysis]
608 Chvetzoff G, Bouleuc C, Lardy-Cléaud A, Saltel P, Dieras V, Morelle M, Guastalla JP, Tredan O, Rebattu P, Pop S, Ray-Coquard I, Pierga JY, Mignot L, Laurence V, Bourne-Branchu V, Pérol D, Bachelot T. Impact of early palliative care on additional line of chemotherapy in metastatic breast cancer patients: results from the randomized study OSS. Support Care Cancer 2022;31:82. [PMID: 36574052 DOI: 10.1007/s00520-022-07561-x] [Reference Citation Analysis]
609 Yu M, Wang H, Xu H, Lv Y, Li Q. High MCM8 expression correlates with unfavorable prognosis and induces immune cell infiltration in hepatocellular carcinoma. Aging (Albany NY) 2022;14:10027-49. [PMID: 36575045 DOI: 10.18632/aging.204440] [Reference Citation Analysis]
610 Gao C, Tong YX, Zhu L, Dan Zeng CD, Zhang S. Short-term prognostic role of peripheral lymphocyte subsets in patients with gastric cancer. Int Immunopharmacol 2022;115:109641. [PMID: 36584574 DOI: 10.1016/j.intimp.2022.109641] [Reference Citation Analysis]
611 Diniz TP, Menezes JN, Goncalves BT, Faloppa CC, Mantoan H, Kumagai LY, Badiglian-Filho L, Bovolim G, Guimaraes APG, De Brot L, Baiocchi G. Can mismatch repair status be added to sentinel lymph node mapping algorithm in endometrioid endometrial cancer? Gynecol Oncol 2022;169:131-6. [PMID: 36580755 DOI: 10.1016/j.ygyno.2022.12.010] [Reference Citation Analysis]
612 Wu G, Li L, Liu M, Chen C, Wang G, Jiang Z, Qin Y, He L, Li H, Cao J, Gu H. Therapeutic effect of a MUC1-specific monoclonal antibody-drug conjugates against pancreatic cancer model. Cancer Cell Int 2022;22:417. [PMID: 36572921 DOI: 10.1186/s12935-022-02839-w] [Reference Citation Analysis]
613 Tafuri A, Panunzio A, Soldano A, Mazzucato G, Ornaghi PI, Di Filippo G, Gozzo A, De Maria N, Cianflone F, Shakir A, Tian Z, Brunelli M, Porcaro AB, Pagliarulo V, Artibani W, Karakiewicz PI, Antonelli A, Cerruto MA. AB0 blood groups and oncological and functional outcomes in bladder cancer patients treated with radical cystectomy. Arch Ital Urol Androl 2022;94:428-33. [PMID: 36576469 DOI: 10.4081/aiua.2022.4.428] [Reference Citation Analysis]
614 Ma Z, Han X, Ren J, Liu K, Zhang W, Li G. Design, Synthesis, and Biological Activity of Guaiazulene Derivatives. Chem Biodivers 2022;:e202201174. [PMID: 36573597 DOI: 10.1002/cbdv.202201174] [Reference Citation Analysis]
615 Feng J, He H. Identification of tumour antigens and immune subtypes in the development of an anti-cancer vaccine for endometrial carcinoma. Scand J Immunol 2022;:e13250. [PMID: 36575819 DOI: 10.1111/sji.13250] [Reference Citation Analysis]
616 Khachfe HH, Hammad AY, AlMasri S, deSilva A, Kraftician J, Lee KK, Zureikat AH, Paniccia A. Obesity is Associated With Increased Risk for Adverse Postoperative Outcomes After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma. J Surg Res 2022;284:164-72. [PMID: 36577229 DOI: 10.1016/j.jss.2022.11.050] [Reference Citation Analysis]
617 Xu Y, Wu Q, Tang Z, Tan Z, Pu D, Tan W, Zhang W, Liu S. Comprehensive Analysis of Necroptosis-Related Genes as Prognostic Factors and Immunological Biomarkers in Breast Cancer. J Pers Med 2022;13. [PMID: 36675706 DOI: 10.3390/jpm13010044] [Reference Citation Analysis]
618 Dong P, Yan Y, Fan Y, Wang H, Wu D, Yang L, Zhang J, Yin X, Lv Y, Zhang J, Hou Y, Liu F, Yu X. The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer. Technol Cancer Res Treat 2022;21:15330338221142472. [PMID: 36573015 DOI: 10.1177/15330338221142472] [Reference Citation Analysis]
619 Ioffe YJ, Hong L, Joachim-Célestin M, Soret C, Montgomery S, Unternaehrer JJ. Genetic Testing in the Latinx community: Impact of acculturation and provider relationships. Gynecol Oncol 2022;169:125-30. [PMID: 36577267 DOI: 10.1016/j.ygyno.2022.12.001] [Reference Citation Analysis]
620 Jia Y, Shi K, Dai L, He X, Deng H, Han R, Yang F, Chu B, Liao J, Wei X, Qian Z. Gold Nanorods and Polymer Micelles Mediated Dual TLR Stimulators Delivery System CPG@Au NRs/M‐R848 Regulate Macrophages Reprogramming and DC Maturation for Enhanced Photothermal Immunotherapy of Melanoma. Small Methods 2022. [DOI: 10.1002/smtd.202201087] [Reference Citation Analysis]
621 Xu J, Zheng Z, Yang L, Li R, Ma X, Zhang J, Yin F, Liu L, Xu Q, Shen Q, Shen X, Wu C, Liu J, Qin N, Sheng J, Jin P. A novel promising diagnosis model for colorectal advanced adenoma and carcinoma based on the progressive gut microbiota gene biomarkers. Cell Biosci 2022;12:208. [PMID: 36572910 DOI: 10.1186/s13578-022-00940-1] [Reference Citation Analysis]
622 Zhou N, Yang L, Zhang B, Zhu S, Huo H, He J, Zu L, Song Z, Xu S. Lobectomy versus sublobar resection for stage I (T1-T2aN0M0) small cell lung cancer: A SEER population-based propensity score matching analysis. Cancer Med 2022. [PMID: 36567517 DOI: 10.1002/cam4.5568] [Reference Citation Analysis]
623 Duan ZP, Yu XJ, Wei HL. Circular RNA Sec61 subunit alpha isoform 1 by competitive absorption of microRNA-513a-5p mediates peroxisomal biogenesis factor 5 expression and promotes the malignant phenotype of non-small cell lung cancer. Kaohsiung J Med Sci 2022. [PMID: 36567627 DOI: 10.1002/kjm2.12639] [Reference Citation Analysis]
624 Tang W, Xu N, Zhou J, He Z, Lenahan C, Wang C, Ji H, Liu B, Zou Y, Zeng H, Guo H. ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma. Cell Death Discov 2022;8:497. [PMID: 36566230 DOI: 10.1038/s41420-022-01286-w] [Reference Citation Analysis]
625 Song SY, Park JH, Park SJ, Kang IC, Yoo HS. Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer. Integr Cancer Ther 2022;21:15347354221144311. [PMID: 36565160 DOI: 10.1177/15347354221144311] [Reference Citation Analysis]
626 Wang N, Zhao L, Zhang D, Kong F. Efficacy and safety of anlotinib as maintenance therapy after induction chemotherapy in extensive-stage small-cell lung cancer. Anticancer Drugs 2022. [PMID: 36728981 DOI: 10.1097/CAD.0000000000001488] [Reference Citation Analysis]
627 Li R, Zhang S, Liu G. Identification and validation of a pyroptosis-related prognostic model for colorectal cancer. Funct Integr Genomics 2022;23:21. [PMID: 36564624 DOI: 10.1007/s10142-022-00935-8] [Reference Citation Analysis]
628 Raja R, Wu C, Bassoy EY, Rubino TE Jr, Utagawa EC, Magtibay PM, Butler KA, Curtis M. PP4 inhibition sensitizes ovarian cancer to NK cell-mediated cytotoxicity via STAT1 activation and inflammatory signaling. J Immunother Cancer 2022;10. [PMID: 36564125 DOI: 10.1136/jitc-2022-005026] [Reference Citation Analysis]
629 Kharfan-Dabaja MA, Yassine F, Moustafa MA, Iqbal M, Murthy H. Lisocabtagene Maraleucel in Relapsed or Refractory Diffuse Large B Cell Lymphoma: What is the Evidence? Hematol Oncol Stem Cell Ther 2022;15:168-75. [PMID: 34699774 DOI: 10.1016/j.hemonc.2021.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
630 Wang J, Xu P, Zou G, Yin M, Mao X, Zhang X. ROMA Index Is an Effective Predictor for Advanced Endometrial Cancer before Surgery. Dis Markers 2022;2022:7409368. [PMID: 36590753 DOI: 10.1155/2022/7409368] [Reference Citation Analysis]
631 Zwezerijnen-Jiwa FH, Sivov H, Paizs P, Zafeiropoulou K, Kinross J. A systematic review of microbiome-derived biomarkers for early colorectal cancer detection. Neoplasia 2023;36:100868. [PMID: 36566591 DOI: 10.1016/j.neo.2022.100868] [Reference Citation Analysis]
632 Jin X, Du M, Wang Y, Wang Y, Lu Y, Xu C, Zhang X. Evaluation of serum CA125-Tn glycoform in peritoneal dissemination and surgical completeness of high-grade serous ovarian cancer. J Ovarian Res 2022;15:134. [PMID: 36564848 DOI: 10.1186/s13048-022-01066-1] [Reference Citation Analysis]
633 Chin K, Yamamoto S, Takahashi M, Kadowaki S, Kubota Y, Amanuma Y, Okada M, Kanda M, Kimura Y, Nogi Y, Arimitsu Y, Kitagawa Y. Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3. Esophagus 2022. [PMID: 36564602 DOI: 10.1007/s10388-022-00972-z] [Reference Citation Analysis]
634 Kyaw KZ, Byun WS, Shin YH, Huynh TH, Lee JY, Bae ES, Park HJ, Oh DC, Lee SK. Antitumor Activity of Piceamycin by Upregulation of N-Myc Downstream-Regulated Gene 1 in Human Colorectal Cancer Cells. J Nat Prod 2022;85:2817-27. [PMID: 36458922 DOI: 10.1021/acs.jnatprod.2c00832] [Reference Citation Analysis]
635 Zhang H, Liao M, Guo Q, Chen J, Wang S, Liu S, Xiao F. Predicting N2 lymph node metastasis in presurgical stage I-II non-small cell lung cancer using multiview radiomics and deep learning method. Med Phys 2022. [PMID: 36563341 DOI: 10.1002/mp.16177] [Reference Citation Analysis]
636 Huang G, Zhang J, Gong L, Wang X, Zhang B, Liu D. Characterization of the fatty acid metabolism-related genes in lung adenocarcinoma to guide clinical therapy. BMC Pulm Med 2022;22:486. [PMID: 36564744 DOI: 10.1186/s12890-022-02286-3] [Reference Citation Analysis]
637 Adams AM, Vreeland TJ, Newhook TE. Circulating Tumor DNA: Towards More Individualized Treatment for Patients with Resectable Colorectal Cancer. J Gastrointest Cancer 2022. [PMID: 36562938 DOI: 10.1007/s12029-022-00888-y] [Reference Citation Analysis]
638 Zhang K, Zhang C, Wang K, Teng X, Chen M. Identifying diagnostic markers and constructing a prognostic model for small-cell lung cancer based on blood exosome-related genes and machine-learning methods. Front Oncol 2022;12:1077118. [PMID: 36620585 DOI: 10.3389/fonc.2022.1077118] [Reference Citation Analysis]
639 Aziz MA, Islam MS. MAP3K1 rs889312 polymorphism and cancer prognosis: A systematic review and meta-analysis. Cancer Rep (Hoboken) 2023;6:e1773. [PMID: 36560873 DOI: 10.1002/cnr2.1773] [Reference Citation Analysis]
640 M Salama, L. Nahata, Y. Jayasinghe, V. Gomez-Lobo, MM. Laronda, MB. Moravek, LR. Meacham, MS. Christianson, M. Lambertini, A. Anazodo, GP. Quinn, TK. Woodruff. Pediatric oncofertility care in limited versus optimum resource settings: results from 39 surveyed centers in Repro-Can-OPEN Study Part I & II. J Assist Reprod Genet 2022. [PMID: 36542312 DOI: 10.1007/s10815-022-02679-7] [Reference Citation Analysis]
641 Song Y, Wang J, Xu J, Gao Y, Xu Z. Circ_0018909 knockdown inhibits the development of pancreatic cancer via the miR‐545‐3p/FASN axis and reduces macrophage polarization to M2. J Biochem & Molecular Tox 2022. [DOI: 10.1002/jbt.23293] [Reference Citation Analysis]
642 Xu B, Ye Z, Zhu L, Xu C, Lu M, Wang Q, Yao W, Zhu Z. Development and validation of a nomogram for predicting survival time and making treatment decisions for clinical stage IA NSCLC based on the SEER database. Front Med (Lausanne) 2022;9:972879. [PMID: 36619647 DOI: 10.3389/fmed.2022.972879] [Reference Citation Analysis]
643 Liu Q, Tan J, Zhao Z, Li R, Zheng L, Chen X, Li L, Dong X, Wen T, Liu J. Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line. Biomedicines 2022;11. [PMID: 36672515 DOI: 10.3390/biomedicines11010008] [Reference Citation Analysis]
644 Shridhar R, Blinn P, Huston J, Meredith KL. Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis. Cancer 2022. [DOI: 10.1002/cncr.34625] [Reference Citation Analysis]
645 Su J, Deng L, Wang YD. Roles and Mechanisms of Long Non-Coding RNAs in Breast Cancer. Int J Mol Sci 2022;24. [PMID: 36613528 DOI: 10.3390/ijms24010089] [Reference Citation Analysis]
646 Han L, Zhang Y, Zhang Q, Hu J, Li L, Shi X, Ding Z, Qian X. Clinicopathological features and survival outcomes of colorectal medullary carcinoma: a retrospective study based on the SEER database.. [DOI: 10.21203/rs.3.rs-2392043/v1] [Reference Citation Analysis]
647 Yao H, Li N, Yuan H. Clinical characteristics and survival analysis of Chinese ovarian cancer patients with RAD51D germline mutations. BMC Cancer 2022;22:1337. [PMID: 36544182 DOI: 10.1186/s12885-022-10456-z] [Reference Citation Analysis]
648 Vivek S, Kundan M, Rajat B, Gaurav S, Manu D, Suman P, Singh V. Hyperviscosity syndrome complicating immunoglobulin G myeloma—Cognisance of early plasmapheresis is crucial. Seminars in Dialysis 2022. [DOI: 10.1111/sdi.13135] [Reference Citation Analysis]
649 Zheng YZ, Li JY, Ning LW, Xie N. Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy. Breast Cancer (Dove Med Press) 2022;14:475-87. [PMID: 36578908 DOI: 10.2147/BCTT.S387209] [Reference Citation Analysis]
650 Victorson D, Morgan T, Kutikov A, Novakovic K, Kundu S, Horowitz B, Jackson K, Addington E, Murphy K, Sauer C, Brendler C. Mindfulness-based stress reduction for men on active surveillance for prostate cancer and their spouses: Design and methodology of a randomized controlled trial. Contemp Clin Trials 2022;125:107059. [PMID: 36563902 DOI: 10.1016/j.cct.2022.107059] [Reference Citation Analysis]
651 Yu L, Ding L, Wang ZY, Zhao XZ, Wang YH, Liang C, Li J. Hybrid Metabolic Activity-Related Prognostic Model and Its Effect on Tumor in Renal Cell Carcinoma. J Healthc Eng 2022;2022:1147545. [PMID: 36591111 DOI: 10.1155/2022/1147545] [Reference Citation Analysis]
652 Tan K, Mo J, Li M, Dong Y, Han Y, Sun X, Ma Y, Zhu K, Wu W, Lu L, Liu J, Zhao K, Zhang L, Tang Y, Lv Z. SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma. J Exp Clin Cancer Res 2022;41:352. [PMID: 36539767 DOI: 10.1186/s13046-022-02563-3] [Reference Citation Analysis]
653 Iacovelli R, Cicala CM, Ciccarese C, Sacco E, Racioppi M, Bassi PF, Tortora G. Management of metastatic urothelial carcinoma: Current approach, emerging agents, and future perspectives. Urologia 2022. [DOI: 10.1177/03915603221139907] [Reference Citation Analysis]
654 Itaya T, Sano M, Kajiwara I, Oshima Y, Kuramochi T, Kim J, Ichimaru Y, Kitajima O, Masamune A, Ijichi H, Ishii Y, Suzuki T. Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. Pain 2022. [PMID: 36701124 DOI: 10.1097/j.pain.0000000000002852] [Reference Citation Analysis]
655 Dayanidhi DL, Somarelli JA, Mantyh JB, Rupprecht G, Roghani RS, Vincoff S, Shin I, Zhao Y, Kim SY, Mccall S, Hong J, Hsu DS. Psymberin, a marine-derived natural product, induces cancer cell growth arrest and protein translation inhibition. Front Med 2022;9. [DOI: 10.3389/fmed.2022.999004] [Reference Citation Analysis]
656 Hirofumi Tsuzuki, Tatsuya Kawase, Taisuke Nakazawa, Masamichi Mori, Taku Yoshida. Anti-tumor effect of antibody drug conjugate ASP1235 targeting Fms-like tyrosine kinase 3 with venetoclax plus azacitidine in an acute myeloid leukemia xenograft mouse model. Oncotarget 2022;13. [PMID: 36537913 DOI: 10.18632/oncotarget.28331] [Reference Citation Analysis]
657 Williams N, Grimm M, Gast K, Lustberg M. Right Sizing Systemic Therapy for Patients with Breast Cancer. Where are we Today? Curr Breast Cancer Rep 2022. [DOI: 10.1007/s12609-022-00463-1] [Reference Citation Analysis]
658 Zhu Y, Chen B, Pan H, Sun L, Yu T. PLIC11 drives lung cancer progression through regulating the YY1/PIWIL4 axis. Molecular Carcinogenesis 2022. [DOI: 10.1002/mc.23496] [Reference Citation Analysis]
659 Chen C, Zhang Q, Kong B. miRNA-576-5p promotes endometrial cancer cell growth and metastasis by targeting ZBTB4. Clin Transl Oncol 2022. [DOI: 10.1007/s12094-022-02976-8] [Reference Citation Analysis]
660 Yu J, Zhang Y, Zheng J, Jia M, Lu X. Ultrasound images-based deep learning radiomics nomogram for preoperative prediction of RET rearrangement in papillary thyroid carcinoma. Front Endocrinol (Lausanne) 2022;13:1062571. [PMID: 36605945 DOI: 10.3389/fendo.2022.1062571] [Reference Citation Analysis]
661 Vu JV, Sommovilla J. The Molecular Genetics of Colorectal Cancer, Hereditary Colorectal Cancer Syndromes, and Early-Onset Colorectal Cancer. Digestive Disease Interventions 2022. [DOI: 10.1055/s-0042-1757325] [Reference Citation Analysis]
662 Qi SA, Kumar N, Xu JY, Patel J, Damaraju S, Shen-Tu G, Greiner R. Personalized breast cancer onset prediction from lifestyle and health history information. PLoS One 2022;17:e0279174. [PMID: 36534670 DOI: 10.1371/journal.pone.0279174] [Reference Citation Analysis]
663 Chen X, Ma J, Wang X, Zi T, Qian D, Li C, Xu C. CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine. Front Endocrinol (Lausanne) 2022;13:1106175. [PMID: 36601001 DOI: 10.3389/fendo.2022.1106175] [Reference Citation Analysis]
664 Lian-kai Zhu, Zhong-jian Li, Zhi-bo Wang, Jin-tao Chen, Hua-jun Zhang, Xu-wei Zhao, Hong-yao Liu. A rare case of bladder cancer that metastasized to brain, heart, and lung lymph nodes benefited from immunotherapy. World J Surg Oncol 2022;20:402. [PMID: 36529739 DOI: 10.1186/s12957-022-02876-9] [Reference Citation Analysis]
665 Li H, Zheng S, Wan T, Yang X, Ouyang Y, Xia H, Wang X. Circular RNA circ_0000212 accelerates cervical cancer progression by acting as a miR-625-5p sponge to upregulate PTP4A1. Anticancer Drugs 2022. [PMID: 36729102 DOI: 10.1097/CAD.0000000000001435] [Reference Citation Analysis]
666 Liang Y, Cen J, Huang Y, Fang Y, Wang Y, Shu G, Pan Y, Huang K, Dong J, Zhou M, Xu Y, Luo J, Liu M, Zhang J. CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug. Mol Cancer 2022;21:224. [PMID: 36536414 DOI: 10.1186/s12943-022-01694-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
667 Feng L, Jin Y, Chai L, Xiong W, Wang W, Feng X, Chen B. The rs41291957 polymorphism of miR-143/145 and cancer risk: a case-control study and meta-analysis. Nucleosides, Nucleotides & Nucleic Acids 2022. [DOI: 10.1080/15257770.2022.2157436] [Reference Citation Analysis]
668 Abdelbaki MS, DeWire Schottmiller MD, Cripe TP, Curry RC, Cruze CA, Her L, Demko S, Casey D, Setty B. An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon 2022;8:e12450. [PMID: 36590576 DOI: 10.1016/j.heliyon.2022.e12450] [Reference Citation Analysis]
669 Long X, Wang D, Wu Z, Liao Z, Xu J. Circular RNA hsa_circ_0004689 (circSWT1) promotes NSCLC progression via the miR‐370‐3p/SNAIL axis by inducing cell epithelial‐mesenchymal transition (EMT). Cancer Medicine 2022. [DOI: 10.1002/cam4.5527] [Reference Citation Analysis]
670 Guo T, Zhang J, Yuan Z, Tang H, Wang T, Wang X, Chen S. Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell Carcinoma. J Clin Med 2022;11. [PMID: 36556123 DOI: 10.3390/jcm11247507] [Reference Citation Analysis]
671 Zafar A, Baessler F, Ihrig A, Mayer G, Bugaj TJ, Maatouk I, Staeudle J, Friederich H, Schultz J. Barriers to access cancer‐related services for men in high‐income countries: A narrative review looking beyond socioeconomic disadvantages. Aging and Cancer 2022. [DOI: 10.1002/aac2.12059] [Reference Citation Analysis]
672 Daido W, Masuda T, Imano N, Matsumoto N, Hamai K, Iwamoto Y, Takayama Y, Ueno S, Sumii M, Shoda H, Ishikawa N, Yamasaki M, Nishimura Y, Kawase S, Shiota N, Awaya Y, Suzuki T, Kitaguchi S, Fujitaka K, Nagata Y, Hattori N. Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer. Cancers (Basel) 2022;14. [PMID: 36551721 DOI: 10.3390/cancers14246236] [Reference Citation Analysis]
673 Wang F, Yu C, Chen L, Xu S. Landscape of circular RNAs in different types of lung cancer and an emerging role in therapeutic resistance (Review). Int J Oncol 2023;62:21. [PMID: 36562354 DOI: 10.3892/ijo.2022.5469] [Reference Citation Analysis]
674 Yang D, Liu M, Jiang J, Luo Y, Wang Y, Chen H, Li D, Wang D, Yang Z, Chen H. Comprehensive Analysis of DMRT3 as a Potential Biomarker Associated with the Immune Infiltration in a Pan-Cancer Analysis and Validation in Lung Adenocarcinoma. Cancers (Basel) 2022;14. [PMID: 36551704 DOI: 10.3390/cancers14246220] [Reference Citation Analysis]
675 Qu N, Qu J, Huang N, Zhang K, Ye T, Shi J, Chen B, Kan C, Zhang J, Han F, Hou N, Sun X, Pan R. Calycosin induces autophagy and apoptosis via Sestrin2/AMPK/mTOR in human papillary thyroid cancer cells. Front Pharmacol 2022;13:1056687. [PMID: 36588732 DOI: 10.3389/fphar.2022.1056687] [Reference Citation Analysis]
676 Cui X, Yao Z, Zhao T, Guo J, Ding J, Zhang S, Liang Z, Wei Z, Zoa A, Tian Y, Li J. siAKR1C3@PPA complex nucleic acid nanoparticles inhibit castration-resistant prostate cancer in vitro. Front Oncol 2022;12:1069033. [PMID: 36591491 DOI: 10.3389/fonc.2022.1069033] [Reference Citation Analysis]
677 Roberson J, Huang H, Noldner C, Hou W, Mani K, Valentine E, Ryu S, Stessin A. Thyroid volume changes following adjuvant radiation therapy for breast cancer. Clin Transl Radiat Oncol 2023;39:100566. [PMID: 36582422 DOI: 10.1016/j.ctro.2022.100566] [Reference Citation Analysis]
678 Dong B, Zhu X, Li K, Chen M. Identification of a novel glycolysis-related prognostic signature for predicting prognosis and tumor microenvironment of lung adenocarcinoma.. [DOI: 10.21203/rs.3.rs-2375858/v1] [Reference Citation Analysis]
679 Guo Y, Hu G, Tian B, Ma M, Long F, Chen M. Circ_RNF13 Regulates the Stemness and Chemosensitivity of Colorectal Cancer by Transcriptional Regulation of DDX27 Mediated by TRIM24 Stabilization. Cancers (Basel) 2022;14. [PMID: 36551703 DOI: 10.3390/cancers14246218] [Reference Citation Analysis]
680 Jani C, Mouchati C, Abdallah N, Mariano M, Jani R, Salciccioli JD, Marshall DC, Singh H, Sheng I, Shalhoub J, Mckay RR. Trends in prostate cancer mortality in the United States of America, by state and race, from 1999 to 2019: estimates from the centers for disease control WONDER database. Prostate Cancer Prostatic Dis 2022. [DOI: 10.1038/s41391-022-00628-0] [Reference Citation Analysis]
681 Yang Wang, Ruizhi Zheng, Yanhui Zhang, Yuhong Guo, Zhenzhen Hui, Peijing Wang, Yan Sun. Galectin-9 expression clinically associated with mature dendritic cells infiltration and T cell immune response in colorectal cancer. BMC Cancer 2022;22:1319. [PMID: 36527024 DOI: 10.1186/s12885-022-10435-4] [Reference Citation Analysis]
682 Shiau JP, Lee MY, Tang JY, Huang H, Lin ZY, Su JH, Hou MF, Cheng YB, Chang HW. Marine Sponge Aaptos suberitoides Extract Improves Antiproliferation and Apoptosis of Breast Cancer Cells without Cytotoxicity to Normal Cells In Vitro. Pharmaceuticals (Basel) 2022;15. [PMID: 36559026 DOI: 10.3390/ph15121575] [Reference Citation Analysis]
683 Kena Zhou, Congbo Cai, Guanjun Ding, Yi He, Di Hu. A signature of six-hypoxia-related genes to evaluate the tumor immune microenvironment and predict prognosis in gastric cancer. BMC Med Genomics 2022;15:261. [PMID: 36527012 DOI: 10.1186/s12920-022-01411-9] [Reference Citation Analysis]
684 Yin W, Huang J, Chen J, Ji Y. A study on skin tumor classification based on dense convolutional networks with fused metadata. Front Oncol 2022;12:989894. [PMID: 36601473 DOI: 10.3389/fonc.2022.989894] [Reference Citation Analysis]
685 Zhu J, Leng X, Gao B, Wang B, Zhang H, Wu L, Ma J, Tan Y, Peng L, Han Y, Wang Q. Efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or gastroesophageal junction carcinoma: A pooled analysis of prospective clinical trials. Front Immunol 2022;13:1041233. [PMID: 36591306 DOI: 10.3389/fimmu.2022.1041233] [Reference Citation Analysis]
686 Shanshan Wang, Lijun Xu, Kangle Zhu, Huixia Zhu, Dan Zhang, Chongyu Wang, Qingqing Wang. Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD. BMC Med Genomics 2022;15:260. [PMID: 36522691 DOI: 10.1186/s12920-022-01409-3] [Reference Citation Analysis]
687 Kanno H, Hisaka T, Fujiyoshi K, Akiba J, Hashimoto K, Fujita F, Akagi Y. Prognostic Significance of the Histopathological Growth Pattern and Tumor-Infiltrating Lymphocytes in Stratifying Survival After Hepatectomy for Colorectal Liver Metastases. Ann Surg Oncol 2022. [DOI: 10.1245/s10434-022-12905-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
688 Yang K, Feng S, Luo Z. Oncolytic Adenovirus, a New Treatment Strategy for Prostate Cancer. Biomedicines 2022;10. [PMID: 36552019 DOI: 10.3390/biomedicines10123262] [Reference Citation Analysis]
689 Liu W, Zhou X, Zhou T, Zou R, Wang X, Liu W. Identifying new driver genes for castration resistance for prostate cancer based on protein mass spectrometry and transcriptome big data.. [DOI: 10.21203/rs.3.rs-2372054/v1] [Reference Citation Analysis]
690 Fang C, Zhong Y, Chen T, Li D, Li C, Qi X, Zhu J, Wang R, Zhu J, Wang S, Ruan Y, Zhou M. Impairment mechanism of nasal mucosa after radiotherapy for nasopharyngeal carcinoma. Front Oncol 2022;12:1010131. [PMID: 36591522 DOI: 10.3389/fonc.2022.1010131] [Reference Citation Analysis]
691 Shengbo Han, Decai Wang, Yan Huang, Zhu Zeng, Peng Xu, Hewei Xiong, Zunxiang Ke, Ya Zhang, Yuhang Hu, Fan Wang, Jie Wang, Yong Zhao, Wenfeng Zhuo, Gang Zhao. A reciprocal feedback between colon cancer cells and Schwann cells promotes the proliferation and metastasis of colon cancer. J Exp Clin Cancer Res 2022;41:348. [PMID: 36522730 DOI: 10.1186/s13046-022-02556-2] [Reference Citation Analysis]
692 Papalazarou V, Drew J, Juin A, Spence HJ, Whitelaw J, Nixon C, Salmeron-Sanchez M, Machesky LM. Collagen VI expression is negatively mechanosensitive in pancreatic cancer cells and supports the metastatic niche. J Cell Sci 2022;135:jcs259978. [PMID: 36546396 DOI: 10.1242/jcs.259978] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
693 Kang Y, Deng J, Ling J, Li X, Chiang YJ, Koay EJ, Wang H, Burks JK, Chiao PJ, Hurd MW, Bhutani MS, Lee JH, Weston BR, Maitra A, Ikoma N, Tzeng CD, Lee JE, DePinho RA, Wolff RA, Pant S, McAllister F, Katz MH, Fleming JB, Kim MP. 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. J Clin Invest 2022;132. [PMID: 36282600 DOI: 10.1172/JCI151604] [Reference Citation Analysis]
694 Ioannis A. Vathiotis, Leonidas Salichos, Sandra Martinez-Morilla, Niki Gavrielatou, Thazin Nwe Aung, Saba Shafi, Pok Fai Wong, Shlomit Jessel, Harriet M. Kluger, Konstantinos N. Syrigos, Sarah Warren, Mark Gerstein, David L. Rimm. Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade. NPJ Precis Oncol 2022;6:92. [PMID: 36522538 DOI: 10.1038/s41698-022-00330-3] [Reference Citation Analysis]
695 Ko YS, Choi YM, Kim M, Park Y, Ashraf M, Quiñones Robles WR, Kim MJ, Jang J, Yun S, Hwang Y, Jang H, Yi MY. Improving quality control in the routine practice for histopathological interpretation of gastrointestinal endoscopic biopsies using artificial intelligence. PLoS One 2022;17:e0278542. [PMID: 36520777 DOI: 10.1371/journal.pone.0278542] [Reference Citation Analysis]
696 Wang T, Zhang D, Tang D, Heng Y, Lu L, Tao L. The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol 2022. [DOI: 10.1007/s00432-022-04469-1] [Reference Citation Analysis]
697 Ghali F, Zhao Y, Patel D, Jewell T, Yu EY, Grivas P, Montgomery RB, Gore JL, Etzioni RB, Wright JL. Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis. Eur Urol Open Sci 2023;47:58-64. [PMID: 36601043 DOI: 10.1016/j.euros.2022.11.003] [Reference Citation Analysis]
698 Kasuga A, Nojima M, Okamoto T, Ishitsuka T, Yamada M, Nakagawa H, Udagawa S, Mori C, Mie T, Furukawa T, Yamada Y, Takeda T, Matsuyama M, Sasaki T, Ozaka M, Sasahira N. Impact of the COVID-19 Pandemic on the Management and End-of-life Care of Unresectable Pancreatic Cancer. Intern Med 2022;61:3641-9. [PMID: 36198597 DOI: 10.2169/internalmedicine.0492-22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
699 Zheng C, Ren Z, Chen H, Yuan X, Suye S, Yin H, Zhou Z, Fu C. FANCD2 promotes the malignant behavior of endometrial cancer cells and its prognostic value. Exp Cell Res 2022;421:113388. [PMID: 36257352 DOI: 10.1016/j.yexcr.2022.113388] [Reference Citation Analysis]
700 Goangul MS, Stewart WC, Erenso D, Crogman HT. The radiation response measurement of a single and multiple cell ionization of neuroblastoma cells by infrared laser trap. J Radiat Res 2023;64:113-25. [PMID: 36527720 DOI: 10.1093/jrr/rrac082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
701 Lu J, Liu Q, Zhu L, Liu Y, Zhu X, Peng S, Chen M, Li P. Endothelial cell-specific molecule 1 drives cervical cancer progression. Cell Death Dis 2022;13:1043. [PMID: 36522312 DOI: 10.1038/s41419-022-05501-5] [Reference Citation Analysis]
702 Yu H, Li E, Liu S, Wu Z, Gao F. Identification of Signature Genes in the PD-1 Relative Gastric Cancer Using a Combined Analysis of Gene Expression and Methylation Data. J Oncol 2022;2022:4994815. [PMID: 36568638 DOI: 10.1155/2022/4994815] [Reference Citation Analysis]
703 Sabbagh A, Mohamad O, Lichter KE, Hope TA. Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET. Cancers (Basel) 2022;14. [PMID: 36551678 DOI: 10.3390/cancers14246194] [Reference Citation Analysis]
704 Li J, Ye Z, Hu X, Hou S, Hang Q. Prognostic, Diagnostic, and Clinicopathological Significance of Circular RNAs in Pancreatic Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel) 2022;14. [PMID: 36551673 DOI: 10.3390/cancers14246187] [Reference Citation Analysis]
705 Ji Y, Li X, Qi Y, Zhao J, Zhang W, Qu P. Anlotinib Exerts Inhibitory Effects against Cisplatin-Resistant Ovarian Cancer In Vitro and In Vivo. Molecules 2022;27. [PMID: 36558006 DOI: 10.3390/molecules27248873] [Reference Citation Analysis]
706 Zhang L, Guan S, Meng F, Teng L, Zhong D. Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer. Front Oncol 2022;12:1035808. [PMID: 36591485 DOI: 10.3389/fonc.2022.1035808] [Reference Citation Analysis]
707 Zhang L, Gong Y, Zhang L, Liang B, Xu H, Hu W, Jin Z, Wu X, Chen X, Li M, Shi L, Shi Y, Li M, Huang Y, Wang Y, Yang L. Gou Qi Zi inhibits proliferation and induces apoptosis through the PI3K/AKT1 signaling pathway in non-small cell lung cancer. Front Oncol 2022;12:1034750. [PMID: 36591458 DOI: 10.3389/fonc.2022.1034750] [Reference Citation Analysis]
708 Guo Z, Jing S, Jumatai S, Gong Z. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment. Cancer Immunol Immunother 2022. [DOI: 10.1007/s00262-022-03348-5] [Reference Citation Analysis]
709 He J, Wang Y, Chen X, Chen W, Zhou J. Value of thyroid cancer history in the prognosis of pancreatic cancer: a SEER population-based study.. [DOI: 10.21203/rs.3.rs-2354888/v1] [Reference Citation Analysis]
710 Jiang XY, Zhu QC, Zhang XJ, Duan T, Feng J, Sui XB, Sun XN, Mou YP. Roles of lncRNAs in pancreatic ductal adenocarcinoma: Diagnosis, treatment, and the development of drug resistance. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00280-6. [PMID: 36543619 DOI: 10.1016/j.hbpd.2022.12.002] [Reference Citation Analysis]
711 Zhang L, Lovell S, De Vita E, Jagtap PKA, Lucy D, Goya Grocin A, Kjær S, Borg A, Hennig J, Miller AK, Tate EW. A KLK6 Activity-Based Probe Reveals a Role for KLK6 Activity in Pancreatic Cancer Cell Invasion. J Am Chem Soc 2022. [PMID: 36413626 DOI: 10.1021/jacs.2c07378] [Reference Citation Analysis]
712 Li J, Li X, Ma J, Wang F, Cui S, Ye Z. Computed tomography–based radiomics machine learning classifiers to differentiate type I and type II epithelial ovarian cancers. Eur Radiol 2022. [DOI: 10.1007/s00330-022-09318-w] [Reference Citation Analysis]
713 Wang H, Xie H, Wang S, Zhao J, Gao Y, Chen J, Zhao Y, Guo G. PARP-1 genetic polymorphism associated with radiation sensitivity of non-small cell lung cancer. Pathol Oncol Res 2022;28:1610751. [PMID: 36590386 DOI: 10.3389/pore.2022.1610751] [Reference Citation Analysis]
714 Freedland SJ, Hong A, El-chaar N, Murty S, Ramaswamy K, Coutinho AD, Nimke D, Morgans AK. Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting. Prostate Cancer Prostatic Dis 2022. [DOI: 10.1038/s41391-022-00622-6] [Reference Citation Analysis]
715 Thrastardottir TO, Copeland VJ, Constantinou C. The Association Between Nutrition, Obesity, Inflammation, and Endometrial Cancer: A Scoping Review. Curr Nutr Rep 2022. [DOI: 10.1007/s13668-022-00447-8] [Reference Citation Analysis]
716 Xiong S, Lazovich DA, Hassan F, Ambo N, Ghebre R, Kulasingam S, Mason SM, Pratt RJ. Health care personnel’s perspectives on human papillomavirus (HPV) self-sampling for cervical cancer screening: a pre-implementation, qualitative study. Implement Sci Commun 2022;3:130. [DOI: 10.1186/s43058-022-00382-3] [Reference Citation Analysis]
717 Yang L, Zhong J, Wang W, Zhou F. Prognostic Nutritional Index Associates with Immunotherapy Response in Patients with Metastatic Biliary Tract Cancer. Nutrition and Cancer 2022. [DOI: 10.1080/01635581.2022.2153880] [Reference Citation Analysis]
718 Dong M, Cao L, Cui R, Xie Y. The connection between innervation and metabolic rearrangements in pancreatic cancer through serine. Front Oncol 2022;12:992927. [PMID: 36582785 DOI: 10.3389/fonc.2022.992927] [Reference Citation Analysis]
719 Wang N, Yang J, Han W, Han M, Liu X, Jiang L, Cao H, Jing M, Sun T, Xu J. Identifying distinctive tissue and fecal microbial signatures and the tumor-promoting effects of deoxycholic acid on breast cancer. Front Cell Infect Microbiol 2022;12:1029905. [PMID: 36583106 DOI: 10.3389/fcimb.2022.1029905] [Reference Citation Analysis]
720 Wang L, Ji J, Li S, Zhang L, Song Y, Zhang X, Wang H, Li K, Cao L. Prognostic effect of lymphadenectomy extent on ovarian cancer:A population-based analysis.. [DOI: 10.21203/rs.3.rs-2360812/v1] [Reference Citation Analysis]
721 Zhou H, Yu X, Wei Y, Zhao Z, Peng L, Li Y, Lu N, Yu M. A clinical study on microwave ablation of multifocal (≤ 3) T1N0M0 papillary thyroid carcinoma. Eur Radiol 2022. [DOI: 10.1007/s00330-022-09333-x] [Reference Citation Analysis]
722 Germanos AA, Arora S, Zheng Y, Goddard ET, Coleman IM, Ku AT, Wilkinson S, Song H, Brady NJ, Amezquita RA, Zager M, Long A, Yang YC, Bielas JH, Gottardo R, Rickman DS, Huang FW, Ghajar CM, Nelson PS, Sowalsky AG, Setty M, Hsieh AC. Defining cellular population dynamics at single-cell resolution during prostate cancer progression. eLife 2022;11. [DOI: 10.7554/elife.79076] [Reference Citation Analysis]
723 Syed M, Mushtaq S, Loya A, Hassan U, Mir K, Hussain M, Hameed M, Sheikh UN. Prognostic significance of minor high grade component in non-invasive papillary urothelial carcinoma of urinary bladder: (A study of 273 consecutive cases over a period of 3 years). Ann Diagn Pathol 2022;63:152079. [PMID: 36549142 DOI: 10.1016/j.anndiagpath.2022.152079] [Reference Citation Analysis]
724 Yuan G, Hu B, Ma J, Zhang C, Xie H, Wei T, Yang Y, Ni B. Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma. Cancer Medicine 2022. [DOI: 10.1002/cam4.5451] [Reference Citation Analysis]
725 Li X, Cui J, Song J, Jia M, Zou Z, Ding G, Zheng Y. Contextual Features and Information Bottleneck-Based Multi-Input Network for Breast Cancer Classification from Contrast-Enhanced Spectral Mammography. Diagnostics (Basel) 2022;12. [PMID: 36553140 DOI: 10.3390/diagnostics12123133] [Reference Citation Analysis]
726 Zhang X, Wang J, Zhu L, Wang X, Meng F, Xia L, Zhang H. Advances in Stigmasterol on its anti-tumor effect and mechanism of action. Front Oncol 2022;12:1101289. [PMID: 36578938 DOI: 10.3389/fonc.2022.1101289] [Reference Citation Analysis]
727 Nielsen SK, Nouhravesh N, Jensen MH, Jensen RFG, Klein MF, Saghir Z, Nielsen D, Schou M, Lamberts M. The validity of a new procedure-based definition of cancer status in patients with breast-, lung- and colorectal cancer in the Danish National Patient Registry.. [DOI: 10.21203/rs.3.rs-2315185/v1] [Reference Citation Analysis]
728 Parvathareddy SK, Siraj AK, Bu R, Iqbal K, Al-Rasheed M, Al-Haqawi W, Annaiyappanaidu P, Siraj N, Ahmed SO, Al-Sobhi SS, Al-Dayel F, Al-Kuraya KS. X-linked inhibitor of apoptosis protein (XIAP) predicts disease-free survival in BRAFV600E mutant papillary thyroid carcinoma in middle eastern patients. Front Endocrinol (Lausanne) 2022;13:1054882. [PMID: 36578953 DOI: 10.3389/fendo.2022.1054882] [Reference Citation Analysis]
729 Mugaanyi J, Lu C, Huang J, Lu C. Undifferentiated Pancreatic Carcinomas, Clinical Features and Therapeutic Options: What We Know. Cancers (Basel) 2022;14. [PMID: 36551588 DOI: 10.3390/cancers14246102] [Reference Citation Analysis]
730 Salamekh S, Yan J, D'Cunha P, Hoang AQ, Zhu H, Albuquerque K. Addition of Postoperative Radiation Therapy After Preoperative Chemotherapy and Surgery in Patients With Locally Advanced Endometrial Cancer Is Associated With Improved Outcomes. Adv Radiat Oncol 2023;8:101126. [PMID: 36711063 DOI: 10.1016/j.adro.2022.101126] [Reference Citation Analysis]
731 Li R, Liu M, Yang Z, Li J, Gao Y, Tan R. Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future. Molecules 2022;27. [PMID: 36557960 DOI: 10.3390/molecules27248828] [Reference Citation Analysis]
732 Bi F, Li X, Zhang Y, Wang Z, Dong Q, Zhang J, Sun D. Prognostic value of elastic lamina staining in patients with stage III colon cancer. World J Surg Oncol 2022;20:391. [PMID: 36503509 DOI: 10.1186/s12957-022-02865-y] [Reference Citation Analysis]
733 Zhong Y, Li ZN, Jiang XY, Tian X, Deng MH, Cheng MS, Yang HL, Liu Y. Identification of Novel Artemisinin Hybrids Induce Apoptosis and Ferroptosis in MCF-7 Cells. Int J Mol Sci 2022;23. [PMID: 36555409 DOI: 10.3390/ijms232415768] [Reference Citation Analysis]
734 Xiao J, Sharma U, Arab A, Miglani S, Bhalla S, Suguru S, Suter R, Mukherji R, Lippman ME, Pohlmann PR, Zeck J, Marshall JL, Weinberg BA, He AR, Noel MS, Schlegel R, Goodarzi H, Agarwal S. Propagated circulating tumor cells uncovers the role of NFκB and COP1 in metastasis.. [DOI: 10.1101/2022.12.09.519805] [Reference Citation Analysis]
735 Lehner KR, Jiang K, Rincon-Torroella J, Perera R, Bettegowda C. Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review. Neoplasia 2023;35:100852. [PMID: 36516487 DOI: 10.1016/j.neo.2022.100852] [Reference Citation Analysis]
736 Frumovitz M, Chisholm GB, Jhingran A, Ramalingam P, Flores-Legarreta A, Bhosale P, Gonzales NR, Hillman RT, Salvo G. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study. Am J Obstet Gynecol 2022:S0002-9378(22)02270-0. [PMID: 36516952 DOI: 10.1016/j.ajog.2022.12.009] [Reference Citation Analysis]
737 Yao Y, Gong G, Guo Z, Zhang D. A pan-cancer analysis of ring finger protein 135 and its relationship to triple-negative breast cancer proliferation and metastasis. Aging (Albany NY) 2022;14:9758-72. [PMID: 36495591 DOI: 10.18632/aging.204429] [Reference Citation Analysis]
738 Luan Y, Ding XF, Lu SM, Huang TB, Chen J, Xiao Q, Wang LP, Chen HP, Han YX. The Efficacy of Urinary Continence in Patients Undergoing Robot-Assisted Radical Prostatectomy with Bladder-Prostatic Muscle Reconstruction and Bladder Neck Eversion Anastomosis. Medicina (Kaunas) 2022;58. [PMID: 36557023 DOI: 10.3390/medicina58121821] [Reference Citation Analysis]
739 Copeland LJ, Brady MF, Burger RA, Rodgers WH, Huang HQ, Cella D, O'Malley DM, Street DG, Tewari KS, Bender DP, Morris RT, Lowery WJ, Miller DS, Dewdney SB, Spirtos NM, Lele SB, Guntupalli S, Ueland FR, Glaser GE, Mannel RS, DiSaia PJ. Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study. J Clin Oncol 2022;40:4119-28. [PMID: 35759733 DOI: 10.1200/JCO.22.00146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
740 Issanov A, Karim ME, Aimagambetova G, Dummer TJB. Does Vaccination Protect against Human Papillomavirus-Related Cancers? Preliminary Findings from the United States National Health and Nutrition Examination Survey (2011-2018). Vaccines (Basel) 2022;10. [PMID: 36560523 DOI: 10.3390/vaccines10122113] [Reference Citation Analysis]
741 Yuan Y, Liu X, Cai Y, Li W. Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis. Syst Rev 2022;11:264. [PMID: 36496473 DOI: 10.1186/s13643-022-02134-9] [Reference Citation Analysis]
742 Kim J, Kang S, Kim D, Kang H. Associations of Physical Activity and Handgrip Strength with Health-Related Quality of Life in Older Korean Cancer Survivors. Cancers (Basel) 2022;14. [PMID: 36551553 DOI: 10.3390/cancers14246067] [Reference Citation Analysis]
743 Kani MAJM, Parvathy MS, Banu SM, Kareem MSA. Classification of skin lesion images using modified Inception V3 model with transfer learning and augmentation techniques. IFS 2022. [DOI: 10.3233/jifs-221386] [Reference Citation Analysis]
744 Necchi A, Spiess PE, Bandini M, Basile G, Grivas P, Bratslavsky G, Jacob J, Danziger N, Lin D, Decker B, Sokol ES, Huang RSP, Kulkarni SB, Ross JS. Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study. Oncologist 2022;27:1016-24. [PMID: 35881043 DOI: 10.1093/oncolo/oyac144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
745 Fu JX, Wang XJ, Xia M, Wang XJ. Peritoneal carcinomatosis secondary to metastatic lung cancer complicated with acute suppurative appendicitis: A case report and literature review. Medicine (Baltimore) 2022;101:e31866. [PMID: 36626502 DOI: 10.1097/MD.0000000000031866] [Reference Citation Analysis]
746 Wu Y, Zhang X, Duan X, Yang X, Wang F, Zhang J. Optimized Therapeutic (177)Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer. Pharmaceuticals (Basel) 2022;15. [PMID: 36558981 DOI: 10.3390/ph15121530] [Reference Citation Analysis]
747 Song Z, Liao C, Yao L, Xu X, Shen X, Tian S, Wang S, Xing F. miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2. Cancer Gene Ther 2022. [DOI: 10.1038/s41417-022-00574-y] [Reference Citation Analysis]
748 Peng T, Liu B, Lin S, Cao C, Wu P, Zhi W, Wei Y, Chu T, Gui L, Ding W. APOBEC3G expression correlates with unfavorable prognosis and immune infiltration in kidney renal clear cell carcinoma. Heliyon 2022;8:e12191. [PMID: 36568653 DOI: 10.1016/j.heliyon.2022.e12191] [Reference Citation Analysis]
749 Diehl AC, Hannan LM, Zhen DB, Coveler AL, King G, Cohen SA, Harris WP, Shankaran V, Wong KM, Green S, Ng N, Pillarisetty VG, Sham JG, Park JO, Reddi D, Konnick EQ, Pritchard CC, Baker K, Redman M, Chiorean EG. KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas. Oncologist 2022;27:1025-33. [PMID: 36124727 DOI: 10.1093/oncolo/oyac179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
750 Berenson JR, Martinez D, Safaie T, Boccia R, Yang H, Moezi M, Lim S, Schwartz G, Eshaghian S, Swift R, Eades BM, Bujarski S, Regidor B, Kim C, Kim S, Vescio R. Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma. Br J Haematol 2022. [DOI: 10.1111/bjh.18593] [Reference Citation Analysis]
751 Zhang X, Liu X, Zhu K, Zhang X, Li N, Sun T, Fan S, Dai L, Zhang J. CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma. Cancer Cell Int 2022;22:393. [PMID: 36494696 DOI: 10.1186/s12935-022-02820-7] [Reference Citation Analysis]
752 Huang B, Wu C, Hu Y, Rao L, Yang M, Zhao M, Chen H, Li Y. Osmanthus-Loaded PVP/PVA Hydrogel Inhibits the Proliferation and Migration of Oral Squamous Cell Carcinoma Cells CAL-27. Polymers (Basel) 2022;14. [PMID: 36559766 DOI: 10.3390/polym14245399] [Reference Citation Analysis]
753 Mucciolo G, Henríquez JA, Teles SP, Manansala JS, Jihad M, Li W, Lloyd EG, Cheng PS, Biffi G. ERBB-activated myofibroblastic cancer-associated fibroblasts promote local metastasis of pancreatic cancer.. [DOI: 10.1101/2022.12.05.519080] [Reference Citation Analysis]
754 Bilen MA, Akintayo A, Liu Y, Abiodun-Ojo O, Kucuk O, Carthon BC, Schuster DM, Parent EE. Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [(68)Ga]Ga DOTATATE PET-CT. Cancers (Basel) 2022;14. [PMID: 36551525 DOI: 10.3390/cancers14246039] [Reference Citation Analysis]
755 Unger JM, Leblanc M, George S, Wolmark N, Curran WJ, O'dwyer PJ, Schnall MD, Mannel RS, Mandrekar SJ, Gray RJ, Zhao F, Bah M, Vaidya R, Blanke CD. Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies. JCO 2022. [DOI: 10.1200/jco.22.01826] [Reference Citation Analysis]
756 Jia L, Chen N, Chen X, Niu C, Liu Z, Ma K, Wang N, Yang L, Zhao Y, Song W, Lu J, Chen C, Cong X, Wang X, Xu Y, Cui G, Liu Z, Chen R, Li W, Cui J. Sintilimab plus autologous NK cells as second-line treatment for advanced non-small-cell lung cancer previous treated with platinum-containing chemotherapy. Front Immunol 2022;13:1074906. [PMID: 36569881 DOI: 10.3389/fimmu.2022.1074906] [Reference Citation Analysis]
757 Pan X, Tan J, Yin X, Liu Q, Zheng L, Su Z, Zhou Q, Chen N. The roles of mutated SPINK1 gene in prostate cancer cells. Mutagenesis 2022;37:238-47. [PMID: 36112498 DOI: 10.1093/mutage/geac019] [Reference Citation Analysis]
758 Luque M, Sanz-Álvarez M, Morales-Gallego M, Madoz-Gúrpide J, Zazo S, Domínguez C, Cazorla A, Izarzugaza Y, Arranz JL, Cristóbal I, Rojo F. Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer. Cancers (Basel) 2022;14. [PMID: 36551522 DOI: 10.3390/cancers14246034] [Reference Citation Analysis]
759 Tian R, Wiley B, Liu J, Zong X, Truong B, Zhao S, Uddin MM, Niroula A, Miller CA, Mukherjee S, Heiden BT, Luo J, Puri V, Kozower BD, Walter MJ, Ding L, Link DC, Amos CI, Ebert BL, Govindan R, Natarajan P, Bolton KL, Cao Y. Clonal Hematopoiesis and Risk of Incident Lung Cancer. J Clin Oncol 2022;:JCO2200857. [PMID: 36480766 DOI: 10.1200/JCO.22.00857] [Reference Citation Analysis]
760 Kai Fu, Fachao Xie, Fang Wang, Liwu Fu. Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance. J Hematol Oncol 2022;15:173. [PMID: 36482474 DOI: 10.1186/s13045-022-01391-4] [Reference Citation Analysis]
761 Xiao T, Ou CQ, Yang J, Wang C, Yang M, Yu T, Shen L, Xu X, Xing H. The Risk Factors for Cervical Cytological Abnormalities Among Women Infected With Non-16/18 High-Risk Human Papillomavirus: Cross-sectional Study. JMIR Public Health Surveill 2022;8:e38628. [PMID: 36480259 DOI: 10.2196/38628] [Reference Citation Analysis]
762 Canick JE, Bhardwaj A, Patel A, Kuziez D, Larsen R, Misra S, Pearson B, Smith BD, Rohde RL, Adjei Boakye E, Kahmke RR, Osazuwa-peters N. Sociodemographic Differences in Patient-Reported Pain and Pain Management of Patients With Head and Neck Cancer in a Community Oncology Setting. JCO Oncology Practice 2022. [DOI: 10.1200/op.22.00132] [Reference Citation Analysis]
763 Orsi G, Cavaliere A, Tortora G, Lonardi S, Macchini M, Di Marco M, Giordano G, Vasile E, Scartozzi M, Bozzarelli S, Noventa S, Rodriquenz MG, Militello AM, Rapposelli IG, Garajova I, De Lorenzo S, Merelli B, Bittoni A, Salvatore L, Procaccio L, Paratore C, Spallanzani A, Peretti U, Niger M, Giommoni E, Bernardini I, Tamburini E, Bernardino K, Forti L, Valente MM, Cascinu S, Milella M, Reni M. Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv). Br J Cancer 2022. [DOI: 10.1038/s41416-022-02086-w] [Reference Citation Analysis]
764 Chen J, Na F. Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities. Front Bioeng Biotechnol 2022;10:1066869. [PMID: 36568297 DOI: 10.3389/fbioe.2022.1066869] [Reference Citation Analysis]
765 Li J, Li Z, Gao Y, Zhao H, Guo J, Liu Z, Yin C, Zhao X, Yue W. Integrating single-cell RNA sequencing and prognostic model revealed the carcinogenicity and clinical significance of FAM83D in ovarian cancer. Front Oncol 2022;12:1055648. [PMID: 36568230 DOI: 10.3389/fonc.2022.1055648] [Reference Citation Analysis]
766 Hyams T, Ammons S, Seminara D, Tonorezos E, Mollica MA. A mixed methods evaluation of the unmet needs of early-onset colorectal cancer survivors. Cancer Causes Control 2022. [DOI: 10.1007/s10552-022-01656-w] [Reference Citation Analysis]
767 Acevedo F, Walbaum B, Muñiz S, Petric M, Martínez R, Guerra C, Navarro M, Córdova-Delgado M, Pinto MP, Sánchez C. Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy. Sci Rep 2022;12:21145. [PMID: 36477462 DOI: 10.1038/s41598-022-25043-2] [Reference Citation Analysis]
768 Hou Y, Xiang B, Yang Z, Liu J, Xu D, Geng L, Zhan M, Xu Y, Zhang B. Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinoma.. [DOI: 10.21203/rs.3.rs-2283797/v1] [Reference Citation Analysis]
769 Yang M, Zhan Y, Hou Z, Wang C, Fan W, Guo T, Li Z, Fang L, Lv S, Li S, Gu C, Ye M, Qin H, Liu Q, Cui X. VLDLR disturbs quiescence of breast cancer stem cells in a ligand-independent function. Front Oncol 2022;12:887035. [PMID: 36568166 DOI: 10.3389/fonc.2022.887035] [Reference Citation Analysis]
770 Liu L, Liu N, Zhang H, Li D. Exploring and validating the metastasis mechanism of pathenolide interfering with cutaneous melanoma through ER stress‐dependent apoptosis based on the network pharmacology. Phytochemical Analysis 2022. [DOI: 10.1002/pca.3193] [Reference Citation Analysis]
771 Zhang D, Zhu X, Jiang J. Papillary Thyroid Carcinoma With Breast and Bone Metastasis. Ear Nose Throat J 2022. [DOI: 10.1177/01455613221145273] [Reference Citation Analysis]
772 Mian A, Wei J, Shi Z, Rifkin AS, Zheng SL, Glaser AP, Kearns JT, Helfand BT, Xu J. Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort. BJUI Compass 2022. [DOI: 10.1002/bco2.206] [Reference Citation Analysis]
773 Chu J, Min K, Kim D, Son BK, Kim HS, Jung US, Kwon MJ, Do S. High PPFIA1 expression promotes cancer survival by suppressing CD8+ T cells in breast cancer: drug discovery and machine learning approach. Breast Cancer 2022. [DOI: 10.1007/s12282-022-01419-0] [Reference Citation Analysis]
774 Tan Q, Ma J, Zhang H, Wu X, Li Q, Zuo X, Jiang Y, Liu H, Yan L. miR-125b-5p upregulation by TRIM28 induces cisplatin resistance in non-small cell lung cancer through CREB1 inhibition. BMC Pulm Med 2022;22:469. [PMID: 36476351 DOI: 10.1186/s12890-022-02272-9] [Reference Citation Analysis]
775 Kamya E, Lu Z, Cao Y, Pei R. Effective design of organic luminogens for near-infrared-II fluorescence imaging and photo-mediated therapy. J Mater Chem B 2022;10:9770-88. [PMID: 36448479 DOI: 10.1039/d2tb01903e] [Reference Citation Analysis]
776 Wu J, Zhang L, Kuchi A, Otohinoyi D, Hicks C. CpG Site-Based Signature Predicts Survival of Colorectal Cancer. Biomedicines 2022;10. [PMID: 36551919 DOI: 10.3390/biomedicines10123163] [Reference Citation Analysis]
777 Shi J, Yang X, Kang Q, Lu J, Denzinger M, Kornmann M, Traub B. JNK inhibitor IX restrains pancreatic cancer through p53 and p21. Front Oncol 2022;12:1006131. [PMID: 36568248 DOI: 10.3389/fonc.2022.1006131] [Reference Citation Analysis]
778 Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH. A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma. J Gynecol Oncol 2022. [PMID: 36509462 DOI: 10.3802/jgo.2023.34.e15] [Reference Citation Analysis]
779 Lei L, Yu L, Fan W, Hao X. Prostate cancer small extracellular vesicles participate in androgen-independent transformation of prostate cancer by transferring let-7a-5p. Heliyon 2022;8:e12114. [PMID: 36578414 DOI: 10.1016/j.heliyon.2022.e12114] [Reference Citation Analysis]
780 Yao Shen, Pan Zhao, Kewei Dong, Jiajia Wang, Huichen Li, Mengyang Li, Ruikai Li, Suning Chen, Yuxia Shen, Zhiyu Liu, Mianjiao Xie, Peng Shen, Jian Zhang. Tadalafil increases the antitumor activity of 5-FU through inhibiting PRMT5-mediated glycolysis and cell proliferation in colorectal cancer. Cancer Metab 2022;10:22. [PMID: 36474242 DOI: 10.1186/s40170-022-00299-4] [Reference Citation Analysis]
781 Qiu Y, Zhang X, Dong Z, Zhang Y, Zhai Q, Lv S, Wei Q. Comparable survival benefits of partial ureterectomy to radical nephroureterectomy in non-metastatic ureter carcinoma: a population-matched study. Int Urol Nephrol 2022. [DOI: 10.1007/s11255-022-03429-5] [Reference Citation Analysis]
782 Grant SJ, Jansen M, Kuo T, Rubinstein SM, Wildes TM, Tuchman SA, Muss HB, Lichtman EI, Charlot M. Cross-Sectional Analysis of Clinical Trial Availability and North Carolina Neighborhood Social Vulnerability. JCO Oncology Practice 2022. [DOI: 10.1200/op.22.00325] [Reference Citation Analysis]
783 Salek S, Ionova T, Oliva EN, Andreas M, Skoetz N, Kreuzberger N, Laane E. The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review. Cancers (Basel) 2022;14. [PMID: 36497488 DOI: 10.3390/cancers14236007] [Reference Citation Analysis]
784 Guo-Qiang Pan, Chun-Cheng Yang, Xiao-ling Shang, Zhao-Ru Dong, Tao Li. The causal relationship between white blood cell counts and hepatocellular carcinoma: a Mendelian randomization study. Eur J Med Res 2022;27:278. [PMID: 36471350 DOI: 10.1186/s40001-022-00900-y] [Reference Citation Analysis]
785 Liu Y, Xu C, Xing C, Chen M. Influencing factors and prediction methods of radiotherapy and chemotherapy in patients with lung cancer based on logistic regression analysis. Sci Rep 2022;12:21094. [PMID: 36473918 DOI: 10.1038/s41598-022-25592-6] [Reference Citation Analysis]
786 Li Y, Chen F, Shi J, Huang Y, Wang M. Convolutional Neural Networks for Classifying Cervical Cancer Types Using Histological Images. J Digit Imaging 2022. [DOI: 10.1007/s10278-022-00722-8] [Reference Citation Analysis]
787 Chang W, Li H, Wu C, Zhong L, Zhu T, Chang Z, Ou W, Wang S. Identification of an Amino Acid Metabolism-Related Gene Signature for Predicting Prognosis in Lung Adenocarcinoma. Genes (Basel) 2022;13. [PMID: 36553562 DOI: 10.3390/genes13122295] [Reference Citation Analysis]
788 Lu G, Li J, Ruan Y, Shi Y, Zhang X, Xia Y, Zhu Z, Lin J, Li L. A prognostic nomogram to predict survival in elderly patients with small-cell lung cancer: a large population-based cohort study and external validation. BMC Cancer 2022;22:1271. [PMID: 36474197 DOI: 10.1186/s12885-022-10333-9] [Reference Citation Analysis]
789 Amrutkar M, Verbeke CS, Finstadsveen AV, Dorg L, Labori KJ, Gladhaug IP. Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma. Mol Oncol 2023;17:59-81. [PMID: 36400567 DOI: 10.1002/1878-0261.13344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
790 Zhang C, Kim RY, McGrath CM, Andronov M, Haas AR, Ma KC, Lanfranco AR, Hutchinson CT, Morrissette JJD, DiBardino DM. The Performance of an Extended Next Generation Sequencing Panel Using Endobronchial Ultrasound-Guided Fine Needle Aspiration Samples in Non-Squamous Non-Small Cell Lung Cancer: A Pragmatic Study. Clin Lung Cancer 2022:S1525-7304(22)00270-4. [PMID: 36599742 DOI: 10.1016/j.cllc.2022.11.010] [Reference Citation Analysis]
791 Jones S, Beyers M, Shukla M, Xia F, Brettin T, Stevens R, Weil MR, Ranganathan Ganakammal S. TULIP: An RNA-seq-based Primary Tumor Type Prediction Tool Using Convolutional Neural Networks. Cancer Inform 2022;21:11769351221139491. [PMID: 36507076 DOI: 10.1177/11769351221139491] [Reference Citation Analysis]
792 Mayo ZS, Parsai S, Asha W, Dinh M, Mesko N, Nystrom L, Shah CS, Scott JG, Campbell SR. Early outcomes of ultra-hypofractionated preoperative radiation therapy for soft tissue sarcoma followed by immediate surgical resection. Radiother Oncol 2022;180:109439. [PMID: 36481382 DOI: 10.1016/j.radonc.2022.109439] [Reference Citation Analysis]
793 Chen J, Jiang Y, Yang K, Ye X, Cui C, Shi S, Wu H, Tian H, Song D, Yao J, Wang L, Huang S, Xu J, Xu D, Dong F. Feasibility of using AI to auto-catch responsible frames in ultrasound screening for breast cancer diagnosis. iScience 2023;26:105692. [PMID: 36570770 DOI: 10.1016/j.isci.2022.105692] [Reference Citation Analysis]
794 Wang H, Zhu H, Ding L. Accurate classification of lung nodules on CT images using the TransUnet. Front Public Health 2022;10:1060798. [PMID: 36544802 DOI: 10.3389/fpubh.2022.1060798] [Reference Citation Analysis]
795 Zhou J, Schwenk-Zieger S, Kranz G, Walz C, Klauschen F, Dhawan S, Canis M, Gires O, Haubner F, Baumeister P, Kohlbauer V. Isolation and characterization of head and neck cancer-derived peritumoral and cancer-associated fibroblasts. Front Oncol 2022;12:984138. [PMID: 36544698 DOI: 10.3389/fonc.2022.984138] [Reference Citation Analysis]
796 Joshi D, Khursheed R, Gupta S, Wadhwa D, Singh TG, Sharma S, Porwal S, Gauniyal S, Vishwas S, Goyal S, Gupta G, Eri RD, Williams KA, Dua K, Singh SK. Biosimilars in Oncology: Latest Trends and Regulatory Status. Pharmaceutics 2022;14. [PMID: 36559215 DOI: 10.3390/pharmaceutics14122721] [Reference Citation Analysis]
797 Sonigo C, Amsellem N, Mayeur A, Laup L, Pistilli B, Delaloge S, Eustache F, Sifer C, Rakrouki S, Benoit A, Peigné M, Grynberg M. Disease-free survival does not differ according to fertility preservation technique for young women with breast cancer. Fertil Steril 2022:S0015-0282(22)02048-9. [PMID: 36473609 DOI: 10.1016/j.fertnstert.2022.11.020] [Reference Citation Analysis]
798 Ventura E, Xie C, Buraschi S, Belfiore A, Iozzo RV, Giordano A, Morrione A. Complexity of progranulin mechanisms of action in mesothelioma. J Exp Clin Cancer Res 2022;41:333. [PMID: 36471440 DOI: 10.1186/s13046-022-02546-4] [Reference Citation Analysis]
799 Zhao G, Wang C, Jiao J, Zhang W, Yang H. The novel subclusters based on cancer-associated fibroblast for pancreatic adenocarcinoma. Front Oncol 2022;12:1045477. [PMID: 36544710 DOI: 10.3389/fonc.2022.1045477] [Reference Citation Analysis]
800 Khouzam MS, Wood DE, Vigneswaran W, Goyal A, Czerlanis C, Blackmon SH, Donington J, Albain KS, Freeman RK, Abdelsattar ZM. Impact of Federal Lung Cancer Screening Policy on the Incidence of Early-stage Lung Cancer. Ann Thorac Surg 2022:S0003-4975(22)01500-4. [PMID: 36470567 DOI: 10.1016/j.athoracsur.2022.11.021] [Reference Citation Analysis]
801 Li C, Zhu P, Xiang H, Jin Y, Lu B, Shen Y, Wang W, Huang B, Chen Y. 3D-CEUS tracking of injectable chemo-sonodynamic therapy-enabled mop-up of residual renal cell carcinoma after thermal ablation. Mater Today Bio 2023;18:100513. [PMID: 36569591 DOI: 10.1016/j.mtbio.2022.100513] [Reference Citation Analysis]
802 Oderkerk TJ, van de Kar MRD, Cornel KMC, Bongers MY, Geomini PMAJ. Endometrial cancer after endometrial ablation: a systematic review. Int J Gynecol Cancer 2022;32:1555-60. [PMID: 36375895 DOI: 10.1136/ijgc-2022-003866] [Reference Citation Analysis]
803 Fulle N, Sabundjian G. Comparison of 18F-FDG and 68-PSMA-11 in PET for prostate cancer diagnosis. Braz J Rad Sci 2022;10. [DOI: 10.15392/2319-0612.2022.2007] [Reference Citation Analysis]
804 Jun Peng, Jinfeng Liu, Huining Liu, Yan Huang, Yingchun Ren. Prognostic value of microRNAs in patients with small cell lung cancer: a meta-analysis. World J Surg Oncol 2022;20:381. [PMID: 36464702 DOI: 10.1186/s12957-022-02851-4] [Reference Citation Analysis]
805 Liu X, Cui Q. Identification of CISD1 as a Prognostic Biomarker for Breast Cancer. Int J Gen Med 2022;15:8451-65. [PMID: 36507250 DOI: 10.2147/IJGM.S388537] [Reference Citation Analysis]
806 Rezaeian A, Khatami F, Heidari Keshel S, Akbari MR, Mirzaei A, Gholami K, Mohammadi Farsani R, Aghamir SMK. The effect of mesenchymal stem cells-derived exosomes on the prostate, bladder, and renal cancer cell lines. Sci Rep 2022;12:20924. [PMID: 36463254 DOI: 10.1038/s41598-022-23204-x] [Reference Citation Analysis]
807 Luo Y, Liu L, Liu D, Shen H, Wang X, Fan C, Zeng Z, Zhang J, Tan Y, Zhang X, Wu J, Zhang J. Extracellular volume fraction determined by equilibrium contrast-enhanced CT for the prediction of the pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Eur Radiol 2022. [DOI: 10.1007/s00330-022-09307-z] [Reference Citation Analysis]
808 Huang K, Xie L, Wang F. A Novel Defined Pyroptosis-Related Gene Signature for the Prognosis of Acute Myeloid Leukemia. Genes (Basel) 2022;13. [PMID: 36553549 DOI: 10.3390/genes13122281] [Reference Citation Analysis]
809 Fang Y, Qu Y, Ji L, Sun H, Li J, Zhao Y, Liang F, Wang Z, Su J, Liu J, Dai L, Ouyang S. Novel blood-based FUT7 DNA methylation is associated with lung cancer: especially for lung squamous cell carcinoma. Clin Epigenetics 2022;14:167. [PMID: 36463240 DOI: 10.1186/s13148-022-01389-2] [Reference Citation Analysis]
810 Chen D, Gao S, Gao F, Liu A, Li J, Li J, Liu Q. SMEK1 promotes lung adenocarcinoma proliferation and invasion by activating Wnt/β-catenin signaling pathway. Clin Transl Oncol 2022. [DOI: 10.1007/s12094-022-03001-8] [Reference Citation Analysis]
811 Jung K, Lee S, Na HY, Kim JW, Lee JC, Hwang JH, Kim JW, Kim J. NGS-based targeted gene mutational profiles in Korean patients with pancreatic cancer. Sci Rep 2022;12:20937. [PMID: 36463295 DOI: 10.1038/s41598-022-24732-2] [Reference Citation Analysis]
812 Konopka J, Kołodziejek D, Flont M, Żuchowska A, Jastrzębska E, Brzózka Z. Exploring Endothelial Expansion on a Chip. Sensors (Basel) 2022;22. [PMID: 36502120 DOI: 10.3390/s22239414] [Reference Citation Analysis]
813 Kemp Bohan PM, Chang S, Grunkemeier GL, Spitzer HV, Carpenter EL, Adams AM, Vreeland TJ, Nelson DW. Impact of Mediating and Confounding Variables on the Volume–Outcome Association in the Treatment of Pancreatic Cancer. Ann Surg Oncol 2022. [DOI: 10.1245/s10434-022-12908-z] [Reference Citation Analysis]
814 Huang J, Liu W, Song S, Li JC, Gan K, Shen C, Holzbeierlein J, Li B. The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1080055] [Reference Citation Analysis]
815 Palermos D, Sergentanis TN, Gavriatopoulou M, Malandrakis P, Psaltopoulou T, Terpos E, Ntanasis-Stathopoulos I. Lung Cancer Clinical Trials with a Seamless Phase II/III Design: Systematic Review. J Clin Med 2022;11. [PMID: 36498749 DOI: 10.3390/jcm11237176] [Reference Citation Analysis]
816 Wang S, Wan D, Liu W, Kang X, Zhou X, Sefidkon F, Hosseini MMZ, Zhang T, Pan X, Yang X. A Biflavonoid-Rich Extract from Selaginella doederleinii Hieron. against Throat Carcinoma via Akt/Bad and IKKβ/NF-κB/COX-2 Pathways. Pharmaceuticals (Basel) 2022;15. [PMID: 36558956 DOI: 10.3390/ph15121505] [Reference Citation Analysis]
817 Hu J, Jiang Y, Wei Q, Li B, Xu S, Wei G, Li P, Chen W, Lv W, Xiao X, Lu Y, Huang X. Development of a Cancer-Associated Fibroblast-Related Prognostic Model in Breast Cancer via Bulk and Single-Cell RNA Sequencing. Biomed Res Int 2022;2022:2955359. [PMID: 36510567 DOI: 10.1155/2022/2955359] [Reference Citation Analysis]
818 Gao Y, Nie Z, Cao H, Huang D, Chen M, Xiang Y, Yu X, Zhang S. Scabertopin Derived from Elephantopus scaber L. Mediates Necroptosis by Inducing Reactive Oxygen Species Production in Bladder Cancer In Vitro. Cancers (Basel) 2022;14. [PMID: 36497458 DOI: 10.3390/cancers14235976] [Reference Citation Analysis]
819 Schnellhardt S, Ott OJ, Höfler D, Szkitsak J, Weissmann T, Putz F, Fietkau R. Radiotherapie von Lungenkarzinomen: Längere Überlebenszeit – cave kardiale Toxizität. Deutsches Ärzteblatt Online 2022. [DOI: 10.3238/personko.2022.12.02.01] [Reference Citation Analysis]
820 Yuan XQ, Zhou N, Wang JP, Yang XZ, Wang S, Zhang CY, Li GC, Peng L. Anchoring super-enhancer-driven oncogenic lncRNAs for anti-tumor therapy in hepatocellular carcinoma. Mol Ther 2022:S1525-0016(22)00671-2. [PMID: 36461633 DOI: 10.1016/j.ymthe.2022.11.013] [Reference Citation Analysis]
821 Zhu Q, Zhang C, Qu T, Lu X, He X, Li W, Yin D, Han L, Guo R, Zhang E. MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc-Mediated Cell-Cycle Progression and Proliferation in Lung Cancer. Cancer Res 2022;82:4340-58. [PMID: 36214649 DOI: 10.1158/0008-5472.CAN-22-1289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
822 Li D, Shen L, Zhang X, Chen Z, Huang P, Huang C, Qin S. LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex. J Exp Clin Cancer Res 2022;41:332. [PMID: 36457025 DOI: 10.1186/s13046-022-02541-9] [Reference Citation Analysis]
823 Sarwar A, Zhu M, Su Q, Zhu Z, Yang T, Chen Y, Peng X, Zhang Y. Targeting mitochondrial dysfunctions in pancreatic cancer evokes new therapeutic opportunities. Critical Reviews in Oncology/Hematology 2022;180:103858. [DOI: 10.1016/j.critrevonc.2022.103858] [Reference Citation Analysis]
824 Liang M, Meng X, Zhou B, Gao Y. RASAL3 predicts overall survival and CD8+ T lymphocyte infiltration in lung adenocarcinoma. J Cell Mol Med 2022;26:6056-65. [PMID: 36420686 DOI: 10.1111/jcmm.17625] [Reference Citation Analysis]
825 Farley JH, Brady WE, O'Malley D, Fujiwara K, Yonemori K, Bonebrake A, Secord AA, Stephan JM, Walker JL, Nam JH, Birrer MJ, Gershenson DM. A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial. Gynecol Oncol 2022;167:423-8. [PMID: 36244829 DOI: 10.1016/j.ygyno.2022.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
826 Ng S, Healey AJ, Sontum PC, Kvåle S, Torp SH, Sulheim E, Von Hoff D, Han H. Effect of acoustic cluster therapy (ACT®) combined with chemotherapy in a patient-derived xenograft mouse model of pancreatic cancer. J Control Release 2022;352:1134-43. [PMID: 36372388 DOI: 10.1016/j.jconrel.2022.11.016] [Reference Citation Analysis]
827 Wei C, Chen X, Ji J, Xu Y, He X, Zhang H, Mo Z, Wang F. Urinary exosomal prostate-specific antigen is a noninvasive biomarker to detect prostate cancer: Not only old wine in new bottles. Int J Cancer 2022. [PMID: 36454163 DOI: 10.1002/ijc.34388] [Reference Citation Analysis]
828 Alhamss MM, Mathbout LF, Nassri RB, Alabdaljabar MS, Hashmi S, Muhsen IN. Quality of Life in Hematologic Malignancy in the Eastern Mediterranean Region: A Systematic Review. Cureus 2022;14:e32436. [PMID: 36644089 DOI: 10.7759/cureus.32436] [Reference Citation Analysis]
829 Li G, Guo BY, Wang HD, Lin GT, Lan TJ, Ying H, Xu J. CircRNA hsa_circ_0014130 function as a miR-132-3p sponge for playing oncogenic roles in bladder cancer via upregulating KCNJ12 expression. Cell Biol Toxicol 2022;38:1079-96. [PMID: 34755307 DOI: 10.1007/s10565-021-09668-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
830 Cheng Y, Yao J, Fang Q, Chen B, Zang G. A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. Aging (Albany NY) 2022;14:9617-31. [PMID: 36455876 DOI: 10.18632/aging.204411] [Reference Citation Analysis]
831 Griswold E, Cappello J, Ghandehari H. Silk-elastinlike protein-based hydrogels for drug delivery and embolization. Adv Drug Deliv Rev 2022;191:114579. [PMID: 36306893 DOI: 10.1016/j.addr.2022.114579] [Reference Citation Analysis]
832 Farhangnia P, Akbarpour M, Yazdanifar M, Aref AR, Delbandi AA, Rezaei N. Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives. Expert Rev Clin Immunol 2022;18:1217-37. [PMID: 36154551 DOI: 10.1080/1744666X.2022.2128107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
833 He Z, Zhang CY, Lei Y, Song G, Yao Y. Plasmonic nanomaterials: A versatile phototheranostic platform of cancers. Materials Today 2022. [DOI: 10.1016/j.mattod.2022.11.011] [Reference Citation Analysis]
834 Sherif S, Roelands J, Mifsud W, Ahmed EI, Raynaud CM, Rinchai D, Sathappan A, Maaz A, Saleh A, Ozer E, Fakhro KA, Mifsud B, Thorsson V, Bedognetti D, Hendrickx WRL. The immune landscape of solid pediatric tumors. J Exp Clin Cancer Res 2022;41:199. [DOI: 10.1186/s13046-022-02397-z] [Reference Citation Analysis]
835 Chen C, Wang K, Luo L. AuNPs and 2D functional nanomaterial-assisted SPR development for the cancer detection: a critical review. Cancer Nano 2022;13. [DOI: 10.1186/s12645-022-00138-7] [Reference Citation Analysis]
836 Dias Costa A, Väyrynen SA, Chawla A, Zhang J, Väyrynen JP, Lau MC, Williams HL, Yuan C, Morales-Oyarvide V, Elganainy D, Singh H, Cleary JM, Perez K, Ng K, Freed-Pastor W, Mancias JD, Dougan SK, Wang J, Rubinson DA, Dunne RF, Kozak MM, Brais L, Reilly E, Clancy T, Linehan DC, Chang DT, Hezel AF, Koong AC, Aguirre AJ, Wolpin BM, Nowak JA. Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer. Clin Cancer Res 2022;28:5167-79. [PMID: 36129461 DOI: 10.1158/1078-0432.CCR-22-1125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
837 Sun L, Zuo C, Liu X, Guo Y, Wang X, Dong Z, Han M. Combined Photothermal Therapy and Lycium barbarum Polysaccharide for Topical Administration to Improve the Efficacy of Doxorubicin in the Treatment of Breast Cancer. Pharmaceutics 2022;14. [PMID: 36559180 DOI: 10.3390/pharmaceutics14122677] [Reference Citation Analysis]
838 Yang K, Xu L, Xu Y, Shen Q, Qin T, Yu Y, Nie Y, Yao H, Xu X. Nanoparticles (NPs)-mediated lncBCMA silencing to promote eEF1A1 ubiquitination and suppress breast cancer growth and metastasis. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.12.004] [Reference Citation Analysis]
839 Zhang L, Qian Y. An epithelial-mesenchymal transition-related prognostic model for colorectal cancer based on weighted gene co-expression network analysis. J Int Med Res 2022;50:3000605221140683. [PMID: 36510452 DOI: 10.1177/03000605221140683] [Reference Citation Analysis]
840 Curto EM, Kaza AG, Sturdevant DA, Tuvin DM, Ganai S, Sticca RP. Improved outcomes for borderline resectable adenocarcinoma of the pancreas after neoadjuvant chemotherapy in a community cancer center. Am J Surg 2022;224:1426-31. [PMID: 36372580 DOI: 10.1016/j.amjsurg.2022.10.027] [Reference Citation Analysis]
841 Kaur N, Puppala ER, Srivastava R, Naidu VGM, Shanavas A. Gold-capsuled polymeric nanomedicine for synergistic breast cancer photo-chemotherapy. J Nanopart Res 2022;24:261. [DOI: 10.1007/s11051-022-05640-y] [Reference Citation Analysis]
842 Sato K, Hikita H, Shigekawa M, Kato S, Sasaki Y, Shinkai K, Fukuoka M, Kudo S, Sato Y, Fukumoto K, Shirai K, Myojin Y, Sakane S, Murai K, Yoshioka T, Nishio A, Kodama T, Sakamori R, Tatsumi T, Takehara T. Pentraxin 3 is an adipose tissue-related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss. Cancer Sci 2022. [PMID: 36074525 DOI: 10.1111/cas.15569] [Reference Citation Analysis]
843 Li X, Fang H, Zhang D, Xia L, Wang X, Yang J, Zhang S, Su Y, Zhu Y. Long-term survival analysis of patients with stage IIIB-IV non-small cell lung cancer complicated by type 2 diabetes mellitus: A retrospective propensity score matching analysis. Thorac Cancer 2022;13:3268-73. [PMID: 36217741 DOI: 10.1111/1759-7714.14676] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
844 Qin G, Lei J, Li S, Jiang Y, Qiao L, Ren M, Gao Q, Song C, Fu S, Zhou J, Xiao S, Zhang M, Wang G. Efficient, green extraction of two biflavonoids from Selaginella uncinata with deep eutectic solvents. Microchemical Journal 2022;183:108085. [DOI: 10.1016/j.microc.2022.108085] [Reference Citation Analysis]
845 Langlais CS, Chen Y, Van Blarigan EL, Chan JM, Ryan CJ, Zhang L, Borno HT, Newton RU, Luke A, Bang AS, Panchal N, Tenggara I, Schultz B, Lavaki E, Pinto N, Aggarwal R, Friedlander T, Koshkin VS, Harzstark AL, Small EJ, Kenfield SA. Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention. Urologic Oncology: Seminars and Original Investigations 2022. [DOI: 10.1016/j.urolonc.2022.11.016] [Reference Citation Analysis]
846 Sugumaran A, Sadhasivam J, Gawas P, Nutalapati V, Pandian R, Kumar Perumal S. Curcumin conjugated dextran coated Fe3O4 Nanoparticles: Cytotoxic effect on lung cancer cell line A549. Materials Science and Engineering: B 2022;286:116047. [DOI: 10.1016/j.mseb.2022.116047] [Reference Citation Analysis]
847 Li M, Zhu Y, Yang C, Yang M, Ran H, Zhu Y, Zhang W. Acoustic triggered nanobomb for US imaging guided sonodynamic therapy and activating antitumor immunity. Drug Deliv 2022;29:2177-89. [PMID: 35815688 DOI: 10.1080/10717544.2022.2095058] [Reference Citation Analysis]
848 Xu J, Xie Y, Li J, Liu R, Chen M, Ren Y, Luo Q, Duan J, Bao C, Liu Y, Li P, Lu W. Development of fullerene nanospherical miRNA and application in overcoming resistant breast cancer. Materials Today Chemistry 2022;26:101019. [DOI: 10.1016/j.mtchem.2022.101019] [Reference Citation Analysis]
849 Zhang X, Miao Y, Sun HW, Wang YX, Zhao WM, Pang AY, Wu XY, Shen CC, Chen XD. Integrated analysis from multi-center studies identities m7G-derived modification pattern and risk stratification system in skin cutaneous melanoma. Front Immunol 2022;13:1034516. [PMID: 36532001 DOI: 10.3389/fimmu.2022.1034516] [Reference Citation Analysis]
850 Mao T, Zhang X, Xu H, Zhang X, Ge W, Li S, Ma J, Yue M, Xue S, Cui J, Wang L. HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53. Cancer Cell Int 2022;22:380. [PMID: 36457011 DOI: 10.1186/s12935-022-02807-4] [Reference Citation Analysis]
851 Tidd-Johnson A, Sebastian SA, Co EL, Afaq M, Kochhar H, Sheikh M, Mago A, Poudel S, Fernandez JA, Rodriguez ID, Razdan S. Prostate cancer screening: Continued controversies and novel biomarker advancements. Curr Urol 2022;16:197-206. [PMID: 36714234 DOI: 10.1097/CU9.0000000000000145] [Reference Citation Analysis]
852 Solanki AA, Puckett LL, Kujundzic K, Katsoulakis E, Park J, Kapoor R, Hagan M, Kelly M, Palta J, Ballas LK, Demarco J, Hoffman KE, Lawton CA, Michalski J, Potters L, Zelefsky M, Kudner R, Dawes S, Wilson E, Sandler H. Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel. Practical Radiation Oncology 2022. [DOI: 10.1016/j.prro.2022.08.018] [Reference Citation Analysis]
853 Filon MJ, Gillette AA, Yang B, Khemees TA, Skala MC, Jarrard DF. Prostate cancer cells demonstrate unique metabolism and substrate adaptability acutely after androgen deprivation therapy. Prostate 2022;82:1547-57. [PMID: 35980831 DOI: 10.1002/pros.24428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
854 Michielon E, de Gruijl TD, Gibbs S. From simplicity to complexity in current melanoma models. Exp Dermatol 2022;31:1818-36. [PMID: 36103206 DOI: 10.1111/exd.14675] [Reference Citation Analysis]
855 Zhao L, Jin L, Petrick JL, Zeng H, Wang F, Tang L, Smith-warner SA, Eliassen AH, Zhang FF, Campbell PT, Giovannucci E, Liao LM, Mcglynn KA, Steck SE, Zhang X. Specific botanical groups of fruit and vegetable consumption and liver cancer and chronic liver disease mortality: A prospective cohort study. The American Journal of Clinical Nutrition 2022. [DOI: 10.1016/j.ajcnut.2022.12.004] [Reference Citation Analysis]
856 Zhou E, Wu F, Guo M, Yin Z, Li Y, Li M, Xia H, Deng J, Yang G, Jin Y. Identification of a novel gene signature of lung adenocarcinoma based on epidermal growth factor receptor-tyrosine kinase inhibitor resistance. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1008283] [Reference Citation Analysis]
857 Chen L, Zhang G, Xu L, Zhang X, Zhang J, Bai X, Jin R, Mao L, Xiao X, Li X, Xie Y, Jin Z, Sun H. Preoperative CT features to predict risk stratification of non-muscle invasive bladder cancer. Abdom Radiol 2022. [DOI: 10.1007/s00261-022-03730-y] [Reference Citation Analysis]
858 Rubinstein M, Shen S, Monk BJ, Tan DSP, Nogueira-Rodrigues A, Aoki D, Sehouli J, Makker V. Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer. Gynecol Oncol 2022;167:540-6. [PMID: 36280455 DOI: 10.1016/j.ygyno.2022.10.012] [Reference Citation Analysis]
859 Bian Z, Chen J, Liu C, Ge Q, Zhang M, Meng J, Liang C. Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy. Computational and Structural Biotechnology Journal 2023;21:74-85. [DOI: 10.1016/j.csbj.2022.11.052] [Reference Citation Analysis]
860 Dou J, Dawuti W, Zheng X, Zhang R, Zhou J, Lin R, Lü G. Urine fluorescence spectroscopy combined with machine learning for screening of hepatocellular carcinoma and liver cirrhosis. Photodiagnosis Photodyn Ther 2022;40:103102. [PMID: 36057362 DOI: 10.1016/j.pdpdt.2022.103102] [Reference Citation Analysis]
861 Tewari S, Vargas R, Reizes O. The impact of obesity and adipokines on breast and gynecologic malignancies. Ann N Y Acad Sci 2022;1518:131-50. [PMID: 36302117 DOI: 10.1111/nyas.14916] [Reference Citation Analysis]
862 Lin X, Lin X, Guo L, Wang Y, Zhang G. Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification. Thorac Cancer 2022;13:3441-50. [PMID: 36305094 DOI: 10.1111/1759-7714.14703] [Reference Citation Analysis]
863 Xia J, Chen J, Vashisth MK, Ge Y, Dai Q, He S, Shi Y, Wang X. Metformin ameliorates 5-fluorouracil-induced intestinal injury by inhibiting cellular senescence, inflammation, and oxidative stress. International Immunopharmacology 2022;113:109342. [DOI: 10.1016/j.intimp.2022.109342] [Reference Citation Analysis]
864 Wu J, Li L, Zhong H, Zhang HH, Li J, Zhang HB, Zhao YQ, Xu B, Song QB. Bioinformatic and Experimental Analyses Reveal That KIF4A Is a Biomarker of Therapeutic Sensitivity and Predicts Prognosis in Cervical Cancer Patients. Curr Med Sci 2022;42:1273-84. [PMID: 36260268 DOI: 10.1007/s11596-022-2636-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
865 Shan X, Zhang C, Li C, Fan X, Song G, Zhu J, Cao R, Zhang X, Zhu W. miR-338-3p acts as a tumor suppressor in lung squamous cell carcinoma by targeting FGFR2/FRS2. Cancer Pathogenesis and Therapy 2022. [DOI: 10.1016/j.cpt.2022.12.004] [Reference Citation Analysis]
866 Chen H, Wang Q, Liu J, Chen Y, Zhang Q, Chai L, Wang Y, Li D, Qiu Y, Li M. CEMIP as a prognostic biomarker for cancers: a meta- and bioinformatic analysis. Expert Rev Mol Diagn 2022;22:1107-15. [PMID: 36631437 DOI: 10.1080/14737159.2022.2168191] [Reference Citation Analysis]
867 Chen YD, Gao KX, Wang Z, Deng Q, Chen YT, Liang H. Glycine Decarboxylase Suppresses the Renal Cell Carcinoma Growth and Regulates Its Gene Expressions and Functions. World J Oncol 2022;13:387-402. [PMID: 36660213 DOI: 10.14740/wjon1539] [Reference Citation Analysis]
868 Yao C, Zhang T, Wu T, Brugarolas J. Facts and Hopes for Immunotherapy in Renal Cell Carcinoma. Clin Cancer Res 2022;28:5013-20. [PMID: 35819272 DOI: 10.1158/1078-0432.CCR-21-2372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
869 Hamel LM, Dougherty DW, Hastert TA, Seymour EK, Kim S, Assad H, Phalore J, Soulliere R, Eggly S. The DISCO App: A pilot test of a multi-level intervention to reduce the financial burden of cancer through improved cost communication. PEC Innovation 2022;1:100002. [DOI: 10.1016/j.pecinn.2021.100002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
870 Babaei G, Asghari Vostakolaei M, Rajabi Bazl M, Gholizadeh-ghaleh Aziz S, Gholipour E, Nejati-koshki K. The role of exosomes in the molecular mechanisms of metastasis: Focusing on EMT and cancer stem cells. Life Sciences 2022;310:121103. [DOI: 10.1016/j.lfs.2022.121103] [Reference Citation Analysis]
871 Zhao B, Qin C, Li Z, Wang Y, Li T, Cao H, Yang X, Li T, Wang W. Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs. Cancer Cell Int 2022;22:374. [PMID: 36457017 DOI: 10.1186/s12935-022-02785-7] [Reference Citation Analysis]
872 Metropulos AE, Becker JH, Principe DR. Chromium (VI) promotes lung cancer initiation by activating EGF/ALDH1A1 signalling. Clinical and Translational Dis 2022;2. [DOI: 10.1002/ctd2.155] [Reference Citation Analysis]
873 Guo L, Huai Q, Zhou B, Ying J, Guo W. Comprehensive analysis of the prognostic impact and immune implication of KIAA1429 in lung adenocarcinoma. Cancer Innovation 2022;1:328-343. [DOI: 10.1002/cai2.40] [Reference Citation Analysis]
874 Guo Z, He J, Huang L, Wang Z, Hu P, Wang S, Bai Z, Pan J. Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: A systematic review and meta-analysis. Int braz j urol 2022;48:915-929. [DOI: 10.1590/s1677-5538.ibju.2021.0653] [Reference Citation Analysis]
875 Wu Y, Ma L, Cai Y, Li F, Luo J, Bai B, Dai Y, Zheng F, Pi Z, Yue H. Ginseng fermentation solution is associated with immune response in lung adenocarcinoma by modulating the differential expression of the m7G regulators. Journal of Functional Foods 2022;99:105337. [DOI: 10.1016/j.jff.2022.105337] [Reference Citation Analysis]
876 Otite FO, Somani S, Aneni E, Akano E, Patel SD, Anikpezie N, Lamikanra O, Masoud H, Latorre JG, Chaturvedi S, Mehndiratta P. Trends in age and sex-specific prevalence of cancer and cancer subtypes in acute ischemic stroke from 2007-2019. Journal of Stroke and Cerebrovascular Diseases 2022;31:106818. [DOI: 10.1016/j.jstrokecerebrovasdis.2022.106818] [Reference Citation Analysis]
877 Mao J, Xu Z, Lin W. Nanoscale metal–organic frameworks for photodynamic therapy and radiotherapy. Current Opinion in Chemical Engineering 2022;38:100871. [DOI: 10.1016/j.coche.2022.100871] [Reference Citation Analysis]
878 Tsivgoulis M, Papastergiou T, Megalooikonomou V. An improved SqueezeNet model for the diagnosis of lung cancer in CT scans. Machine Learning with Applications 2022;10:100399. [DOI: 10.1016/j.mlwa.2022.100399] [Reference Citation Analysis]
879 Talimi R, Shahsavari Z, Dadashzadeh S, Ten Hagen TLM, Haeri A. Sirolimus-exuding core-shell nanofibers as an implantable carrier for breast cancer therapy: preparation, characterization, in vitro cell studies, and in vivo anti-tumor activity. Drug Dev Ind Pharm 2022;48:694-707. [PMID: 36594256 DOI: 10.1080/03639045.2022.2161559] [Reference Citation Analysis]
880 Villalba A, Gonzalez-Rodriguez AP, Arzuaga-Mendez J, Puig N, Arnao M, Arguiñano JM, Jimenez M, Canet M, Teruel AI, Sola M, Díaz FJ, Encinas C, Garcia A, Rosiñol L, Suárez A, Gonzalez MS, Izquierdo I, Hernández MT, Infante MS, Sánchez MJ, Sampol A, de la Rubia J. Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM). Leuk Lymphoma 2022;63:3438-47. [PMID: 36124538 DOI: 10.1080/10428194.2022.2123229] [Reference Citation Analysis]
881 Kurnit KC, Nobre SP, Fellman BM, Iglesias DA, Lindemann K, Jhingran A, Eriksson AGZ, Ataseven B, Glaser GE, Mueller JJ, Westin SN, Soliman PT. Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study. Gynecol Oncol 2022;167:452-7. [PMID: 36243601 DOI: 10.1016/j.ygyno.2022.09.025] [Reference Citation Analysis]
882 Gonzalez-Bosquet J, Weroha SJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Dowdy SC, Famuyide AO, Kipp BR, Halling KC, Yadav S, Couch FJ, Podratz KC. ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer. PLoS One 2022;17:e0278408. [PMID: 36454788 DOI: 10.1371/journal.pone.0278408] [Reference Citation Analysis]
883 Li B, Shao H, Gao L, Li H, Sheng H, Zhu L. Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Deliv 2022;29:2130-61. [PMID: 35815678 DOI: 10.1080/10717544.2022.2094498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
884 Farahani H, Boschman J, Farnell D, Darbandsari A, Zhang A, Ahmadvand P, Jones SJM, Huntsman D, Köbel M, Gilks CB, Singh N, Bashashati A. Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images. Mod Pathol 2022;35:1983-90. [PMID: 36065012 DOI: 10.1038/s41379-022-01146-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
885 Zhang L, Zhang J, Tang M, Lei XY, Li LC. MRI-Based Radiomics Nomogram for Predicting Prostate Cancer with Gray-Zone Prostate-Specific Antigen Levels to Reduce Unnecessary Biopsies. Diagnostics (Basel) 2022;12. [PMID: 36553012 DOI: 10.3390/diagnostics12123005] [Reference Citation Analysis]
886 Ohki D, Yamamichi N, Sakaguchi Y, Takahashi Y, Kageyama-Yahara N, Yamamichi M, Takeuchi C, Tsuji Y, Sakai Y, Sakurai K, Tomida S, Koike K, Fujishiro M. Transcriptome of sessile serrated adenoma/polyps is associated with MSI-high colorectal cancer and decreased expression of CDX2. Cancer Med 2022;11:5066-78. [PMID: 35535692 DOI: 10.1002/cam4.4810] [Reference Citation Analysis]
887 Wang Y, Wang Y, Yu J, Meng X. The treatment in patients with unresectable locally advanced non-small cell lung cancer: Explorations on hot issues. Cancer Letters 2022;551:215947. [DOI: 10.1016/j.canlet.2022.215947] [Reference Citation Analysis]
888 Meng X, Fan J, Yu H, Mu J, Li Z, Yang A, Liu B, Lv K, Ai D, Lin Y, Song H, Fu T, Xiao D, Ma G, Yang J, Gu Y. Volume-awareness and outlier-suppression co-training for weakly-supervised MRI breast mass segmentation with partial annotations. Knowledge-Based Systems 2022;258:109988. [DOI: 10.1016/j.knosys.2022.109988] [Reference Citation Analysis]
889 Tezuka R, Iwashita T, Uemura S, Senju A, Yoshida K, Maruta A, Iwata K, Shimizu M. The efficacy and safety of modified FOLFIRINOX for unresectable advanced pancreatic cancer in elderly versus young patients: A multicenter retrospective cohort study. Pancreatology 2022;22:1134-40. [PMID: 36404200 DOI: 10.1016/j.pan.2022.11.005] [Reference Citation Analysis]
890 Liu Y, Shi L, Chen K, Ye W. Identification and validation of serum tumor-markers based nomogram to predict the prognostic value of patients with cervical adenocarcinoma. Curr Probl Cancer 2022;46:100899. [PMID: 36270166 DOI: 10.1016/j.currproblcancer.2022.100899] [Reference Citation Analysis]
891 Park L, O'Connell K, Herzog K, Chatila W, Walch H, Palmaira RLD, Cercek A, Shia J, Shike M, Markowitz AJ, Garcia-Aguilar J, Schattner MA, Kantor ED, Du M, Mendelsohn RB. Clinical features of young onset colorectal cancer patients from a large cohort at a single cancer center. Int J Colorectal Dis 2022;37:2511-6. [PMID: 36441197 DOI: 10.1007/s00384-022-04286-5] [Reference Citation Analysis]
892 Greenberg JA, Thiesmeyer JW, Egan CE, Lee YJ, Sivarajah M, Zarnegar R, Fahey TJ 3rd, Beninato T, Finnerty BM. Care Fragmentation in Patients with Differentiated Thyroid Cancer. World J Surg 2022;46:3007-16. [PMID: 36038731 DOI: 10.1007/s00268-022-06712-9] [Reference Citation Analysis]
893 van Mackelenbergh MG, Metselaar DS, Meel MH, Hulleman E. Clustered regularly interspaced short palindromic repeats screens in pediatric tumours: A review. Clinical and Translational Dis 2022;2. [DOI: 10.1002/ctd2.142] [Reference Citation Analysis]
894 Luo G, Li Z, Zheng J, Yang H, Li X, Guishan X, Duo Y. Recent progresses on radiotherapeutics-based treatment of cancer with two-dimensional nanomaterials. Applied Materials Today 2022;29:101584. [DOI: 10.1016/j.apmt.2022.101584] [Reference Citation Analysis]
895 Li Z, Yang H, Zhang X, Zhang X, Huang Y, Dai X, Shi L, Zhou G, Wei J, Ding Q. Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway. J Exp Clin Cancer Res 2022;41:168. [DOI: 10.1186/s13046-022-02373-7] [Reference Citation Analysis]
896 Kuang Y, Singh R, Nevo A, Deitz AC, Pietanza MC, Liu A, Uyei J, Zu K. Incidence of Pneumonitis Among Limited Stage Small Cell Lung Cancer Patients Exposed to Concurrent Chemoradiation: A Systematic Literature Review and Meta-Analysis. Clin Lung Cancer 2022;23:659-69. [PMID: 36266183 DOI: 10.1016/j.cllc.2022.09.008] [Reference Citation Analysis]
897 Wang X, Zhang H, Lu Y. Breast metastasis of signet ring cell carcinoma from the colon: a case report. World J Surg Oncol 2022;20:376. [PMID: 36451153 DOI: 10.1186/s12957-022-02840-7] [Reference Citation Analysis]
898 Feng LS, Wu XQ, Li QL, Yang Q, Yin FL, Wang QY, Zhu YL, Yan RY, Tu CL, Yang LY, Zhong WJ, Dong ZJ. Development and reliability and validity test of the Fear of Cancer Scale (FOCS). Ann Med 2022;54:2354-62. [PMID: 36066037 DOI: 10.1080/07853890.2022.2113914] [Reference Citation Analysis]
899 Feng Y, Xiao M, Cao G, Liu H, Li Y, Wang S, Zijtveld S, Delvoux B, Xanthoulea S, Romano A, Liu C, Zhang Z. Human monocytes differentiate into tumor-associated macrophages upon SKOV3 cells coculture and/or lysophosphatidic acid stimulation. J Inflamm 2022;19:11. [DOI: 10.1186/s12950-022-00307-w] [Reference Citation Analysis]
900 Wang W, Li W, Wang K, Wu J, Qiu J, Zhang Y, Zhang X, Wang H, Wang X. Integrating radiomics with the vesical imaging-reporting and data system to predict muscle invasion of bladder cancer. Urologic Oncology: Seminars and Original Investigations 2022. [DOI: 10.1016/j.urolonc.2022.10.024] [Reference Citation Analysis]
901 Man QW, Li RF, Bu LL, Zhao Y, Liu B. Salivary non-apoptotic tumoral microvesicles: A potential progressive marker in oral cancer patients. J Cell Mol Med 2022;26:5955-65. [PMID: 36448260 DOI: 10.1111/jcmm.17461] [Reference Citation Analysis]
902 Imperiale TF. Uptake of Colorectal Cancer Screening in 45 to 49 Year Olds: An Early-Inning View from the Endoscopy Suite. Clin Gastroenterol Hepatol 2022;20:2722-4. [PMID: 35870767 DOI: 10.1016/j.cgh.2022.07.014] [Reference Citation Analysis]
903 Ye Q, Wang J, Xu D, Liu Y, Zhang D, Ye J, Li H. Diagnostic performance of urine and blood microRNAs for bladder cancer: a meta-analysis. Expert Rev Anticancer Ther 2022;22:1357-69. [PMID: 36374119 DOI: 10.1080/14737140.2022.2147511] [Reference Citation Analysis]
904 Thavaneswaran S, Chan WY, Asghari R, Grady JP, Deegan M, Jansen VM, Thomas DM. Clinical Response to Seribantumab, an Anti-Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an NRG1 Fusion. JCO Precis Oncol 2022;6:e2200263. [PMID: 36455193 DOI: 10.1200/PO.22.00263] [Reference Citation Analysis]
905 Pelloux-Prayer R, Bataillard T, Thiery-Vuillemin A, Vincent A, Fagnoni P, Nerich V. Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review of Economic Evaluations. Clin Genitourin Cancer 2022;20:594-602. [PMID: 35610112 DOI: 10.1016/j.clgc.2022.04.014] [Reference Citation Analysis]
906 Raffone A, Raimondo D, Raspollini A, Oliviero A, Travaglino A, Santoro A, Renzulli F, Lopez G, Maio CMD, Casadio P, Zannoni GF, Seracchioli R, Mollo A. Accuracy of cytological examination of Tao brush endometrial sampling in diagnosing endometrial premalignancy and malignancy. Int J Gynaecol Obstet 2022;159:615-21. [PMID: 35365908 DOI: 10.1002/ijgo.14204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
907 Jiang L, Chen P, Zha L, Liu J, Sun D, Dai C, Li Y, Miao Y, Ouyang R. Enhanced catalytic amplification of mesoporous bismuth-gold nano-electrocatalyst triggering efficient capture of tumor marker. Colloids and Surfaces B: Biointerfaces 2022;220:112924. [DOI: 10.1016/j.colsurfb.2022.112924] [Reference Citation Analysis]
908 Yuan J, Liu Z, Wu Z, Yang J, Yang J. Construction and validation of an IRF4 risk score to predict prognosis and response to immunotherapy in hepatocellular carcinoma. International Immunopharmacology 2022;113:109411. [DOI: 10.1016/j.intimp.2022.109411] [Reference Citation Analysis]
909 Hinojos M, Li X, Mikesell S, Studden S, Odean M, Boylan MJ, Arvold DS, Bachelder VD, Gowda N, Arvold ND. Impact of Low-dose Chest CT Screening on the Association Between Rurality and Lung Cancer Outcomes. Am J Clin Oncol 2022;45:519-25. [PMID: 36326127 DOI: 10.1097/COC.0000000000000956] [Reference Citation Analysis]
910 Cho SK, Bekaii-Saab T, Kavati A, Babajanyan S, Hocum B, Barzi A. Value-Based Analysis of Therapies in Refractory Metastatic Colorectal Cancer in US. Clin Colorectal Cancer 2022;21:277-84. [PMID: 36216759 DOI: 10.1016/j.clcc.2022.09.003] [Reference Citation Analysis]
911 Gan C, Zhou K, Li M, Shang J, Liu L, Zhao Q. NUP153 promotes HCC cells proliferation via c-Myc-mediated downregulation of P15(INK4b). Dig Liver Dis 2022;54:1706-15. [PMID: 35288064 DOI: 10.1016/j.dld.2022.02.008] [Reference Citation Analysis]
912 Wu M, Huang Q, Liao M, Wu X, Xi H, Ma H, Li S, Zhang Y, Xia Y. OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis. Cell Oncol (Dordr) 2022. [PMID: 36155886 DOI: 10.1007/s13402-022-00716-2] [Reference Citation Analysis]
913 Chen B, Wang M, Qiu J, Liao K, Zhang W, Lv Q, Ma C, Qian Z, Shi Z, Liang R, Lin Y, Ye J, Qiu Y, Lin Y. Cleavage of tropomodulin-3 by asparagine endopeptidase promotes cancer malignancy by actin remodeling and SND1/RhoA signaling. J Exp Clin Cancer Res 2022;41:209. [DOI: 10.1186/s13046-022-02411-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
914 Demir-dora D, Öner F. Development and evaluation of polyethylenimine polyplexes as non-viral vectors for delivery of plasmid DNA encoding shRNA against STAT3 activity into triple negative breast cancer cells. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104113] [Reference Citation Analysis]
915 Deneff JI, Butler KS, Reyes RA, Sava Gallis DF. Harnessing Particle Size‐Control and DNA‐Oligo Functionalization in ZIF‐76 for Biological Applications. Adv Materials Inter 2022. [DOI: 10.1002/admi.202201532] [Reference Citation Analysis]
916 Floodeen EG, Newman MF, Abdelsayed R, Patel P. Numb chin syndrome as initial symptom of T-cell acute lymphoblastic leukemia in a 14-year-old female: A case report. Oral and Maxillofacial Surgery Cases 2022;8:100277. [DOI: 10.1016/j.omsc.2022.100277] [Reference Citation Analysis]
917 Hudry D, Bécourt S, Scambia G, Fagotti A. Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision-a Literature Review. Curr Oncol Rep 2022;24:1661-8. [PMID: 35969358 DOI: 10.1007/s11912-022-01318-9] [Reference Citation Analysis]
918 Yuan L, Su Y, Cong H, Yu B, Shen Y. Application of multifunctional small molecule fluorescent probe BODIPY in life science. Dyes and Pigments 2022;208:110851. [DOI: 10.1016/j.dyepig.2022.110851] [Reference Citation Analysis]
919 Zou Y, Cai L, Chen C, Shao Q, Fu X, Yu J, Wang L, Chen Z, Yang X, Yuan B, Liu P, Lu Q. Multi-task deep learning based on T2-Weighted Images for predicting Muscular-Invasive Bladder Cancer. Comput Biol Med 2022;151:106219. [PMID: 36343408 DOI: 10.1016/j.compbiomed.2022.106219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
920 Xu K, Han Y, Huang Y, Wei P, Yin J, Jiang J. The application of 3D bioprinting in urological diseases. Mater Today Bio 2022;16:100388. [PMID: 35967737 DOI: 10.1016/j.mtbio.2022.100388] [Reference Citation Analysis]
921 Gong X, Rong G, Wang Z, Zhang A, Li X, Wang L. Baduanjin exercise for patients with breast cancer: A systematic review and meta-analysis. Complement Ther Med 2022;71:102886. [PMID: 36122861 DOI: 10.1016/j.ctim.2022.102886] [Reference Citation Analysis]
922 Kuss B, Nagarajan C, Hsieh WS, Cheah CY. Practical management of chronic lymphocytic leukemia with acalabrutinib. Leuk Lymphoma 2022;63:2785-94. [PMID: 35852229 DOI: 10.1080/10428194.2022.2098289] [Reference Citation Analysis]
923 Kim A, Gitlin M, Fadli E, Mcgarvey N, Cong Z, Chung KC. Breast, Colorectal, Lung, Prostate, and Cervical Cancer Screening Prevalence in a Large Commercial and Medicare Advantage Plan, 2008–2020. Preventive Medicine Reports 2022;30:102046. [DOI: 10.1016/j.pmedr.2022.102046] [Reference Citation Analysis]
924 Xiong L, Tan J, Feng Y, Wang D, Liu X, Feng Y, Li S. Protein expression profiling identifies a prognostic model for ovarian cancer. BMC Women's Health 2022;22:292. [DOI: 10.1186/s12905-022-01876-x] [Reference Citation Analysis]
925 El-tanani M, Platt-higgins A, Lee Y, Al Khatib AO, Haggag Y, Sutherland M, Zhang S, Aljabali AA, Mishra V, Serrano-aroca Á, Tambuwala MM, Rudland PS. Matrix metalloproteinase 2 is a target of the RAN-GTP pathway and mediates migration, invasion and metastasis in human breast cancer. Life Sciences 2022;310:121046. [DOI: 10.1016/j.lfs.2022.121046] [Reference Citation Analysis]
926 Akgul M, Williamson SR. How New Developments Impact Diagnosis in Existing Renal Neoplasms. Surgical Pathology Clinics 2022;15:695-711. [DOI: 10.1016/j.path.2022.07.005] [Reference Citation Analysis]
927 Garzon S, Grassi T, Mariani A, Kollikonda S, Weaver AL, McGree ME, Petersen IA, Weroha SJ, Glaser GE, Langstraat CL, Amarnath SR, AlHilli MM. Not all stage I and II endometrial cancers are created equal: Recurrence-free survival and cause-specific survival after observation or vaginal brachytherapy alone in all subgroups of early-stage high-intermediate and high-risk endometrial cancer. Gynecol Oncol 2022;167:444-51. [PMID: 36244826 DOI: 10.1016/j.ygyno.2022.10.004] [Reference Citation Analysis]
928 Faisal Hamdi AI, How SH, Islam MK, Lim JCW, Stanslas J. Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant? Expert Rev Anticancer Ther 2022;22:1309-23. [PMID: 36376248 DOI: 10.1080/14737140.2022.2147671] [Reference Citation Analysis]
929 Meng D, Yang S, Yang Y, Zhang L, Cui L. Synergistic chemotherapy and phototherapy based on red blood cell biomimetic nanomaterials. J Control Release 2022;352:146-62. [PMID: 36252749 DOI: 10.1016/j.jconrel.2022.10.019] [Reference Citation Analysis]
930 Wu T, Liao C, Lu W, Chang C, Tsai F, Jiang S, Chen T, Lin KM, Chen L, Chang WW. Identification of distinct slow mode of reversible adaptation of pancreatic ductal adenocarcinoma to the prolonged acidic pH microenvironment. J Exp Clin Cancer Res 2022;41:137. [DOI: 10.1186/s13046-022-02329-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
931 Sogutlu F, Pekerbas M, Biray Avci C. Epigenetic signatures in gastric cancer: current knowledge and future perspectives. Expert Rev Mol Diagn 2022;22:1063-75. [PMID: 36522183 DOI: 10.1080/14737159.2022.2159381] [Reference Citation Analysis]
932 Abdulkarim D, Mattsson F, Lagergren J. Recent incidence trends of oesophago-gastric cancer in Sweden. Acta Oncol 2022;61:1490-8. [PMID: 36594265 DOI: 10.1080/0284186X.2022.2163592] [Reference Citation Analysis]
933 Kubo H, Ohgi K, Ohike N, Tone K, Norose T, Sugiura T, Ashida R, Yamada M, Otsuka S, Uesaka K. Clinical significance of immunocytochemical staining for peritoneal lavage cytology in pancreatic cancer. Surgery 2022;172:1776-81. [PMID: 36371356 DOI: 10.1016/j.surg.2022.09.025] [Reference Citation Analysis]
934 Cherny NI, Parrinello CM, Kwiatkowsky L, Hunnicutt J, Beck T, Schaefer E, Thurow T, Kolodziej M. Feasibility of Large-Scale Implementation of an Electronic Patient-Reported Outcome Remote Monitoring System for Patients on Active Treatment at a Community Cancer Center. JCO Oncol Pract 2022;18:e1918-26. [PMID: 36240475 DOI: 10.1200/OP.22.00180] [Reference Citation Analysis]
935 Li X, Michels BE, Tosun OE, Jung J, Kappes J, Ibing S, Nataraj NB, Sahay S, Schneider M, Wörner A, Becki C, Ishaque N, Feuerbach L, Heßling B, Helm D, Will R, Yarden Y, Müller-decker K, Wiemann S, Körner C. 5’isomiR-183-5p|+2 elicits tumor suppressor activity in a negative feedback loop with E2F1. J Exp Clin Cancer Res 2022;41:190. [DOI: 10.1186/s13046-022-02380-8] [Reference Citation Analysis]
936 Demus T, Lopategui DM, Vieweg J, Masel J, Bhandari A, Nieder AM. Variations in Opioid Use Following Robotic Radical Prostatectomy in South Florida. J Endourol 2022;36:1532-7. [PMID: 35856823 DOI: 10.1089/end.2022.0212] [Reference Citation Analysis]
937 Bera S, Diamond AM. Role of SELENBP1 and SELENOF in prostate cancer bioenergetics. Archives of Biochemistry and Biophysics 2022;732:109451. [DOI: 10.1016/j.abb.2022.109451] [Reference Citation Analysis]
938 Takemoto K, Hayashi T, Hsi RS, Kobatake K, Sekino Y, Kitano H, Ikeda K, Goto K, Hieda K, Sentani K, Kajiwara M, Nishizaka T, Teishima J, Oue N, Hinata N. Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomy. Urol Oncol 2022;40:539.e9-539.e16. [PMID: 36244916 DOI: 10.1016/j.urolonc.2022.08.010] [Reference Citation Analysis]
939 Duan H, Baratto L, Fan RE, Soerensen SJC, Liang T, Chung BI, Thong AEC, Gill H, Kunder C, Stoyanova T, Rusu M, Loening AM, Ghanouni P, Davidzon GA, Moradi F, Sonn GA, Iagaru A. Correlation of (68)Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer. J Nucl Med 2022;63:1829-35. [PMID: 35552245 DOI: 10.2967/jnumed.122.263971] [Reference Citation Analysis]
940 Yu H, Zhang J, Liu J, Pan R, Wang Y, Jin X, Ahmed RZ, Zheng Y. TBBPA rather than its main derivatives enhanced growth of endometrial cancer via p53 ubiquitination. Journal of Environmental Sciences 2022. [DOI: 10.1016/j.jes.2022.12.030] [Reference Citation Analysis]
941 Ma H, Jiang K, Hong Y, Lei Y, Fan Y, Jiang W, Zhao L, Liu J, Yao W, Xu J, He M, Wei M. Screening of an annexin-A2-targeted heptapeptide for pancreatic adenocarcinoma localization. Mol Oncol 2022. [PMID: 36453020 DOI: 10.1002/1878-0261.13352] [Reference Citation Analysis]
942 Abd-rabou AA, Edris AE. Frankincense essential oil nanoemulsion specifically induces lung cancer apoptosis and inhibits survival pathways. Cancer Nano 2022;13. [DOI: 10.1186/s12645-022-00128-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
943 Fan Y, Zhao Z, Wang X, Ai H, Yang C, Luo Y, Jiang X. Radiomics for prediction of response to EGFR-TKI based on metastasis/brain parenchyma (M/BP)-interface. Radiol Med 2022. [PMID: 36284030 DOI: 10.1007/s11547-022-01569-3] [Reference Citation Analysis]
944 Benoit L, Koual M, Tomkiewicz C, Bats AS, Antignac JP, Coumoul X, Barouki R, Cano-Sancho G. Impact of mixtures of persistent organic pollutants on breast cancer aggressiveness. Environ Int 2022;170:107615. [PMID: 36343552 DOI: 10.1016/j.envint.2022.107615] [Reference Citation Analysis]
945 Lee E, Kazerooni EA. Lung Cancer Screening. Semin Respir Crit Care Med 2022;43:839-50. [PMID: 36442474 DOI: 10.1055/s-0042-1757885] [Reference Citation Analysis]
946 Kucukoglu K, Faydali N, Bul D, Nadaroglu H, Sever B, Altıntop MD, Ozturk B, Guzel I. Synthesis, in silico and in vitro evaluation of new 3,5-disubstituted-1,2,4-oxadiazole derivatives as carbonic anhydrase inhibitors and cytotoxic agents. Journal of Molecular Structure 2022. [DOI: 10.1016/j.molstruc.2022.134699] [Reference Citation Analysis]
947 Cohen CM, Wentzensen N, Castle PE, Schiffman M, Zuna R, Arend RC, Clarke MA. Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype. JCO 2022. [DOI: 10.1200/jco.22.01424] [Reference Citation Analysis]
948 chen Z, Wang W, Tang L, Wei C, Wang B, Xiao H, Tao X, Yang J, Yu T, Guan J, Yuan R, Yu X, Hu Z, Wu H, Wang K. EIF2S3 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma.. [DOI: 10.21203/rs.3.rs-2312592/v1] [Reference Citation Analysis]
949 Gong X, Zhu Y, Zhang Q, Qiu X, Lu C, Tong F, Wang Q, Kong W, Zhou H, Liu B, Zhou Y, Du J. Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort. Hum Vaccin Immunother 2022;18:2143154. [PMID: 36412232 DOI: 10.1080/21645515.2022.2143154] [Reference Citation Analysis]
950 Sun YQ, Sun D, Zhang X, Zhang YQ, Lin YS. Radioiodine adjuvant therapy in differentiated thyroid cancer: An update and reconsideration. Front Endocrinol (Lausanne) 2022;13:994288. [PMID: 36531486 DOI: 10.3389/fendo.2022.994288] [Reference Citation Analysis]
951 Liu G, Feng Y, Li J, Deng T, Yin A, Yan L, Zheng M, Xiong Y, Li J, Huang Y, Zhang C, Huang H, Wan T, Huang Q, Lin A, Jiang J, Kong B, Liu J. A novel combination of niraparib and anlotinib in platinum-resistant ovarian cancer: Efficacy and safety results from the phase II, multi-center ANNIE study. EClinicalMedicine 2022;54:101767. [PMID: 36583171 DOI: 10.1016/j.eclinm.2022.101767] [Reference Citation Analysis]
952 Inderjeeth AJ, Topp M, Sanij E, Castro E, Sandhu S. Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer. Cancers (Basel) 2022;14. [PMID: 36497408 DOI: 10.3390/cancers14235922] [Reference Citation Analysis]
953 Gozzetti A, Ciofini S, Simoncelli M, Santoni A, Pacelli P, Raspadori D, Bocchia M. Anti CD38 monoclonal antibodies for multiple myeloma treatment. Hum Vaccin Immunother 2022;18:2052658. [PMID: 35404740 DOI: 10.1080/21645515.2022.2052658] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
954 Oluwasegun A, Ntungwe E, Bunyamin A, Saraiva L, Princiotto S, Rijo P. Celosia trigyna Linn (Cucurbitaceae) Annihilate Human Breast, Colon, and Lung Cancer Cells: Combination of Cheap Template for Anticancer Screening. IJTM 2022;2:574-585. [DOI: 10.3390/ijtm2040043] [Reference Citation Analysis]
955 Trendowski MR, Sample C, Baird T, Sadeghpour A, Moon D, Ruterbusch JJ, Beebe-Dimmer JL, Cooney KA. Germline Variants in DNA Damage Repair Genes and HOXB13 Among Black Patients With Early-Onset Prostate Cancer. JCO Precis Oncol 2022;6:e2200460. [PMID: 36446039 DOI: 10.1200/PO.22.00460] [Reference Citation Analysis]
956 Lu H, Zhou L, Zhang B, Xie Y, Yang H, Wang Z. Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma. Front Med 2022;9. [DOI: 10.3389/fmed.2022.939776] [Reference Citation Analysis]
957 Pilleron S, Withrow D, Nicholson BD, Morris EJ. Age-related differences in colon and rectal cancer survival: An analysis of United States SEER-18 data.. [DOI: 10.1101/2022.11.29.22282871] [Reference Citation Analysis]
958 Zhang WJ, Li S, Yan YZ, Park SS, Mohan A, Chung I, Ahn SK, Kim JR, Ha CS. Dual (pH- and ROS-) Responsive Antibacterial MXene-Based Nanocarrier for Drug Delivery. Int J Mol Sci 2022;23. [PMID: 36499252 DOI: 10.3390/ijms232314925] [Reference Citation Analysis]
959 Wang Y, Chen F, Zhou H, Huang L, Ye J, Liu X, Sheng W, Gao W, Yu H, Wang F. Redox Dyshomeostasis with Dual Stimuli‐Activatable Dihydroartemisinin Nanoparticles to Potentiate Ferroptotic Therapy of Pancreatic Cancer. Small Methods 2022. [DOI: 10.1002/smtd.202200888] [Reference Citation Analysis]
960 Zeng W, Zhu JF, Guo J, Huang GJ, Ai LS, Zeng Y, Liao WJ. m(6)A-modified circFNDC3B inhibits colorectal cancer stemness and metastasis via RNF41-dependent ASB6 degradation. Cell Death Dis 2022;13:1008. [PMID: 36446779 DOI: 10.1038/s41419-022-05451-y] [Reference Citation Analysis]
961 Matthews AH, Pratz KW, Carroll MP. Targeting Menin and CD47 to Address Unmet Needs in Acute Myeloid Leukemia. Cancers (Basel) 2022;14. [PMID: 36497385 DOI: 10.3390/cancers14235906] [Reference Citation Analysis]
962 Watanabe H, Hayashi S, Kondo Y, Matsuyama E, Hayashi N, Ogura T, Shimosegawa M. Quality Control System for Mammographic Breast Positioning Using Deep Learning.. [DOI: 10.21203/rs.3.rs-2288325/v1] [Reference Citation Analysis]
963 Wang Y, Wang C, Zhu Y. CARD9 contributes to ovarian cancer cell proliferation, cycle arrest, and cisplatin sensitivity. BMC Mol Cell Biol 2022;23:49. [PMID: 36443670 DOI: 10.1186/s12860-022-00447-0] [Reference Citation Analysis]
964 Li S, Li W, Ma T, Fu S, Gao X, Qin N, Wu Y, Zhang X, Wang J, Pan Y, Liu Z. Assessing the efficacy of immunotherapy in lung squamous carcinoma using artificial intelligence neural network. Front Immunol 2022;13:1024707. [PMID: 36518765 DOI: 10.3389/fimmu.2022.1024707] [Reference Citation Analysis]
965 Jin Y, Fan S, Jiang W, Zhang J, Yang L, Xiao J, An H, Ren L. Two effective models based on comprehensive lipidomics and metabolomics can distinguish BC versus HCs, and TNBC versus Non-TNBC. Proteomics Clin Appl 2022;:e2200042. [PMID: 36443927 DOI: 10.1002/prca.202200042] [Reference Citation Analysis]
966 Tang X, Lin Y, He J, Luo X, Liang J, Zhu X. Downregulated miRNA-491-3p accelerates colorectal cancer growth by increasing uMtCK expression. PeerJ 2022;10:e14285. [PMID: 36518289 DOI: 10.7717/peerj.14285] [Reference Citation Analysis]
967 Lv J, Jia H, Mo M, Yuan J, Wu Z, Zhang S, Zhe F, Gu B, Fan B, Li C, Zhang T, Zhu J. Changes of serum metabolites levels during neoadjuvant chemoradiation and prediction of the pathological response in locally advanced rectal cancer. Metabolomics 2022;18:99. [PMID: 36441416 DOI: 10.1007/s11306-022-01959-8] [Reference Citation Analysis]
968 Wang H, Wei X, Zhang D, Li W, Hu Y. Lncap-AI prostate cancer cell line establishment by Flutamide and androgen-free environment to promote cell adherent. BMC Mol and Cell Biol 2022;23:51. [DOI: 10.1186/s12860-022-00453-2] [Reference Citation Analysis]
969 Liu K, Zhao H, Alvarez-Maestro M, Gravas S, Van Renterghem K, Zeng G, Ng CF, Laguna P, Teoh JY, De La Rosette J. Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract. Curr Oncol 2022;29:9284-93. [PMID: 36547141 DOI: 10.3390/curroncol29120727] [Reference Citation Analysis]
970 Yi C, He J, Huang D, Zhao Y, Zhang C, Ye X, Huang Y, Nussinov R, Zheng J, Liu M, Lu W. Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia. Cell Death Dis 2022;13:1004. [PMID: 36437247 DOI: 10.1038/s41419-022-05434-z] [Reference Citation Analysis]
971 Kajiwara Y, Tazawa H, Yamada M, Kanaya N, Fushimi T, Kikuchi S, Kuroda S, Ohara T, Noma K, Yoshida R, Umeda Y, Urata Y, Kagawa S, Fujiwara T. Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer. Cancer Immunol Immunother 2022. [DOI: 10.1007/s00262-022-03334-x] [Reference Citation Analysis]
972 Skiba MB, Dieckmann NF, Lyons KS, Winters-stone KM. Associations between perceptions of relationship quality and markers of inflammation and insulin resistance among couples coping with cancer. J Cancer Surviv 2022. [DOI: 10.1007/s11764-022-01299-5] [Reference Citation Analysis]
973 Diong NC, Liu CC, Shih CS, Wu MC, Huang CJ, Hung CF. Is there a role for lung surgery in initially unresectable non-small cell lung cancer after tyrosine kinase inhibitor treatment? World J Surg Oncol 2022;20:370. [PMID: 36434641 DOI: 10.1186/s12957-022-02833-6] [Reference Citation Analysis]
974 Shrestha A, Lahooti B, Mikelis CM, Mattheolabakis G. Chlorotoxin and Lung Cancer: A Targeting Perspective for Drug Delivery. Pharmaceutics 2022;14. [PMID: 36559106 DOI: 10.3390/pharmaceutics14122613] [Reference Citation Analysis]
975 Song G, Zhang Y, Cui Y. Clinicopathological characteristics, treatments, and prognosis of breast ductal carcinoma in situ with microinvasion: A narrative review. Chronic Diseases and Translational Medicine 2022. [DOI: 10.1002/cdt3.53] [Reference Citation Analysis]
976 Luo B, Lin J, Ni A, Cai W, Yu X, Wang M. A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma. Front Oncol 2022;12:927028. [PMID: 36505872 DOI: 10.3389/fonc.2022.927028] [Reference Citation Analysis]
977 Wu H, Guo S, Liu X, Li Y, Su Z, He Q, Liu X, Zhang Z, Yu L, Shi X, Gao S, Wang H, Pan Y, Ma C, Liu R, Dai M, Jin G, Liang Z. Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA. BMC Med 2022;20:458. [PMID: 36434648 DOI: 10.1186/s12916-022-02647-z] [Reference Citation Analysis]
978 Huang Q, Wu L, Wang Y, Kong X, Xiao X, Huang Q, Li M, Zhai Y, Shi F, Zhao R, Zhong J, Xiong L. Caveolin-1-deficient fibroblasts promote migration, invasion, and stemness via activating the TGF-β/Smad signaling pathway in breast cancer cells. Acta Biochim Biophys Sin (Shanghai) 2022;54:1587-98. [PMID: 36604141 DOI: 10.3724/abbs.2022150] [Reference Citation Analysis]
979 Zhao Y, Ren P, Yang Z, Wang L, Hu C. Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis. Oncol Rep 2023;49:16. [PMID: 36453257 DOI: 10.3892/or.2022.8453] [Reference Citation Analysis]
980 Guo F, Wang H. Potential of histone deacetylase inhibitors for the therapy of ovarian cancer. Front Oncol 2022;12:1057186. [PMID: 36505774 DOI: 10.3389/fonc.2022.1057186] [Reference Citation Analysis]
981 Zhuo C, Ruan Q, Zhao X, Shen Y, Lin R. CXCL1 promotes colon cancer progression through activation of NF-κB/P300 signaling pathway. Biol Direct 2022;17:34. [PMID: 36434686 DOI: 10.1186/s13062-022-00348-4] [Reference Citation Analysis]
982 Li K, Wu LL, Wang H, Cheng H, Zhuo HM, Hao Y, Liu ZY, Li CW, Qian JY, Li ZX, Xie D, Chen C. The characterization of tumor microenvironment infiltration and the construction of predictive index based on cuproptosis-related gene in primary lung adenocarcinoma. Front Oncol 2022;12:1011568. [PMID: 36505852 DOI: 10.3389/fonc.2022.1011568] [Reference Citation Analysis]
983 Ren S, Zhu Y, Wang S, Zhang Q, Zhang N, Zou X, Wei C, Wang Z. The pseudogene DUXAP10 contributes to gefitinib resistance in NSCLC by repressing OAS2 expression. Acta Biochim Biophys Sin (Shanghai) 2022;54:1-10. [PMID: 36471952 DOI: 10.3724/abbs.2022176] [Reference Citation Analysis]
984 Wu Y, Guo H, Yue J, Xu P. Serum sPD1 and sPDL1 as Biomarkers for Evaluating the Immune State of Lung Adenocarcinoma Patients. J Immunol Res 2022;2022:9101912. [PMID: 36479137 DOI: 10.1155/2022/9101912] [Reference Citation Analysis]
985 Wu G, Ding X, Quan G, Xiong J, Li Q, Li Z, Wang Y. Hypoxia-Induced miR-210 Promotes Endothelial Cell Permeability and Angiogenesis via Exosomes in Pancreatic Ductal Adenocarcinoma. Biochemistry Research International 2022;2022:1-13. [DOI: 10.1155/2022/7752277] [Reference Citation Analysis]
986 Haney SL, Feng D, Chhonker YS, Varney ML, Williams JT, Smith LM, Ford JB, Murry DJ, Holstein SA. Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma. Drug Development Research 2022. [DOI: 10.1002/ddr.22012] [Reference Citation Analysis]
987 Schmeusser BN, Midenberg E, Palacios AR, Vettikattu N, Patil DH, Medline A, Higgins M, Armas-Phan M, Nabavizadeh R, Joshi SS, Narayan VM, Psutka SP, Ogan K, Bilen MA, Master VA. Clinic friendly estimation of muscle composition: Preoperative linear segmentation shows overall survival correlated with muscle mass in patients with nonmetastatic renal cell carcinoma. Front Oncol 2022;12:1068357. [PMID: 36505878 DOI: 10.3389/fonc.2022.1068357] [Reference Citation Analysis]
988 Kobayashi H, Yamada Y. Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report. J Med Case Rep 2022;16:440. [PMID: 36424618 DOI: 10.1186/s13256-022-03666-3] [Reference Citation Analysis]
989 Singharajkomron N, Yodsurang V, Seephan S, Kungsukool S, Petchjorm S, Maneeganjanasing N, Promboon W, Dangwilailuck W, Pongrakhananon V. Evaluating the Expression and Prognostic Value of Genes Encoding Microtubule-Associated Proteins in Lung Cancer. Int J Mol Sci 2022;23. [PMID: 36499051 DOI: 10.3390/ijms232314724] [Reference Citation Analysis]
990 Bruntha PM, Pandian SIA, Sagayam KM, Bandopadhyay S, Pomplun M, Dang H. Lung_PAYNet: a pyramidal attention based deep learning network for lung nodule segmentation. Sci Rep 2022;12:20330. [PMID: 36434060 DOI: 10.1038/s41598-022-24900-4] [Reference Citation Analysis]
991 Ning L, Lang J, Long B, Wu L. Diagnostic value of circN4BP2L2 in type I and type II epithelial ovarian cancer. BMC Cancer 2022;22:1210. [PMID: 36434559 DOI: 10.1186/s12885-022-10138-w] [Reference Citation Analysis]
992 Li H, Wang F, Huang W. A Novel, Simple, and Low-Cost Approach for Machine Learning Screening of Kidney Cancer: An Eight-Indicator Blood Test Panel with Predictive Value for Early Diagnosis. Curr Oncol 2022;29:9135-49. [PMID: 36547129 DOI: 10.3390/curroncol29120715] [Reference Citation Analysis]
993 Ran X, Yang H, Yu XQ, Lu L, Wang Y, Ji JS, Xu M, Wei W, Li B, Zeng H. Patterns and trends in the cause of death for patients with endometrial cancer. JNCI Cancer Spectr 2023;7. [PMID: 36420983 DOI: 10.1093/jncics/pkac082] [Reference Citation Analysis]
994 Gao H, Cai B, Lu Z, Wang G, Gao Y, Miao Y, Jiang K, Zhang K. Cancer‐testis gene STK31 is regulated by methylation and promotes the development of pancreatic cancer. Cancer Medicine 2022. [DOI: 10.1002/cam4.5472] [Reference Citation Analysis]
995 Liu B, Dong C, Chen Q, Fan Z, Zhang Y, Wu Y, Cui T, Liu F. Circ_0007534 as new emerging target in cancer: Biological functions and molecular interactions. Front Oncol 2022;12:1031802. [PMID: 36505874 DOI: 10.3389/fonc.2022.1031802] [Reference Citation Analysis]
996 Madsen EA, Thorlacius-Ussing J, Nissen NI, Jensen C, Chen IM, Johansen JS, Diab HMH, Jørgensen LN, Hansen CP, Karsdal MA, Willumsen N. Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer. Cells 2022;11. [PMID: 36497023 DOI: 10.3390/cells11233763] [Reference Citation Analysis]
997 Deng Y, Guo K, Tang Z, Feng Y, Cai S, Ye J, Xi Y, Li J, Liu R, Cai C, Tan Z, Zhang Y, Han Z, Zeng G, Zhong W. Identification and experimental validation of a tumor-infiltrating lymphocytes-related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma. Front Immunol 2022;13:1046790. [PMID: 36505457 DOI: 10.3389/fimmu.2022.1046790] [Reference Citation Analysis]
998 Yamazaki M, Hosokawa M, Matsunaga H, Arikawa K, Takamochi K, Suzuki K, Hayashi T, Kambara H, Takeyama H. Integrated spatial analysis of gene mutation and gene expression for understanding tumor diversity in formalin-fixed paraffin-embedded lung adenocarcinoma. Front Oncol 2022;12:936190. [PMID: 36505794 DOI: 10.3389/fonc.2022.936190] [Reference Citation Analysis]
999 Zhao C, Liu S, Gao F, Zou Y, Ren Z, Yu Z. The role of tumor microenvironment reprogramming in primary liver cancer chemotherapy resistance. Front Oncol 2022;12:1008902. [PMID: 36505831 DOI: 10.3389/fonc.2022.1008902] [Reference Citation Analysis]
1000 Marino F, Totaro A, Gandi C, Bientinesi R, Moretto S, Gavi F, Pierconti F, Iacovelli R, Bassi P, Sacco E. Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine. Prostate Cancer Prostatic Dis 2022. [PMID: 36434163 DOI: 10.1038/s41391-022-00609-3] [Reference Citation Analysis]
1001 Tang L, Wang Y, Chen P, Chen M, Jiang L. Clinical use and adjustment of ultrasound elastography for breast lesions followed WFUMB guidelines and recommendations in the real world. Front Oncol 2022;12:1022917. [PMID: 36505783 DOI: 10.3389/fonc.2022.1022917] [Reference Citation Analysis]
1002 Khan R, Vaska M, Ruan Y, Bansal R, Gimpaya N, Scaffidi MA, Brenner D, Leontiadis GI, Grover SC, Forbes N. Interventions to improve the quality of screening-related colonoscopy: protocol for a systematic review and network meta-analysis of randomised controlled trials. BMJ Open 2022;12:e061855. [PMID: 36424103 DOI: 10.1136/bmjopen-2022-061855] [Reference Citation Analysis]
1003 Wu J, Bi Q, Zheng X, Cao H, Hao C, Sun Z, Wang W. STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma. BMC Cancer 2022;22:1204. [PMID: 36424540 DOI: 10.1186/s12885-022-10313-z] [Reference Citation Analysis]
1004 Wang J, Huang D, Yang W, Song Q, Jia Y, Chen P, Cheng Y. The efficacy and safety of Apatinib in the treatment of advanced non-small cell lung cancer: A retrospective trial. Front Oncol 2022;12:1030798. [PMID: 36505785 DOI: 10.3389/fonc.2022.1030798] [Reference Citation Analysis]
1005 Wan H, Lin T, Shan M, Lu J, Guo Z. LINC00491 Facilitates Tumor Progression of Lung Adenocarcinoma via Wnt/β-Catenin-Signaling Pathway by Regulating MTSS1 Ubiquitination. Cells 2022;11. [PMID: 36496997 DOI: 10.3390/cells11233737] [Reference Citation Analysis]
1006 Wang CC, Shen WJ, Anuraga G, Khoa Ta HD, Xuan DTM, Chen ST, Shen CF, Jiang JZ, Sun Z, Wang CY, Wang WJ. Novel Potential Therapeutic Targets of PTPN Families for Lung Cancer. J Pers Med 2022;12. [PMID: 36556168 DOI: 10.3390/jpm12121947] [Reference Citation Analysis]
1007 Li K, Qiu J, Pan J, Pan JP. Pyroptosis and Its Role in Cervical Cancer. Cancers (Basel) 2022;14. [PMID: 36497244 DOI: 10.3390/cancers14235764] [Reference Citation Analysis]
1008 Zhang Y, Han L, Zhang Q, Liu Z, Niu H, Li L, Hu J, Shi X, Ding Z, Qian X. Exploring the expression and the prognosis of mismatch repair protein and PD-L1 in colorectal cancer.. [DOI: 10.21203/rs.3.rs-2287083/v1] [Reference Citation Analysis]
1009 Sponholtz TR, Palmer JR, Rosenberg L, Chen C, Chen Y, Clarke MA, Clendenen T, Du M, Johnson L, Liao LM, Michels KA, O'Connell K, Olson SH, Petruzella S, Rebbeck TR, Setiawan VW, Trabert B, Weiss NS, Wentzensen N, Wilkens L, Wise LA. Risk factors for endometrial cancer in Black women. Cancer Causes Control 2022. [PMID: 36418803 DOI: 10.1007/s10552-022-01653-z] [Reference Citation Analysis]
1010 Kim JK, Wu C, Del Latto M, Gao Y, Choi SH, Kierstead M, Gabriel Sauvé CE, Firat C, Perez AC, Sillanpaa J, Chen CT, Lawrence KE, Paty PB, Barriga FM, Wilkinson JE, Shia J, Sawyers CL, Lowe SW, García-Aguilar J, Romesser PB, Smith JJ. An immunocompetent rectal cancer model to study radiation therapy. Cell Rep Methods 2022;2:100353. [PMID: 36590695 DOI: 10.1016/j.crmeth.2022.100353] [Reference Citation Analysis]
1011 Luo W, Wang Y, Tao Y, Zhang T. Is neoadjuvant chemoradiotherapy for pancreatic cancer beneficial: A systematic review and meta-analysis. Front Oncol 2022;12:979390. [PMID: 36505795 DOI: 10.3389/fonc.2022.979390] [Reference Citation Analysis]
1012 Pan L, Wang B, Chen M, Ma Y, Cui B, Chen Z, Song Y, Hu L, Jiang Z. Lack of SIRP-alpha reduces lung cancer growth in mice by promoting anti-tumour ability of macrophages and neutrophils. Cell Prolif 2023;56:e13361. [PMID: 36419386 DOI: 10.1111/cpr.13361] [Reference Citation Analysis]
1013 Li Q, Pan X, Li X, Huang W. Association of Physical Activity Intensity with All-Cause Mortality in Cancer Survivors: A National Prospective Cohort Study. Cancers (Basel) 2022;14. [PMID: 36497247 DOI: 10.3390/cancers14235760] [Reference Citation Analysis]
1014 Zhao R, Xie C, Gong Y, Wei S, Yuan M, Gan J, Chen W. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/5468858] [Reference Citation Analysis]
1015 Zhang H, Zhang GY, Su WC, Chen YT, Liu YF, Wei D, Zhang YX, Tang QY, Liu YX, Wang SZ, Li WC, Wesselius A, Zeegers MP, Zhang ZY, Gu YH, Tao WA, Yu EY. High Throughput Isolation and Data Independent Acquisition Mass Spectrometry (DIA-MS) of Urinary Extracellular Vesicles to Improve Prostate Cancer Diagnosis. Molecules 2022;27. [PMID: 36500247 DOI: 10.3390/molecules27238155] [Reference Citation Analysis]
1016 Jeong O, Broaddus RR, Lessey BA, Risinger JI, Hunter MI, Kim TH. MIG-6 Is Critical for Progesterone Responsiveness in Human Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer. Int J Mol Sci 2022;23. [PMID: 36498921 DOI: 10.3390/ijms232314596] [Reference Citation Analysis]
1017 Luo L, Li F, Gong B, Xi P, Xie W. A novel prognostic model based on cellular senescence-related gene signature for bladder cancer. Front Oncol 2022;12:937951. [PMID: 36505846 DOI: 10.3389/fonc.2022.937951] [Reference Citation Analysis]
1018 Rojek KO, Ćwiklińska M, Kuczak J, Guzowski J. Microfluidic Formulation of Topological Hydrogels for Microtissue Engineering. Chem Rev 2022;122:16839-909. [PMID: 36108106 DOI: 10.1021/acs.chemrev.1c00798] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
1019 Wang Y, Zhou J, Zhang N, Zhu Y, Zhong Y, Wang Z, Jin H, Wang X. A novel defined PANoptosis-related miRNA signature for predicting prognosis and immune characteristics in Kidney Renal Clear Cell Carcinoma.. [DOI: 10.21203/rs.3.rs-2164940/v2] [Reference Citation Analysis]
1020 Ke Z, Chen S, Chen J, Chen S, You Q, Sun J, Xue Y, Sun X, Wu X, Zheng Q, Wei Y, Xue X, Xu N. Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study. Eur J Nucl Med Mol Imaging 2022. [DOI: 10.1007/s00259-022-06047-6] [Reference Citation Analysis]
1021 Shi Y, Xu H, Raynor WY, Ding J, Lin L, Zhou C, Wang W, Meng Y, Wu X, Chen X, Lv D, Yang H. Efficacy and Failure Patterns of Early SBRT to the Primary Tumor in Advanced EGFR-Mutation-Positive Lung Cancer with EFGR-TKI Treatment: A Prospective, Single Arm, Phase II Study. Life (Basel) 2022;12. [PMID: 36556319 DOI: 10.3390/life12121954] [Reference Citation Analysis]
1022 Khalil MI, De Benedetti A. The TLK1-MK5 Axis Regulates Motility, Invasion, and Metastasis of Prostate Cancer Cells. Cancers (Basel) 2022;14. [PMID: 36497211 DOI: 10.3390/cancers14235728] [Reference Citation Analysis]
1023 Seneviratne C, Shetty AC, Geng X, McCracken C, Cornell J, Mullins K, Jiang F, Stass S. A Pilot Analysis of Circulating cfRNA Transcripts for the Detection of Lung Cancer. Diagnostics (Basel) 2022;12. [PMID: 36552904 DOI: 10.3390/diagnostics12122897] [Reference Citation Analysis]
1024 Chen M, Liu J, Liang X, Huang Y, Yang Z, Lu P, Shen J, Shi K, Qu H. Knockdown of Brachyury Suppresses Breast Cancer Cell Proliferation and Migration via Targeting E2F3. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/7913067] [Reference Citation Analysis]
1025 Heiduk M, Plesca I, Glück J, Müller L, Digomann D, Reiche C, von Renesse J, Decker R, Kahlert C, Sommer U, Aust DE, Schmitz M, Weitz J, Seifert L, Seifert AM. Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer. JCI Insight 2022;7:e152761. [PMID: 36509285 DOI: 10.1172/jci.insight.152761] [Reference Citation Analysis]
1026 Lv M, Li X, Tian W, Yang H, Zhou B. ADGRD1 as a Potential Prognostic and Immunological Biomarker in Non-Small-Cell Lung Cancer. BioMed Research International 2022;2022:1-17. [DOI: 10.1155/2022/5699892] [Reference Citation Analysis]
1027 Delgadillo R, Spieler BO, Deana AM, Ford JC, Kwon D, Yang F, Studenski MT, Padgett KR, Abramowitz MC, Dal Pra A, Stoyanova R, Dogan N. Cone-beam CT delta-radiomics to predict genitourinary toxicities and international prostate symptom of prostate cancer patients: a pilot study. Sci Rep 2022;12:20136. [PMID: 36418901 DOI: 10.1038/s41598-022-24435-8] [Reference Citation Analysis]
1028 Su Y, Zeng K, Liu S, Wu Y, Wang C, Wang S, Lin L, Zou R, Sun G, Luan R, Zhou B, Bai Y, Niu J, Zhang Y, Zhao Y. Ubiquitin-specific peptidase 14 maintains estrogen receptor α stability via its deubiquitination activity in endometrial cancer. J Biol Chem 2023;299:102734. [PMID: 36423684 DOI: 10.1016/j.jbc.2022.102734] [Reference Citation Analysis]
1029 Kaul R, Ossai C, Forkan ARM, Jayaraman PP, Zelcer J, Vaughan S, Wickramasinghe N. The role of AI for developing digital twins in healthcare: The case of cancer care. WIREs Data Min & Knowl 2022. [DOI: 10.1002/widm.1480] [Reference Citation Analysis]
1030 Wei W, Jia G, Wu Z, Wang T, Wang H, Wei K, Cheng C, Liu Z, Zuo C. A multidomain fusion model of radiomics and deep learning to discriminate between PDAC and AIP based on (18)F-FDG PET/CT images. Jpn J Radiol 2022;:1-11. [PMID: 36409398 DOI: 10.1007/s11604-022-01363-1] [Reference Citation Analysis]
1031 Yoshimura T, Suzuki H, Takayama H, Higashi S, Hirano Y, Tezuka M, Ishida T, Ishihata K, Amitani M, Amitani H, Nishi Y, Nakamura Y, Imamura Y, Nozoe E, Inui A, Nakamura N. Prognostic value of inflammatory biomarkers in aged patients with oral squamous cell carcinoma. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.996757] [Reference Citation Analysis]
1032 Rašková M, Lacina L, Kejík Z, Venhauerová A, Skaličková M, Kolář M, Jakubek M, Rosel D, Smetana K Jr, Brábek J. The Role of IL-6 in Cancer Cell Invasiveness and Metastasis-Overview and Therapeutic Opportunities. Cells 2022;11. [PMID: 36429126 DOI: 10.3390/cells11223698] [Reference Citation Analysis]
1033 Orlov AV, Burenin AG, Skirda AM, Nikitin PI. Kinetic Analysis of Prostate-Specific Antigen Interaction with Monoclonal Antibodies for Development of a Magnetic Immunoassay Based on Nontransparent Fiber Structures. Molecules 2022;27. [PMID: 36432177 DOI: 10.3390/molecules27228077] [Reference Citation Analysis]
1034 Kim CE, Yoon LS, Michels KB, Tranfield W, Jacobs JP, May FP. The Impact of Prebiotic, Probiotic, and Synbiotic Supplements and Yogurt Consumption on the Risk of Colorectal Neoplasia among Adults: A Systematic Review. Nutrients 2022;14. [PMID: 36432622 DOI: 10.3390/nu14224937] [Reference Citation Analysis]
1035 Rosellini M, Marchetti A, Mollica V, Rizzo A, Santoni M, Massari F. Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma. Nat Rev Urol 2022. [DOI: 10.1038/s41585-022-00676-0] [Reference Citation Analysis]
1036 Wei H, Li Y, Guo Z, Ma X, Li Y, Wei X, Han D, Zhang T, Chen X, Yan C, Zhou J, Pang Q, Wang P, Zhang W. Comparison of dynamic changes in the peripheral CD8(+) T cells function and differentiation in ESCC patients treated with radiotherapy combined with anti-PD-1 antibody or concurrent chemoradiotherapy. Front Immunol 2022;13:1060695. [PMID: 36479110 DOI: 10.3389/fimmu.2022.1060695] [Reference Citation Analysis]
1037 Yin M, Xu X, Han H, Dai J, Sun R, Yang L, Xie J, Wang Y. Preparation of triangular silver nanoparticles and their biological effects in the treatment of ovarian cancer. J Ovarian Res 2022;15:121. [PMID: 36411490 DOI: 10.1186/s13048-022-01056-3] [Reference Citation Analysis]
1038 Zidan ASA, Mosbah HK, Aly AAM, Ibrahim ABM, Mayer P, Saber SH. Synthesis, X-ray structure and anticancer activity evaluation of a binuclear La(III) complex with anthranilic acid. Natural Product Research 2022. [DOI: 10.1080/14786419.2022.2148246] [Reference Citation Analysis]
1039 Younas F, Usman M, Yan WQ. An ensemble framework of deep neural networks for colorectal polyp classification. Multimed Tools Appl 2022. [DOI: 10.1007/s11042-022-14177-0] [Reference Citation Analysis]
1040 Jiang A, Song J, Fang X, Fang Y, Wang Z, Liu B, Wu Z, Qu L, Luo P, Wang L. A novel thinking: DDR axis refines the classification of ccRCC with distinctive prognosis, multi omics landscape and management strategy. Front Public Health 2022;10:1029509. [PMID: 36478716 DOI: 10.3389/fpubh.2022.1029509] [Reference Citation Analysis]
1041 Tang L, Wang T, Zhang Q, Yu S, Li W, Yao S, Cheng H. Safety and Efficacy of Treatment with/without Ramucirumab in Advanced or Metastatic Cancer: A Meta-Analysis of 11 Global, Double-Blind, Phase 3 Randomized Controlled Trials. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/2476469] [Reference Citation Analysis]
1042 Kumar V, Yadav CS, Banerjee BD. Xeno-Estrogenic Pesticides and the Risk of Related Human Cancers. J Xenobiot 2022;12:344-55. [PMID: 36412768 DOI: 10.3390/jox12040024] [Reference Citation Analysis]
1043 Wele P, Wu X, Shi H. Sex-Dependent Differences in Colorectal Cancer: With a Focus on Obesity. Cells 2022;11. [PMID: 36429114 DOI: 10.3390/cells11223688] [Reference Citation Analysis]
1044 Xiong Z, Ge Y, Xiao J, Wang Y, Li L, Ma S, Lan L, Liu B, Qin B, Luan Y, Yang C, Ye Z, Wang Z. GAS1RR, an immune-related enhancer RNA, is related to biochemical recurrence-free survival in prostate cancer. Exp Biol Med (Maywood) 2022. [DOI: 10.1177/15353702221131888] [Reference Citation Analysis]
1045 Kim J. Cell Dissemination in Pancreatic Cancer. Cells 2022;11. [PMID: 36429111 DOI: 10.3390/cells11223683] [Reference Citation Analysis]
1046 Gao Y, Shang S, Guo S, Wang X, Zhou H, Sun Y, Gan J, Zhang Y, Li X, Ning S, Zhang Y. AgingBank: a manually curated knowledgebase and high-throughput analysis platform that provides experimentally supported multi-omics data relevant to aging in multiple species. Brief Bioinform 2022;23:bbac438. [PMID: 36239391 DOI: 10.1093/bib/bbac438] [Reference Citation Analysis]
1047 Al-warhi T, Alqahtani LS, Abualnaja M, Beigh S, Abu Ali OA, Elsaid FG, Shati AA, Saleem RM, Maghrabi AHA, Alharthi AA, Alyamani A, Fayad E, Abu Almaaty AH, Zaki I, Hamouda S. Design, Synthesis, and In Vitro Antiproliferative Screening of New Hydrazone Derivatives Containing cis-(4-Chlorostyryl) Amide Moiety. Symmetry 2022;14:2457. [DOI: 10.3390/sym14112457] [Reference Citation Analysis]
1048 Jiang Q, Tan XP, Zhang CH, Li ZY, Li D, Xu Y, Liu YX, Wang L, Ma Z. Non-Coding RNAs of Extracellular Vesicles: Key Players in Organ-Specific Metastasis and Clinical Implications. Cancers (Basel) 2022;14. [PMID: 36428785 DOI: 10.3390/cancers14225693] [Reference Citation Analysis]
1049 Wang X, Pennello G, deSouza NM, Huang EP, Buckler AJ, Barnhart HX, Delfino JG, Raunig DL, Wang L, Guimaraes AR, Hall TJ, Obuchowski NA. Multiparametric Data-driven Imaging Markers: Guidelines for Development, Application and Reporting of Model Outputs in Radiomics. Acad Radiol 2023;30:215-29. [PMID: 36411153 DOI: 10.1016/j.acra.2022.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1050 Barreto GDA, Cerqueira JC, Reis JHDO, Hodel KVS, Gama LA, Anjos JP, Minafra-rezende CS, Andrade LN, Amaral RG, Pessoa CDÓ, Luciano MCDS, Barbosa JDV, Umsza-guez MA, Machado BAS. Evaluation of the Potential of Brazilian Red Propolis Extracts: An Analysis of the Chemical Composition and Biological Properties. Applied Sciences 2022;12:11741. [DOI: 10.3390/app122211741] [Reference Citation Analysis]
1051 Pallasaho S, Gondane A, Kuivalainen A, Girmay S, Moestue S, Loda M, Itkonen HM. Castration-resistant prostate cancer cells are dependent on the high activity of CDK7. J Cancer Res Clin Oncol 2022. [DOI: 10.1007/s00432-022-04475-3] [Reference Citation Analysis]
1052 Mattoni S, Farolfi A, Formaggio F, Bruno G, Caroli P, Cerci JJ, Eiber M, Fendler WP, Golfieri R, Herrmann K, Matteucci F, Mosconi C, Paolani G, Santoro M, Strigari L, Nanni C, Castellucci P, Fanti S. PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study. Cancers (Basel) 2022;14. [PMID: 36428771 DOI: 10.3390/cancers14225680] [Reference Citation Analysis]
1053 Chang R, Qi S, Wu Y, Song Q, Yue Y, Zhang X, Guan Y, Qian W. Deep multiple instance learning for predicting chemotherapy response in non-small cell lung cancer using pretreatment CT images. Sci Rep 2022;12:19829. [PMID: 36400881 DOI: 10.1038/s41598-022-24278-3] [Reference Citation Analysis]
1054 Wenger A, Carén H. Methylation Profiling in Diffuse Gliomas: Diagnostic Value and Considerations. Cancers (Basel) 2022;14. [PMID: 36428772 DOI: 10.3390/cancers14225679] [Reference Citation Analysis]
1055 Kim H, Kim DH, Song IH, Kim B, Oh SN, Choi JI, Rha SE. Survival Prediction after Curative Resection of Pancreatic Ductal Adenocarcinoma by Imaging-Based Intratumoral Necrosis. Cancers (Basel) 2022;14. [PMID: 36428764 DOI: 10.3390/cancers14225671] [Reference Citation Analysis]
1056 Lee HI, Kang HC, Chie EK. Consolidatory ablative stereotactic body radiation therapy after induction chemotherapy for unresectable pancreatic cancer: A single center experience. Front Oncol 2022;12:974454. [PMID: 36505838 DOI: 10.3389/fonc.2022.974454] [Reference Citation Analysis]
1057 Lee SC, Leung KKC, Chung ACY, Wong ESY, Meehan KL, Chan JYK. Fluid Biomarkers in HPV and Non-HPV Related Oropharyngeal Carcinomas: From Diagnosis and Monitoring to Prognostication-A Systematic Review. Int J Mol Sci 2022;23. [PMID: 36430813 DOI: 10.3390/ijms232214336] [Reference Citation Analysis]
1058 Liu F, Cao B, Zhang H, Zou Q, Liu G, Dong Y, Su D, Ren DL. Exploring the mechanism of Tengli Kangliu Decoction in the prevention and treatment of colorectal cancer precancerous based on network pharmacology. Medicine (Baltimore) 2022;101:e31690. [PMID: 36401413 DOI: 10.1097/MD.0000000000031690] [Reference Citation Analysis]
1059 Suk FM, Wu CY, Chiu WC, Chien CY, Chen TL, Liao YJ. HMGCS2 Mediation of Ketone Levels Affects Sorafenib Treatment Efficacy in Liver Cancer Cells. Molecules 2022;27. [PMID: 36432116 DOI: 10.3390/molecules27228015] [Reference Citation Analysis]
1060 Lin C, Wang Y, Dong Y, Lai S, Wang L, Weng S, Zhang X. N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway. Biol Direct 2022;17:33. [DOI: 10.1186/s13062-022-00347-5] [Reference Citation Analysis]
1061 Boddy AM. The need for evolutionary theory in cancer research. Eur J Epidemiol 2022. [DOI: 10.1007/s10654-022-00936-8] [Reference Citation Analysis]
1062 Zhang H, Ye Q, Chen Z, Zhao C, Wu Q, Ding Y, Shao Q, Zhao Y. A Computationally Constructed lncRNA-Associated Competing Triplet Network in Clear Cell Renal Cell Carcinoma. Disease Markers 2022;2022:1-11. [DOI: 10.1155/2022/8928282] [Reference Citation Analysis]
1063 Chen S, Chen M. Schwann cells promote the migration and invasion of colorectal cancer cells via the activated NF-κB/IL-8 axis in the tumor microenvironment. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1026670] [Reference Citation Analysis]
1064 He C, Yang T, He Y, Guo S, Lin Y, Wu C, Gao L, Liu X, Wu S, Cao B. Relationship between family functioning and self-transcendence in patients with breast cancer: A network analysis. Front Public Health 2022;10:1028860. [PMID: 36466501 DOI: 10.3389/fpubh.2022.1028860] [Reference Citation Analysis]
1065 Chen K, Ren X, Li X, Qi C. Development and validation of ferroptosis-related lncRNA features to improve prognosis prediction in ovarian cancer.. [DOI: 10.21203/rs.3.rs-2274361/v1] [Reference Citation Analysis]
1066 Nishiwada S, Shimura T, Yamamura K, Nakagawa K, Nagai M, Nakamura K, Terai T, Yamada S, Fujii T, Kodera Y, Sho M, Goel A. Clinical significance and functional role of adhesion G-protein-coupled receptors in human pancreatic ductal adenocarcinoma. Br J Cancer 2022. [DOI: 10.1038/s41416-022-02057-1] [Reference Citation Analysis]
1067 Zhang X, Zhang Y, Zhao L, Wang J, Li J, Wang X, Zhang M, Hu X. Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer. Front Immunol 2022;13:1014638. [PMID: 36569935 DOI: 10.3389/fimmu.2022.1014638] [Reference Citation Analysis]
1068 Yin N, Liu Y, Weems C, Shreeder B, Lou Y, Knutson KL, Murray NR, Fields AP. Protein kinase Cι mediates immunosuppression in lung adenocarcinoma. Sci Transl Med 2022;14. [DOI: 10.1126/scitranslmed.abq5931] [Reference Citation Analysis]
1069 Piro G, Carbone C, Agostini A, Esposito A, De Pizzol M, Novelli R, Allegretti M, Aramini A, Caggiano A, Granitto A, De Sanctis F, Ugel S, Corbo V, Martini M, Lawlor RT, Scarpa A, Tortora G. CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer. Br J Cancer 2022. [DOI: 10.1038/s41416-022-02028-6] [Reference Citation Analysis]
1070 Cai Z, Zhuang H, Li X, Liang S, Luo W, Yuan Y, Xu Y, Jin L, Xu G. Sustained release system of paclitaxel based on composite nanofibers for inhibiting renal clear cell carcinoma. J Mater Sci 2022. [DOI: 10.1007/s10853-022-07907-0] [Reference Citation Analysis]
1071 Ling Y, Wang Y, Cao C, Feng L, Zhang B, Li S. Molecular subtypes identified by pyroptosis-related genes are associated with tumor microenvironment cell infiltration in colon cancer. Aging (Albany NY) 2022;14:9020-36. [PMID: 36384889 DOI: 10.18632/aging.204379] [Reference Citation Analysis]
1072 Wu J, Liu Y, Huang H, Zhu M, Zhang X. Identification of a Risk Predictive Signature Based on Genes Associated with Tumor Size and Lymph Node Involvement in Breast Cancer. Genetic Testing and Molecular Biomarkers 2022. [DOI: 10.1089/gtmb.2022.0124] [Reference Citation Analysis]
1073 Shi J, Guo C, Li Y, Ma J. The long noncoding RNA TINCR promotes self-renewal of human liver cancer stem cells through autophagy activation. Cell Death Dis 2022;13:961. [PMID: 36385098 DOI: 10.1038/s41419-022-05424-1] [Reference Citation Analysis]
1074 Zhang T, Xiang Y, Wang H, Yun H, Liu Y, Wang X, Zhang H. Radiomics Combined with Multiple Machine Learning Algorithms in Differentiating Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor: More Hands Produce a Stronger Flame. J Clin Med 2022;11. [PMID: 36431266 DOI: 10.3390/jcm11226789] [Reference Citation Analysis]
1075 Rao Q, Han X, Wei Y, Zhou H, Gong Y, Guan M, Feng X, Lu H, Chen Q. Novel prognostic nomograms in cervical cancer based on analysis of 1075 patients. Cancer Medicine 2022. [DOI: 10.1002/cam4.5335] [Reference Citation Analysis]
1076 Lama N, Kasmi R, Hagerty JR, Stanley RJ, Young R, Miinch J, Nepal J, Nambisan A, Stoecker WV. ChimeraNet: U-Net for Hair Detection in Dermoscopic Skin Lesion Images. J Digit Imaging 2022. [DOI: 10.1007/s10278-022-00740-6] [Reference Citation Analysis]
1077 Bokun J, Popović-Vuković M, Stanić D, Grujičić D, Pekmezović T, Janić D, Paripović L, Ilić V, Pudrlja Slović M, Sarić M, Mišković I, Nidžović B, Gavrilović N, Milinčić M, Nikitović M. Clinical Profile and Outcome of 806 Pediatric Oncology Patients Treated With Radiotherapy at the Serbian National Cancer Center. J Pediatr Hematol Oncol 2022. [PMID: 36730662 DOI: 10.1097/MPH.0000000000002589] [Reference Citation Analysis]
1078 Badheeb M, Abdelrahim A, Esmail A, Umoru G, Abboud K, Al-Najjar E, Rasheed G, Alkhulaifawi M, Abudayyeh A, Abdelrahim M. Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening. Curr Oncol 2022;29:8693-719. [PMID: 36421339 DOI: 10.3390/curroncol29110686] [Reference Citation Analysis]
1079 Shivarov V, Shivarov H, Yordanov A. Seasonality of Deaths Due to Heart Diseases among Cancer Patients. Medicina 2022;58:1651. [DOI: 10.3390/medicina58111651] [Reference Citation Analysis]
1080 Zong H, Zou JQ, Huang JP, Huang ST. Potential role of long noncoding RNA RP5-881L22.5 as a novel biomarker and therapeutic target of colorectal cancer. World J Gastrointest Oncol 2022; 14(11): 2108-2121 [DOI: 10.4251/wjgo.v14.i11.2108] [Reference Citation Analysis]
1081 Yang J, Jin L, Kim HS, Tian F, Yi Z, Bedi K, Ljungman M, Pasca di Magliano M, Crawford H, Shi J. KDM6A Loss Recruits Tumor-Associated Neutrophils and Promotes Neutrophil Extracellular Trap Formation in Pancreatic Cancer. Cancer Res 2022;82:4247-60. [PMID: 36306422 DOI: 10.1158/0008-5472.CAN-22-0968] [Reference Citation Analysis]
1082 Fujishita T, Kojima Y, Kajino-Sakamoto R, Mishiro-Sato E, Shimizu Y, Hosoda W, Yamaguchi R, Taketo MM, Aoki M. The cAMP/PKA/CREB and TGFβ/SMAD4 Pathways Regulate Stemness and Metastatic Potential in Colorectal Cancer Cells. Cancer Res 2022;82:4179-90. [PMID: 36066360 DOI: 10.1158/0008-5472.CAN-22-1369] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1083 Liu T, Zhao H. Long Non-Coding RNAs: A Double-Edged Sword in Renal Cell Carcinoma Carcinogenesis. International J of Pharmacology 2022;18:1537-1549. [DOI: 10.3923/ijp.2022.1537.1549] [Reference Citation Analysis]
1084 Zhang M, Du Y, Zha H, Liu X, Cai M, Chen Z, Chen R, Wang J, Wang S, Zhang J, Li C. Construction and validation of a personalized nomogram of ultrasound for pretreatment prediction of breast cancer patients sensitive to neoadjuvant chemotherapy. BJR 2022. [DOI: 10.1259/bjr.20220626] [Reference Citation Analysis]
1085 Wang L, He W, Shi G, Zhao G, Cen Z, Xu F, Tian W, Zhao X, Mo C. Accuracy of novel urinary biomarker tests in the diagnosis of prostate cancer: A systematic review and network meta-analysis. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1048876] [Reference Citation Analysis]
1086 Fang ZX, Li CL, Wu Z, Hou YY, Wu HT, Liu J. Comprehensive analysis of the potential role and prognostic value of sine oculis homeobox homolog family in colorectal cancer. World J Gastrointest Oncol 2022; 14(11): 2138-2156 [DOI: 10.4251/wjgo.v14.i11.2138] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1087 Salama V, Geng Y, Rigert J, Fuller CD, Moreno AC, Shete S, Reyes-gibby CC. Systematic Review of Genetic Polymorphisms Associated with Acute Pain and Relevant Acute Toxicities Induced by Radiotherapy for Head and Neck Cancer.. [DOI: 10.1101/2022.11.15.22282359] [